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General introduction
Nutrition plays an important role in developing and maintaining a healthy brain. In recent 
years, it has been shown that nutrients such as lipids and polyphenols influence processes 
supporting neuronal health (Cherniack, 2012; Gomez-Pinilla and Nguyen, 2012; Hooijmans 
et al., 2007; Muskiet, 2010; Vauzour, 2013). Current diets are associated with large cultural 
differences in health. For example, the typical Western diet is characterized by a high intake 
of saturated and trans-fatty acids and simple carbohydrates, increasing the risk of obesity and 
cognitive impairment (Davidson et al., 2005; Kanoski and Davidson, 2011). Adversely, it has been 
shown that the Mediterranean diet based on fish, olive oil, but also fruits, nuts, vegetables and 
whole grain leads to a lower risk of cardiovascular disease and contributes to a healthy brain 
(Cherniack, 2012; Estruch et al., 2013; Feart et al., 2009; Gardener et al., 2011; Guasch-Ferre et al., 
2013; Hoevenaar-Blom et al., 2012; Jansen et al., 2013b; Nilsson et al., 2012; Renaud et al., 1995). 
In the 1970s, it was already demonstrated that the traditional Greenland Inuit diet was based 
on whale, seal, fish and wildfowl, which  resulted in lower risk for ischemic heart disease (Bang 
et al., 1971; Bang et al., 1980; Muskiet, 2010). The common factor between these diets is that 
they are high in long-chain polyunsaturated fatty acids and low in saturated fats and refined 
grains. Furthermore, flavonoids, a type of polyphenols, originating from green tea have been 
used in Chinese medicine for thousands of years already (Gomez-Pinilla and Nguyen, 2012). It 
has been shown that epigallocatechin gallate, the main flavonoid in green tea alleviates stress 
and depression (Gomez-Pinilla and Nguyen, 2012). Likewise, flavonoids derived from cocoa and 
berries have demonstrated neuroprotective effects in ageing by supporting neurogenesis and 
cerebral blood flow (Cherniack, 2012; Francis et al., 2006; Vauzour, 2013). These studies suggest 
that nutrients supporting healthy cardiovasculature are also responsible for a healthy brain. 
Conversely, nutrients related to atherosclerosis, such as cholesterol, have also been associated 
with neurodegeneration and cognitive impairment (Hooijmans et al., 2007; Hooijmans et al., 2009; 
Jansen et al., 2012). This implies that the presence of genetic risk factors for Alzheimer’s disease 
(AD), like ApoE4, combined with a high dietary intake of saturated fatty acids or cholesterol may 
result in a synergistic effect and dramatically increase the risk of AD.
In this thesis, we will focus not only on the influence of n-3 PUFA and flavonoids on 
neural development in (healthy) wild type mice, but also on the influence of cholesterol on 
neurodegeneration in ApoE4 and ApoE knockout mice. 
LCPUFA
Long-chain polyunsaturated fatty acids (LCPUFA) are lipids that are mainly derived from diet and 
important in maintaining human health. The dietary intake in western countries has drastically 
changed during the industrial revolution from an omega-3 polyunsaturated fatty acids (n-3 
PUFA) rich diet to an almost n-3 PUFA deficient diet accompanied by a sedentary lifestyle 
(Muskiet, 2010). Concerning fatty acid intake, Western diets have led to an increased intake of 
omega-6 polyunsaturated fatty acids (n-6 PUFA), saturated fatty acids (SFA) and trans fatty acids, 
and a decrease in n-3 PUFA (Muskiet, 2010). Human breast milk also reflects this shift in fatty acid 
composition (Ailhaud et al., 2006; Garcia et al., 2011; Makrides et al., 1996; Storck Lindholm et al., 
2013). LCPUFA play an important role in brain development, especially during the growth spurt in 
the last trimester of pregnancy and the early postnatal period up to 2 years of age (Brenna, 2011; 
Gibson et al., 2011; Innis, 2009). The most abundant LCPUFA in the brain are docosahexaenoic 
acid (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) (Innis, 2009). The fetus obtains fatty acids 
through the placenta from the mother and is therefore depending on the maternal supply. After 
birth, breast milk is the only source of essential fatty acids for breast-fed infants.
Deficiency studies in rodents have demonstrated the importance of n-3 PUFA such as 
DHA, eicosapentaenoic acid (EPA, 20:5n-3), and their precursor α-linolenic acid (ALA, 18:3n-3) 
for brain development and cognitive functioning (Fedorova et al., 2009b; Fedorova and Salem, 
2006; McNamara et al., 2009; Moriguchi and Salem, 2003). Research suggests that a n-3 PUFA 
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deficiency may lead to a variety of neuronal and psychological abnormalities, such as attention-
deficit hyperactivity disorder (ADHD), depression, schizophrenia, autism, and anxiety (Chalon, 
2006; Fedorova et al., 2009b; Fedorova and Salem, 2006; Gustafsson et al., 2010; Lyall et al., 2013; 
Muskiet, 2010; Perera et al., 2012; Yui et al., 2012). N-3 PUFA deficiency in rodents can result in 
hyperactivity, a characteristic underlying these neuropsychiatric disorders (Levant et al., 2004; 
Moriguchi and Salem, 2003; Umezawa et al., 1995). It has been proposed that n-3 PUFA deficiency 
may affect neurotransmission, especially within the dopaminergic and serotonergic systems, 
as a consequence of altered membrane fluidity and related receptor functions (Chalon, 2006; 
Muskiet, 2010). Furthermore, n-3 PUFA are important for the regulation of synaptic plasticity, and 
learning and memory via their involvement in regulating gene expression and retinoid signaling 
pathways (Cao et al., 2009a; Dyall and Michael-Titus, 2008; Dyall et al., 2010; Kitajka et al., 2004; 
Sidhu et al., 2011).
Due to the fact that both ALA and linoleic acid (LA, 18:2n-6; the precursor of n-6 PUFA) 
compete for the same conversion enzymes, delta-5-desaturase and delta-6-desaturase 
respectively (Schmitz and Ecker, 2008; Simopoulos, 2008a), a sufficient dietary intake of n-3 
PUFA is necessary to maintain a healthy LCPUFA status. A high LA intake interferes with the 
desaturation and elongation of ALA and as well with the conversion of ALA via EPA to DHA 
(Simopoulos, 2008a). This imbalance in the n-6/n-3 ratio also results in the production of  the 
n-6 ARA, leading to the formation of more pro-inflammatory eicosanoids, while the n-3 EPA is 
the precursor of anti-inflammatory eicosanoids (Schmitz and Ecker, 2008; Simopoulos, 2011; 
Tassoni et al., 2008). DHA can also interfere with neuroinflammation, as it is the precursor for 
resolvins and neuroprotectins, such as neuroprotectin D1 (NPD1) (Tapiero et al., 2002; Tassoni 
et al., 2008). Resolvins and neuroprotectins are produced in the brain to counteract and resolve 
neuroinflammation, thereby preventing excessive damage from the inflammatory response 
(Tassoni et al., 2008). NPD1 induces signaling for homeostatic maintenance of cellular integrity 
and can inactivate pro-apoptotic and pro-inflammatory signaling (Schmitz and Ecker, 2008). 
Therefore, it has been proposed that a balanced n-6/n-3 ratio is critical for maintaining a healthy 
brain and immune status.
Clinical studies have shown that (perinatal) LCPUFA supplementation may be beneficial 
for healthy neural development in both preterm and full term infants (Birch et al., 2010; Dunstan 
et al., 2008; Fang et al., 2005; Fewtrell et al., 2004; Henriksen et al., 2008; Isaacs et al., 2011; Janssen 
and Kiliaan, 2014; Makrides et al., 2010; Smithers et al., 2011; van Goor et al., 2011b; Westerberg 
et al., 2011; Willatts et al., 2013). Studies in full term infants indicate that pre- and postnatal 
supplementation are able to improve cognition which  correspond with the found importance 
of starting supplementation in the last trimester of gestation in preterm infants (Birch et al., 2010; 
Birch et al., 2007; Birch et al., 2000; Dunstan et al., 2008; Helland et al., 2003b; Hoffman et al., 2003; 
Innis, 2008; Jensen et al., 2005; Judge et al., 2007a, b; Willatts et al., 2013). 
Flavanols
Polyphenols are fruit and plant constituents that are well-known for their antioxidant properties. 
Flavonoids are a class of polyphenols that has been associated with improved cognition (Corcoran 
et al.; Ghosh and Scheepens, 2009; Hollenberg et al., 2009; Rendeiro et al., 2009; Spencer, 2009). 
Studies indicate that flavonoid consumption can beneficially affect normal cognitive function 
and cerebral blood flow in adults (Francis et al., 2006; Sorond et al., 2008; Vauzour, 2012). 
In our study (chapter 4), we focused on flavanols, a group of flavonoids that are present 
in apple and grape seed extract. Flavanols are the most abundant flavonoids in the human diet 
and are mostly provided by fruits (such as apple and grapes), cocoa, tea, wine, nuts, and beans 
(Arola-Arnal et al., 2013). They have the ability to improve health by exerting cardioprotective, 
anti-inflammatory, and antioxidant effects (Arola-Arnal et al., 2013; Vauzour, 2012). Flavanols are 
best known for their antioxidant effects. Due to donation of a hydrogen atom from hydroxyl 
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groups to reactive oxygen species (ROS), phenoxyl radicals arise which can be stabilized by 
reactions with other radicals and stabilized oxygen species (Gomez-Pinilla and Nguyen, 2012). 
After ingestion, the largest portion of dietary flavonoids are metabolized in the small and large 
intestine, in the liver, and in the blood (Rendeiro et al., 2012). They form substrates for phase I 
and II enzymes and are de-glucosylated and further metabolized into glucuronides, sulphates, 
and O-methylated derivatives (Rendeiro et al., 2012). Flavonoids or their metabolites must pass 
the blood-brain barrier (BBB) in order to be able to influence brain health directly. The ability of 
structures to cross the BBB depends on their systemic availability and lipophilicity (Faria et al., 
2014; Rendeiro et al., 2012). As a result, theoretically the O-methylated metabolites would be 
more potent to pass the BBB than sulphates and glucuronides, which has been shown in in vitro 
studies (Rendeiro et al., 2012; Vauzour, 2012; Youdim et al., 2003). 
While the effects of flavonoid supplementation have been studied in normal aging 
and neurodegenerative models, little is known about their influence during development. In 
neurodegeneration, flavonoids have shown to exert neuroprotective properties such as the 
modulation of neuroinflammation and improvement of cognition (Vauzour, 2012). It has been 
shown that flavonoids modulate neuronal signaling pathways involved in synaptic plasticity 
and neurogenesis (Spencer, 2010; Vauzour, 2012). In vivo, flavonoids are able to affect these 
pathways by activation of cyclicAMP-response element binding (CREB) receptors and brain 
derived neurotrophic factor (BDNF), mechanisms that are involved in memory acquisition and 
consolidation (Spencer, 2010). Flavonoids possibly affect neural development, but this has not 
been studied yet. 
Cholesterol & ApoE
A sedentary lifestyle and a high dietary intake of saturated and trans-fatty acids form risk factors 
for a spectrum of diseases, such as cardiovascular disease and neurodegenerative disorders 
(like AD). Risk factors for cardiovascular disease, such as hypertension and atherosclerosis, are 
also associated with cerebrovascular disease. Both hypertension and atherosclerosis cause 
impaired blood flow and blood brain barrier function, hypoperfusion and blood vessel wall 
pathology which may initiate the underlying neurodegenerative processes leading to cognitive 
impairment and ultimately AD (de la Torre, 2004, 2012; Grammas et al., 2002; Kalaria et al., 
2012; Muller et al., 2007; Skoog and Gustafson, 2006). Hypertension can predict both vascular 
dementia and AD already 20 years before onset (Haan and Wallace, 2004; Launer and Hofman, 
2000; Ruitenberg et al., 2001; Skoog and Gustafson, 2006). A genetic risk factor that has been 
associated with both cardiovascular disease and AD is Apolipoprotein E4 (ApoE4) (Tanzi and 
Bertram, 2001). Apolipoprotein E is the most common apolipoprotein in the brain and is involved 
in endocytosis, transport and clearance of lipids, such as cholesterol, playing an essential role in 
lipid metabolism in the brain (Kim et al., 2009). There are 3 alleles known for the APOE gene: ε2, 
ε3, and ε4. While APOEε4 seems to accelerate AD pathogenesis and vasculature, APOEε2 appears 
to have a protective effect (Kim et al., 2009). The most frequent allele is APOEε3, which regulates 
cholesterol transport and clearance in a normal manner (Knouff et al., 1999; Stojakovic et al., 
2004). The APOEε4 allele does not only show a decrease in cholesterol clearance, but in vitro 
studies have also demonstrated a reduction in cholesterol synthesis by astrocytes and neurons 
(Jansen et al., 2009). 
For a long time, two main hypotheses for the development of AD have been supported 
in the scientific community, with on one hand the amyloid hypothesis and on the other hand 
the vascular hypothesis (de la Torre, 2004; de la Torre and Stefano, 2000; Joseph et al., 2001). 
Recently, it has become clear that these hypotheses cannot be as clearly distinguished as 
previously suggested: AD is a multifactorial disease, caused by a combination of risk factors. For 
instance, the presence of APOEε4 (a risk factor for cardiovascular disease and AD) and advanced 
aging may lead to cerebral hypoperfusion. This will result in a neuroglial energy crisis and 
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subsequently white matter lesions causing neurodegeneration and AD. Cerebral hypoperfusion 
also leads to abnormal cleavage of β-amyloid (Aβ) (Kim et al., 2009). This causes Aβ depositioning 
and cerebral amyloid angiopathy (CAA) causing neurodegeneration and AD as well (Klann and 
Dever, 2004). CAA itself again leads to cerebral hypoperfusion which in its turn accelerates the 
process of neurodegeneration.    
Carriers of the APOEε4 allele show high serum cholesterol levels. Cholesterol is absorbed 
from food or synthesized in the liver, intestine or brain.  It is required for the formation of bile acids, 
steroid hormones and membrane synthesis, but excessive levels lead to hypercholesterolemia. 
Cholesterol circulating in the blood is not able to cross the blood brain barrier (BBB). Yet, the 
brain is the organ in the human body that contains the most cholesterol (Jenner et al., 2010). 
In the brain, it is mainly synthesized by astrocytes and especially present in the myelin sheaths 
and membranes of neurons and astrocytes (Donahue and Johanson, 2008). In general, increased 
serum levels of cholesterol (hypercholesterolemia) lead to increased blood levels of low-density 
lipoprotein (LDL) and very low-density lipoprotein (VLDL) (Libby et al., 2013). LDL and VLDL invade 
the endothelium and start accumulating, initiating a state commonly known as atherosclerosis 
(Libby et al., 2013). The damage to the endothelium initiates an inflammatory response and 
monocytes and macrophages start accumulating, while platelets adhere to the affected area 
(Libby et al., 2013). Eventually, this will evolve into a chronic inflammatory state if the cholesterol 
intake is not changed. This situation increases (cerebral) hypoperfusion and ultimately increase 
the risk of cardiovascular disease. Birdsill et al. have demonstrated that decreased cerebral blood 
flow in patients with metabolic syndrome, a collection of cardiovascular risk factors, is associated 
with impaired cognitive functions (Birdsill et al., 2013). Metabolic syndrome is characterized by 
high triglyceride and low HDL cholesterol levels. Furthermore, it has been shown that ApoE4 and 
ApoE knockout mouse models display reduced cerebral blood flow (Zerbi et al., 2014b).
Mouse models expressing human ApoE4 (C57BL/6J background strain with a knock-in 
of the human APOEε4 allele) have shown cognitive impairment and vascular changes (Knouff 
et al., 1999). This homozygous knock-in model has more difficulty clearing serum cholesterol 
from blood vessel membranes and therefore shows impaired vasculature more often (Knouff 
et al., 1999). Furthermore, this model displays an increased risk of developing atherosclerosis. It 
serves as a model for vascular pathology in AD. It was demonstrated that a DHA enriched diet 
can prevent the pathological phenotype in ApoE4 targeted replacement mice (Kariv-Inbal et al., 
2012). APOE deficient mice are used as a model for atherosclerosis (Piedrahita et al., 1992). This 
model will display accumulation of cholesterol in the body, because of its impairment to clear 
cholesterol. Supplementation with a  n-3 fatty acid enriched diet indicated a reduction of the 
increased levels of reactive oxygen species in ApoE-/- mice (Suchy et al., 2009).
15
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Outline thesis
This thesis aims to determine the influence of several nutrients on neural development and 
neurodegeneration. Little is known about the effect of both LCPUFA and flavanols on neural 
development. Therefore, we studied the effect of supplementation starting during gestation and 
lasting throughout life in C57Bl/6J mice. Furthermore, we also studied the effect of a cholesterol 
enhanced diet on neurodegeneration and cognitive impairment in mouse models at risk for 
atherosclerosis and Alzheimer’s disease.
A range of methodologies were applied throughout this thesis to gain a better understanding 
of the role of nutrients on neural development and neurodegeneration. Animals underwent 
cognitive and behavioral tests to study locomotion, sensory motor integration, and spatial 
learning and memory. We used magnetic resonance imaging and spectroscopy (MRI and MRS) 
at 7 and 11.7 Tesla to determine cerebral blood flow (CBF), white and grey matter integrity, and 
brain metabolite levels. Neurohistology was assessed using immunohistochemical stainings for 
synaptic plasticity, neurogenesis, neuroinflammation, and vascular density. Quantitative real-
time PCR (qRT-PCR) was used to study gene expression of inflammatory markers, angiogenesis, 
and synaptic plasticity. 
Chapter 2
In this review, we will focus on the involvement of LCPUFA from genesis to senescence. We will 
cover the stages of neural development, normal aging, and neurodegeneration. In all these 
stages, the role of LCPUFA in the brain will be discussed with emphasis on synaptic plasticity, 
neurogenesis, cognition, and vascular health. 
Chapter 3
The aim of this study was to obtain detailed insights into the mechanisms underlying the 
long-term beneficial effects of n-3 PUFA availability during gestation and throughout life in 
mice. A broad combination of parameters was determined to assess effects on behavior, brain 
structure and function. With behavioral and cognitive tests, changes in cortical and hippocampal 
functionality were studied. Cerebral metabolite status was measured with phosphorus magnetic 
resonance spectroscopy (31P MRS) to assess energy metabolism and neuronal membrane 
turnover, immunohistochemistry evaluated neurogenesis and synaptic plasticity, and qRT-PCR 
was used to study gene expression of inflammatory markers.
Chapter 4
The impact of flavanol availability during gestation and the postnatal period was assessed in mice 
to understand the mechanisms underlying potential long-term beneficial effects throughout 
life. A broad spectrum of parameters was investigated in order to evaluate effects on brain 
structure and function. Changes in cortical and hippocampal functionality were studied with 
behavioral and cognitive tests. Proton magnetic resonance spectroscopy (1H MRS) was used to 
assess brain metabolism, while CBF was measured with arterial spin labeling (ASL), and diffusion 
tensor imaging (DTI) was performed to study brain integrity. Neurogenesis, synaptic plasticity 
and capillary density were evaluated immunohistochemically, and qRT-PCR was used to study 
gene expression of inflammatory markers, synaptic plasticity and angiogenesis.
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Chapter 5
In this study, we hypothesize that ApoE4 and ApoE deficient mice are vulnerable to high-fat diet 
induced neurodegeneration and cognitive impairment. Cognitive tests were performed to study 
(spatial) learning and memory, while neuropathology was evaluated with immunohistochemical 
stainings for neurogenesis, synaptic plasticity, neuroinflammation, and vascular density.
Chapter 6
All study findings presented in this thesis are summarized and discussed in this chapter, and 
we propose suggestions for future experiments to gain a better understanding of the role of 
nutrients on neural development and neurodegeneration.


Chapter 2 
Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the 
influence of LCPUFA on neural development, aging, and neurodegeneration
Carola IF Janssen, Amanda J Kiliaan
Department of Anatomy, Radboud university medical center, Donders Institute for Brain, 
Cognition, and Behaviour
Prog Lipid Res 53 (2014) 1-17
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Abstract 
Many clinical and animal studies demonstrate the importance of long-chain polyunsaturated 
fatty acids (LCPUFA) in neural development and neurodegeneration. This review will focus on 
involvement of LCPUFA from genesis to senescence. The LCPUFA docosahexaenoic acid and 
arachidonic acid are important components of neuronal membranes, while eicosapentaenoic acid, 
docosahexaenoic acid, and arachidonic acid also affect cardiovascular health and inflammation. 
In neural development, LCPUFA deficiency can lead to severe disorders like schizophrenia 
and attention deficit hyperactivity disorder. Perinatal LCPUFA supplementation demonstrated 
beneficial effects in neural development in humans and rodents resulting in improved cognition 
and sensorimotor integration. In normal aging, the effect of LCPUFA on prevention of cognitive 
impairment will be discussed. LCPUFA are important for neuronal membrane integrity and 
function, and also contribute in prevention of brain hypoperfusion. Cerebral perfusion can be 
compromised as result of obesity, cerebrovascular disease, hypertension, or diabetes mellitus 
type 2. Last, we will focus on the role of LCPUFA in most common neurodegenerative diseases 
like  Alzheimer’s disease and Parkinson’s Disease. These disorders are characterized by impaired 
cognition and connectivity and both clinical and animal supplementation studies have shown 
the potential of LCPUFA to decrease neurodegeneration and inflammation. This review shows 
that LCPUFA are essential throughout life.
21
LCPUFA from genesis to senescence
Introduction
Long-chain polyunsaturated fatty acids (LCPUFA) are lipids which are mainly derived from 
diet and important in maintaining human health. With the industrial revolution, the Western 
dietary intake has drastically changed from an omega-3 polyunsaturated fatty acids (n-3 PUFA) 
rich diet to an almost n-3 PUFA deficient diet accompanied by a sedentary lifestyle (Muskiet, 
2010). Regarding fatty acid content, Western dietary intake has shifted to an increase in omega-6 
polyunsaturated fatty acids (n-6 PUFA), saturated fatty acids (SFA) and trans fatty acids, and a 
decrease in n-3 PUFA (Muskiet, 2010).  The current diets are also associated with large cultural 
differences in health. For example, the traditional Greenland Inuit diet was based on whale, seal, 
fish and wildfowl, which was demonstrated to result in lower risk for ischemic heart disease 
(Bang et al., 1971; Bang et al., 1980; Muskiet, 2010). The Mediterranean diet is not only based on 
fish, but also fruits, vegetables and whole grain and it has been shown that it leads to a lower risk 
of cardiovascular disease and contributes to a healthy brain (Estruch et al., 2013; Feart et al., 2009; 
Guasch-Ferre et al., 2013; Hoevenaar-Blom et al., 2012; Jansen et al., 2013b; Nilsson et al., 2012; 
Renaud et al., 1995). The common factor between these diets is that they are low in saturated fats 
and refined grains.
Over the years, the importance of LCPUFA in neural development, aging, and 
neurodegeneration has been shown in both clinical and animal studies (Agostoni, 2008; Belkind-
Gerson et al., 2008; Calon and Cole, 2007; Das, 2008; Freund-Levi et al., 2008; Hooijmans et al., 
2007; Innis, 2008; van Goor et al., 2010). Supplementation with LCPUFA has shown to be beneficial 
in the development of both children and (young) rodents. Several animal studies and studies in 
children revealed an improvement in cognition and motor skills after LCPUFA supplementation 
(Coluccia et al., 2009; Fedorova et al., 2009b; van Goor et al., 2010). On the other hand, LCPUFA 
deficiency can lead to neurodevelopmental disorders such as schizophrenia, ADHD or mood 
disorders (Fedorova et al., 2009a; Mathieu et al., 2011; McNamara et al., 2013a; Richardson, 2006; 
Sethom et al., 2010). LCPUFA have also been shown to be advantageous in neurodegenerative 
disorders. For example, dietary LCPUFA supplementation showed an attenuation of cognitive 
impairment and decreased anxiety in both human and animal studies (Kamphuis et al., 2011; 
Scheltens et al., 2010; Shah, 2011).
In this review, we will focus on the involvement of LCPUFA from genesis to senescence. We 
will cover the stages of neural development, normal aging, and neurodegeneration. In all these 
stages, the role of LCPUFA in the brain will be discussed with emphasis on synaptic plasticity, 
neurogenesis, cognition, and vascular health. 
We searched the PubMed database for original articles published in English from 1995 
until August 31, 2013. The main search topics concerned LCPUFA, influence of LCPUFA in neural 
development of preterm and full term infants, influence of LCPUFA in disorders such as autism, 
attention deficit hyperactivity disorder (ADHD), mild cognitive impairment (MCI), cerebrovascular 
disease, Alzheimer’s disease (AD) and Parkinson’s disease (PD). The search strategy was based 
on the following search terms: LCPUFA, neural development, cognition, autism, ADHD, healthy 
aging, MCI, cerebrovascular disease, AD, PD, filter: clinical trials. Moreover, to identify potentially 
relevant new papers we filtered our total list of relevant papers by hand. Based on the title and 
abstract, we selected the studies. If these two components were not sufficient for selection, we 
evaluated the total publication.
LCPUFA in neural development
During the embryonic phase in humans (until 7 weeks) the structure of the brain is defined, 
while growth during the fetal phase (start at 8 weeks) is characterized by functional development 
(Fitzgerald, 2002; Larsen et al., 2011). At birth, the brain is fully developed but only 25% of its 
definitive volume; postnatally, the brain expands by an increase in glial cells, outgrowth of axons 
and dendrites, and myelination of nerve fibers. This human brain growth spurt starts prenatally 
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in the third trimester of pregnancy (Mostofsky, 2001). At this time, the infant brain starts 
accumulating docosahexaenoic acid (DHA, 22:6n-3) in utero and this continues up to the first 24 
months of neonatal brain growth, although the postnatal DHA accumulation occurs at a slower 
rate (Dagai et al., 2009; Mostofsky, 2001). In this period, neural development is most dependent 
on an adequate supply of LCPUFA. 
LCPUFA are essential nutrients in the development and functioning of brain and visual 
system (Belkind-Gerson et al., 2008; Innis, 2008; Koletzko et al., 2008). The most abundant LCPUFA 
in the brain are DHA which is mainly derived from fish, and arachidonic acid (ARA, 20:4n-6) from 
animal sources like meat and eggs. Linoleic acid (LA, 18:2n-6) is the precursor molecule of ARA 
which is derived from LA by desaturation and elongation of the carbon chain. DHA is derived from 
α-linolenic acid (ALA, 18:3n-3), forming eicosapentaenoic acid (EPA, 20:5n-3) in the process. The 
placental fatty acid composition is dependent on the supply from maternal plasma fatty acids. 
After birth, breast-fed infants are subsequently supplied with n-3 and n-6 fatty acids from breast 
milk, which support the rapid growth and development of the infant brain (Hadders-Algra, 2005; 
Helland et al., 2003b; Hoffman et al., 2009; Innis, 2008).The most important LCPUFA responsible 
for the growth of the brain are DHA and ARA. Aside from inflammation and cardiovascular health, 
LCPUFA are important building blocks of neuronal membranes. The lipid bilayer of neuronal 
membranes consists 
of phospholipids, 
with DHA, ARA, 
and EPA as their 
main components. 
Three compounds 
are important for 
the membrane 
formation as shown 
in the Kennedy cycle 
(Figure 1): a uridine 
source, a fatty acids 
source, and a choline 
source (Kennedy 
and Weiss, 1956; 
Wurtman et al., 2009). 
Other phospholipids 
are also synthesized 
via the Kennedy 
cycle and incorporate 
LCPUFA, such 
as phosphati-
d y l e t h a n o l a m i n e 
(PE) that uses 
e t h a n o l a m i n e 
instead of choline 
(Sastry, 1985). 
Phosphatidylserine 
(PS) exchanges a 
serine molecule 
for choline in 
phosphatidylcholine 
(PC) or ethanolamine 
Figure 1: Formation of neuronal membranes. Schematic overview of the formation of 
neuronal membranes from LCPUFA, also known as the Kennedy pathway (Cansev, 2006; 
Kennedy and Weiss, 1956; Wurtman et al., 2009; Wurtman et al., 2000).
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in PE (Sastry, 1985). 
Humans, like all mammals, can synthesize saturated and monounsaturated fatty acids, 
but they are not able to synthesize the n-3 fatty acid ALA and the n-6 fatty acid LA due to lack 
of the conversion enzyme n-3-desaturase, making ALA and LA essential fatty acids (Simopoulos, 
2008b). Humans are able to convert EPA to DHA, and ARA to all-cis-4,7,10,13,16-docosapentaenoic 
acid (osbond acid), but the conversion rate by the responsible delta-5- and delta-6-desaturase 
is very slow (Rzehak et al., 2009; Xie and Innis, 2008). These n-3 and n-6 PUFA are obtained by 
dietary intake or endogenous conversion of the parent precursors. LA and ALA require the 
same conversion enzymes, which means that there is competitive inhibition between these 2 
substrates. Especially delta-6-desaturase favors the conversion of n-3 fatty acids to that of n-6 
fatty acids (Schmitz and Ecker, 2008; Simopoulos, 2008b). Despite the preference for conversion 
of n-3 PUFA, a high LA intake may shift the balance towards conversion of n-6 PUFA and can 
interfere with the desaturation and elongation of ALA (Gibson et al., 2011). This imbalance can 
also lead to inhibition of the conversion of ALA to DHA, by slowing down the conversion rate of 
ALA into EPA and of EPA into DHA by delta-6-desaturase. The fatty acid desaturase (FADS) 1 and 
FADS2 genes are responsible for the expression of the conversion enzymes delta 5 desaturase 
and delta 6 desaturase making them a rate limiting factor in the LCPUFA conversion (Rzehak et 
al., 2009; Schaeffer et al., 2006; Xie and Innis, 2008). Thus, polymorphisms in these genes are able 
to influence the conversion of LCPUFA.  Some studies suggest that these polymorphisms may 
increase the sensitivity of LCPUFA intervention, which recommend investigation of the genetic 
variation when performing a supplementation study (Schaeffer et al., 2006; Simopoulos, 2010; 
Xie and Innis, 2008).
EPA and ARA are also important during this period for the production of eicosanoids 
(prostaglandins, thromboxanes, leukotrienes) and their involvement in inflammation (Figure 
2). Eicosanoids are lipid mediators that are involved in a wide array of physiological functions, 
some of which are vasoreactivity, platelet aggregation, and inflammation (Schmitz and Ecker, 
2008; Simopoulos, 2011). The eicosanoids derived from LCPUFA exert effects that are involved 
in inflammation, for example the regulation of arrhythmia, platelet activation, vasoreactivity, 
and inflammation, resulting in either enhanced or compromised immunity (Muskiet, 2010; 
Schmitz and Ecker, 2008; Simopoulos, 2011). Prostaglandins, leukotrienes and thromboxanes are 
metabolites that regulate inflammatory mediation and they are metabolized by cyclooxygenase 
(COX) and 5-lipoxygenase (5-LOX) (Tapiero et al., 2002; Tassoni et al., 2008). ARA is the precursor 
for the 2-series of prostaglandins and thromboxanes, and the 4-series of leukotrienes. EPA is a 
precursor for the 3-series of prostaglandins and thromboxanes, and the 5-series of leukotrienes 
and these eicosanoids are less pro-inflammatory (Schmitz and Ecker, 2008). The prostaglandin 
2-series therefore exert pro-arrhythmic effects, while the 3-series shows anti-arrhythmic effects 
and the thromboxane 2-series act as platelet activator and vasoconstrictor, while the 3-series 
performs as a platelet inhibitor and vasodilator. Furthermore, leukotrienes of the 4-series have 
pro-inflammatory effects, while the 5-series exert anti-inflammatory effects. As a result, ARA 
shows typical pro-inflammatory properties opposed to EPA that overall exerts anti-inflammatory 
effects (Schmitz and Ecker, 2008). Furthermore, 5-LOX is responsible for the generation of anti-
inflammatory eicosanoids that are derived from DHA and EPA, the resolvins and neuroprotectins 
(Tapiero et al., 2002; Tassoni et al., 2008). Neuroprotectin D1 (NPD1) induces signaling for 
homeostatic maintenance of cellular integrity, and also has the ability to inactivate pro-apoptotic 
and pro-inflammatory signaling (Schmitz and Ecker, 2008). Besides regulation of inflammation, 
these physiological properties of LCPUFA contribute to cardiovascular health. EPA and DHA have 
the potential to prevent arrhythmia, lower blood pressure, reduce plasma triglycerides, improve 
vasoreactivity, increase plaque stability, reduce platelet aggregation, and decrease inflammation 
(Breslow, 2006; Kris-Etherton et al., 2003; Mozaffarian and Wu, 2012). This will be discussed in 
more detail in the Section on ‘LCPUFA in normal aging’. 
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Several studies in humans 
and rodents have shown that 
an n-3 PUFA deficiency may 
lead to a variety of neuronal 
abnormalities, such as ADHD, 
depression, schizophrenia, 
autism spectrum disorders, and 
anxiety  (Bourre et al., 1984; 
Chalon, 2006; Fedorova et al., 
2009a; Fedorova et al., 2009b; 
Levant et al., 2004; Moriguchi 
and Salem, 2003; Umezawa et 
al., 1995). It is proposed that an 
n-3 PUFA deficiency reduces 
neurotransmission processes, 
especially the dopaminergic and 
serotonergic system, by affecting 
membrane fluidity and related 
receptor functions and thereby 
ultimately affecting brain 
structure and function (Chalon, 
2006; Muskiet, 2010). Studies 
in n-3 PUFA deficient rodents 
indicate that this deficiency 
may result in hyperactivity 
which underlies disorders such 
as ADHD and schizophrenia (Chalon, 2006; Levant et al., 2004; Moriguchi and Salem, 2003; 
Umezawa et al., 1995). ADHD is the most common developmental disorder occurring during 
childhood and has been shown to persist into adulthood (Kooij et al., 2005; Richardson, 2006). 
ADHD often shows comorbidity with behavioral and learning disorders in childhood, while it 
is linked to mood disorders during adulthood (Chalon, 2009; Muskiet, 2010; Richardson, 2006). 
A genetic association has been found between the occurrence of ADHD and disorders such 
as dyslexia, antisocial behavior, mood disorders, and schizophrenia. Studies have also shown 
that environment, in particular nutrition, strongly influences genetic expression (Luchtman and 
Song, 2013; Richardson, 2006). It has been demonstrated that LCPUFA and their metabolites are 
involved in regulating gene expression such as cAMP response element binding protein (CREB), 
which plays an important role in long term potentiation (Cao et al., 2009b; Sidhu et al., 2011). 
But also in the retinoid signaling pathways regulating synaptic plasticity, learning, and memory 
involving the retinoic acid receptor (RAR), retinoid X receptor (RXR), and peroxisome proliferator-
activated receptor (PPAR) (Dyall and Michael-Titus, 2008; Dyall et al., 2010; Kitajka et al., 2004). 
In short, LCPUFA have the ability to influence human health in many different ways. 
DHA, EPA and ARA are important components of neuronal membranes, while DHA and EPA also 
contribute to cardiovascular health, and finally ARA and EPA act as precursors in the production 
of eicosanoids. As mentioned before, ARA (n-6) tends to lead to more pro-inflammatory 
eicosanoids, while EPA (n-3) leads to mostly anti-inflammatory eicosanoids. For this reason, the 
balance between n-3 and n-6 PUFA is critical in maintaining a healthy LCPUFA status and it has 
been suggested that a n-6/n-3 ratio of 1/1 or 2/1 would be the optimal ratio (Simopoulos, 2011). 
A balanced ratio is very important for many bodily and brain functions like in inflammation, 
endocrine and cardiovascular system and (lipid) metabolism (Hjorth and Freund-Levi, 2012; 
Innis, 2008; Simopoulos, 2008b; van Goor et al., 2010; Wall et al., 2010).
Figure 2: Involvement of LCPUFA in inflammation. Schematic overview 
of the involvement of EPA, ARA, and DHA in inflammation.
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Clinical studies 
Table 1A, B and C show an overview of LCPUFA supplementation studies during pregnancy and/
or lactation in pre- and full term infants, and postnatal supplementation in patients that are 
diagnosed with either autism spectrum disorders or ADHD (Table 1A, B and C). 
The influence of LCPUFA in the neural development of preterm infants is being 
studied more and more over the last decade (Table 1A). Only one study investigated prenatal 
supplementation, while most other studies focused on postnatal supplementation (Fang et al., 
2005; Fewtrell et al., 2004; Fewtrell et al., 2002; Henriksen et al., 2008; Isaacs et al., 2011; Makrides 
et al., 2010; O’Connor et al., 2001; Smithers et al., 2010; Smithers et al., 2008; Westerberg et al., 
2011). The results of these studies have been ambiguous, with some studies indicating slight 
beneficial effects (Fang et al., 2005; Henriksen et al., 2008; O’Connor et al., 2001; Smithers et 
al., 2008; Westerberg et al., 2011) and others demonstrating no neurodevelopmental effects 
(Fewtrell et al., 2004; Fewtrell et al., 2002; Isaacs et al., 2011; Makrides et al., 2010; Smithers et al., 
2010) and none showing major adverse effects. Overall, the preterm supplementation studies 
show beneficial effects of the supplementation when the n-6/n-3 ratio is at an optimal balance 
of 1/1 to 2/1. 
The problem with studies on preterm infants is that these infants cannot fully benefit 
from the accumulation of LCPUFA which start in the last trimester of gestation, because of 
their preterm birth. Thus, the nutritional LCPUFA status of preterm infants needs to be optimal 
in order to complement the LCPUFA accumulation. Makrides et al. demonstrated that prenatal 
supplementation did not affect neural development in preterm infants (Table 1A) (Makrides et 
al., 2010). They supplemented preterm infants starting before 21 weeks of gestation until birth 
(Makrides et al., 2010). However, these infants are born in the last trimester of gestation, missing 
the supplementation at a crucial time point. Another issue is that the preterm infants in this study 
were supplemented with n-3 PUFA only (Makrides et al., 2010). It is important in preterm infants 
that they are supplemented with both n-3 and n-6 PUFA. It is also advisable to add the n-6 ARA 
to n-3 PUFA supplements, because n-3 PUFA are known to decrease the plasma concentrations 
of ARA due to the competition for conversion by delta-6 desaturase (Aggett et al., 1991; Carlson, 
1996; Carlson et al., 1991; Carlson et al., 1987; Clandinin et al., 1992; Foreman-van Drongelen et 
al., 1995; Koletzko et al., 1989). 
The postnatal supplementation studies in preterm infants show more beneficial effects 
of LCPUFA than in the prenatal phase (Table 1A). These studies started supplementation at birth 
or directly after birth, a time point that would originally mark the last trimester of gestation 
when DHA accumulation begins. Table 1A shows that in only one cohort the supplementation 
was aborted at the estimated due date (Smithers et al., 2010; Smithers et al., 2008). Smithers et 
al. reported no difference in visual acuity at 2 months, but they did find an improvement at 4 
months of age (Smithers et al., 2008). In the same cohort no differences in language development 
were shown at 26 months, and there was no difference in behavior between 3 and 5 years of age 
(Smithers et al., 2010). In this study only n-3 PUFA was supplemented. As shown in Table 1A, the 
other postnatal supplementation studies continued supplementation ranging from 3 weeks up 
until 12 months (corrected age) with both n-3 and n-6 PUFA (Fang et al., 2005; Fewtrell et al., 2004; 
Fewtrell et al., 2002; Henriksen et al., 2008; Isaacs et al., 2011; O’Connor et al., 2001; Westerberg 
et al., 2011). These studies stress the importance of an optimal n-6/n-3 ratio (1/1 to 2/1). A 9 
months supplementation with a LCPUFA ratio of 1/15 did not affect cognition at 9 months, 18 
months, or 10 years of age (Fewtrell et al., 2004; Isaacs et al., 2011). Studies using a ratio of 1/1 
or 2/1 did show long term improvement of cognitive functions starting already with 9 weeks of 
supplementation (Fang et al., 2005; Henriksen et al., 2008; O’Connor et al., 2001; Westerberg et 
al., 2011). However, Fewtrell et al. used a ”healthy” n-6/n-3 ratio of 1.5/1 but did not find positive 
effects on cognition at 9 or 18 months of age. In this study the duration of supplementation 
was 33 days on average which appears to be too short to establish an effect on cognition. These 
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studies indicate that apart from a balanced n-6/n-3 ratio, the duration of supplementation is 
another key factor contributing to beneficial effects of LCPUFA supplementation.
Numerous studies have been performed investigating the impact of LCPUFA 
supplementation on general and neurological development of full term infants (Table 1B) 
(Auestad et al., 2001; Auestad et al., 2003; Birch et al., 2010; Birch et al., 2007; Birch et al., 2000; 
Bouwstra et al., 2006b; de Jong et al., 2010; Dunstan et al., 2008; Firmansyah et al., 2011; Helland 
et al., 2003b; Hoffman et al., 2003; Horby Jorgensen et al., 1998; Innis and Friesen, 2008; Jensen 
et al., 2005; Judge et al., 2007a, b; Lauritzen et al., 2005; Lucas et al., 1999; Malcolm et al., 2003; 
Pivik et al., 2009; Scott et al., 1998; Smithers et al., 2011; van Goor et al., 2011a; Willatts et al., 2013). 
However, there are only few studies exceeding the age of 18 months (Auestad et al., 2003; Birch et 
al., 2007; Bouwstra et al., 2006b; de Jong et al., 2010; Dunstan et al., 2008; Firmansyah et al., 2011; 
Helland et al., 2003b; Jensen et al., 2005; Willatts et al., 2013). Often, clinical supplementation 
studies show little to no effect of LCPUFA supplementation (Auestad et al., 2001; Auestad et al., 
2003; Bouwstra et al., 2006b; de Jong et al., 2010; Firmansyah et al., 2011; Horby Jorgensen et al., 
1998; Lucas et al., 1999; Malcolm et al., 2003; Pivik et al., 2009; Smithers et al., 2011; van Goor et al., 
2011a) and the few effects found showed just slight improvements in cognition, visual function, 
or motor skills (Birch et al., 2010; Birch et al., 2007; Birch et al., 2000; Dunstan et al., 2008; Helland 
et al., 2003b; Hoffman et al., 2003; Innis and Friesen, 2008; Jensen et al., 2005; Judge et al., 2007a, 
b; Willatts et al., 2013). Two studies reported  decreased language skills at 12 and 14 months 
of age after supplementation with only n-3 PUFA after 4 and 12 months of supplementation 
respectively (Lauritzen et al., 2005; Scott et al., 1998). Table 1B demonstrates the overall finding 
that both pre- and postnatal supplementation are potent in achieving effects on LCPUFA 
supplementation of full term infants. This is in line with the finding in preterm infants that it is 
important to start supplementation in the last trimester of gestation. However, in contrast to 
preterm supplementation where the n-6/n-3 ratio was of importance, full term supplementation 
studies remain inconclusive whether only n-3 PUFA or both n-3 and n-6 PUFA supplementation 
are more suitable. Overall, n-3 PUFA show beneficial effects prenatally, while both n-3 and n-6 
PUFA demonstrate to be favorable during postnatal supplementation (Table 1B). 
Several studies and reviews have made recommendations for a healthy LCPUFA intake 
in preterm and full term infants based on the available data from randomized controlled trials 
(Hadders-Algra, 2011; Koletzko et al., 2001; Lapillonne et al., 2013; Meldrum et al., 2011; Simmer 
et al., 2011). In these studies a DHA intake of 0.35-1% in preterm infants and 0.2-0.32% for full 
term infants is suggested. The advised concentration of ARA is 0.4-0.8% for preterm infants and 
0.35% for full term infants. It should be noted that these concentrations are quite conservative as 
they reflect the average concentrations in maternal milk from Western countries. 
A key factor that one has to keep in mind while interpreting supplementation studies on 
full term infants is that it is plausible that the effect of LCPUFA supplementation is limited in a 
healthy (LCPUFA sufficient) full term cohort. Prenatal supplementation studies have shown to be 
most likely to show beneficial effects, because supplementation already starts at the critical time 
point which is the start of the last trimester of gestation. 
It is difficult to study underlying mechanisms in humans due to limited parameters. In 
infants, the outcomes are limited to non-invasive parameters. It is possible that the tests used 
(mainly Bayley scales of infant development and visual acuity tests) are not sensitive enough 
to measure all effects caused by LCPUFA supplementation (Eilander et al., 2007; Meldrum et al., 
2011). Animal studies have the advantage that they enable invasive techniques and to perform 
histological and biochemical techniques on for example brain tissue, unlike studies on infants. 
Furthermore, animal supplementation studies are less time consuming and long term effects can 
be studied in a broader lifespan. When studying the effect of perinatal supplementation in later 
childhood and beyond in humans, there is a large timeframe that makes the study vulnerable 
to external influences. However, animal studies indicate that it is important to take into account 
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multigenerational influences. In order to reach a model for n-3 PUFA depletion, several studies 
use a multigenerational animal model (Aid et al., 2003; Fedorova et al., 2009b; Moriguchi et al., 
2000). Moriguchi et al. point out stronger effects of n-3 PUFA deficiency when comparing second 
generation to first generation rats (Moriguchi et al., 2000).
Multiple studies have investigated the effect of n-3 PUFA supplementation in 
neurodevelopmental disorders (Table 1C). As mentioned before, it is thought that n-3 PUFA 
deficiency impairs neurotransmission processes, by affecting membrane fluidity and related 
receptor functions (Chalon, 2006; Muskiet, 2010). This suggests that ADHD patients and autism 
spectrum disorders may benefit from LCPUFA supplementation as well. Studies on n-3 PUFA 
supplementation in autism spectrum disorders are scarce and do not show significant results 
due to small sample sizes (Amminger et al., 2007; Bent et al., 2011; Meguid et al., 2008; Politi et 
al., 2008; Yui et al., 2012). However, there are indications that supplementation may be able to 
decrease hyperactivity symptoms (Gillies et al., 2012; James et al., 2011). Table 1C shows that 
studies on n-3 PUFA supplementation as treatment of ADHD remain inconclusive whether 
supplementation can be used as a treatment for ADHD for the same reason (Belanger et al., 
2009; Gustafsson et al., 2010; Hirayama et al., 2004; Johnson et al., 2009; Milte et al., 2012; Perera 
et al., 2012; Raz et al., 2009; Sorgi et al., 2007; Voigt et al., 2001). Gustafsson et al. show some 
improvement in clinical symptoms of ADHD patients, whereas Voigt et al. did not find effects on 
attention and impulsivity (Gustafsson et al., 2010; Voigt et al., 2001). Milte et al. found that the 
improvement in cognition was associated with n-3 PUFA levels in erythrocyte phospholipids and 
suggest that not only the dose of supplementation should be taken into account, but especially 
the erythrocyte n-3 PUFA status of the patient (Milte et al., 2012). They demonstrated that 
patients with an increased erythrocyte n-3 PUFA status were more likely to show improvements 
in cognitive function (Milte et al., 2012). The overall weak points in these studies seem to be the 
small sample size, short duration of supplementation, and short follow-up periods (Gillies et al., 
2012; James et al., 2011). 
All in all, the supplementation studies performed during neural development produce 
inconclusive findings. More research has to be done to elucidate the influence of LCPUFA in 
neural development in health and disease.
LCPUFA in normal aging
LCPUFA concentration in the brain decreases with age in both humans and rodents. In elderly 
subjects, LCPUFA have the potential to act as neuroprotective mediators and intervene in the 
mechanisms resulting in cognitive impairment or inflammation (Cole et al., 2009). DHA, for 
example, has the ability to act as a neurotrophic factor (Wu et al., 2008). It increases the level of 
brain-derived neurotrophic factor (BDNF), which is predominantly synthesized by hippocampal 
neurons. BDNF can act on tyrosine kinase B (Trk B) receptor signaling, resulting in activation of 
synaptic proteins such as synapsin-1 (Wu et al., 2008). This protein may contribute in enhancing 
synaptic plasticity and cognitive function. Synapsin-1 increases the synthesis of synaptic 
membranes leading to elevated levels of phosphatides and specific pre- and postsynaptic 
proteins (Wurtman, 2008). Via this pathway DHA increases the number of dendritic spines and 
possibly synapses on hippocampal neurons, particularly on excitatory glutamatergic synapses 
(Wurtman, 2008). These neurons are involved in learning and memory. Wu et al. have shown a 
synergistic effect of DHA and physical exercise on synaptic plasticity (Wu et al., 2008). Agrawal 
et al. have also demonstrated that an n-3 PUFA deficiency decreased synaptophysin and 
phosphorylation of synapsin-1 (Agrawal and Gomez-Pinilla, 2012). They showed that n-3 PUFA 
supplementation has the ability to normalize this effect, thereby restoring cognitive function 
(Agrawal and Gomez-Pinilla, 2012).
Normal aging is often accompanied by a decline in cognition, marked by decreased 
synaptic density, a decrease in neuronal survival, and loss of both gray and white matter volume 
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(Brown, 2009; Masliah et al., 2006; Masliah et al., 1993; Moretti et al., 2012; Raz et al., 1997; Salat 
et al., 1999; Tisserand et al., 2002). The number of aging individuals experiencing cognitive 
impairment is increasing rapidly worldwide. Age-related cognitive impairment is strongly 
correlated to the development of dementia (van de Rest et al., 2008). Factors contributing to this 
cognitive decline are obesity, cardio- and cerebrovascular disease, hypertension, and diabetes 
mellitus type 2 (DMII). All these factors are risk factors for vascular disorders and dementia as 
well and have in common that they can derive from the metabolic syndrome (MetS) that afflicts 
modern Western society (Singh et al., 2012). These risk factors can derive separately from MetS, 
though they can also act synergistically on each other exerting combined effects. A low n-3 PUFA 
intake and a high intake of n-6 PUFA, saturated fatty acids, or trans fatty acids are also risk factors 
in developing MetS (2003; Agrawal and Gomez-Pinilla, 2012; Singh et al., 2012). This leads to a 
high ratio between ARA and EPA/DHA that activates a pro-inflammatory state resulting in low-
grade inflammation (Muskiet, 2010). 
A sedentary lifestyle is another major risk factor for the development of MetS, besides a 
low n-3 PUFA intake, and is often accompanied by a high cholesterol intake (Singh et al., 2012). 
Cholesterol is absorbed from food or synthesized in the liver, intestine or brain. It is required for 
the formation of bile acids, steroid hormones and membrane synthesis, but excessive levels lead 
to hypercholesterolemia. Cholesterol circulating in the blood is not able to cross the blood brain 
barrier (BBB). Yet, the brain is the organ in the human body that contains the most cholesterol 
(Jenner et al., 2010). It is mainly synthesized by astrocytes and especially present in the myelin 
sheath and membranes of neurons and astrocytes (Donahue and Johanson, 2008). In general, 
increased serum levels of cholesterol (hypercholesterolemia) lead to increased blood levels of 
low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) (Libby et al., 2013). LDL 
and VLDL invade the endothelium and start accumulating, initiating a state commonly known 
as atherosclerosis (Libby et al., 2013). The damage to the endothelium initiates an inflammatory 
response and monocytes and macrophages start accumulating, while platelets adhere to the 
affected area (Libby et al., 2013). Eventually, this will evolve into a chronic inflammatory state if 
the cholesterol intake is not changed. This situation increases hypoperfusion and ultimately the 
risk of cardiovascular disease. 
Important causes of cardiovascular disease are hypertension and atherosclerosis. 
Atherosclerosis is induced by accumulation of cholesterol within the arterial walls, leading to 
plaques and consequently to narrowed arterial lumen and, occasionally, resulting in an acute 
myocardial infarction (AMI) or a cerebral  stroke due to a stenosis, or rupture of a blood vessel 
in case of hemorrhages. Hypertension is thereby also a risk factor for stroke, ischemic white 
matter lesions, silent infarcts, general atherosclerosis, myocardial infarction, and often co-exists 
with other vascular risk factors, such as diabetes mellitus, obesity and hypercholesterolemia. 
Hypertension can predict both vascular dementia and Alzheimer’s disease (AD) already 20 years 
before onset (Haan and Wallace, 2004; Launer and Hofman, 2000; Ruitenberg et al., 2001; Skoog 
and Gustafson, 2006). Atherosclerosis like hypertension, is a process that precedes dementia 
symptoms by many years. Both hypertension and atherosclerosis cause impaired blood flow and 
blood brain barrier function, hypoperfusion and  blood vessel wall pathology which may initiate 
the underlying neurodegenerative processes leading to cognitive impairment and ultimately 
AD (de la Torre, 2012; Grammas et al., 2002; Kalaria et al., 2012; Muller et al., 2007; Skoog and 
Gustafson, 2006). 
As mentioned before, consumption of the n-3 PUFA protects against cardiovascular 
disease (Hu et al., 2002; Kris-Etherton et al., 2003; Thies et al., 2003). These beneficial effects have 
been explained by the capacity to prevent arrhythmias, improving vasoreactivity, decreasing 
blood pressure and inflammation and decreasing atherosclerosis (Calder and Yaqoob, 2010; 
Geleijnse et al., 2002; Goodfellow et al., 2000; Harris et al., 1997; Leaf et al., 2003; Mozaffarian 
and Wu, 2012; von Schacky and Harris, 2007). This was already reported over 30 years ago in 
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1976 when studies on Greenland Inuit suggested that ingestion of n-3 PUFA protects against 
cardiovascular diseases (Bang et al., 1976). The Inuit consumed diets with large quantities 
of the long-chain polyunsaturated fatty acids EPA and DHA present in traditional Inuit food 
of seals, whales, and fish (Dyerberg and Bang, 1979). In other studies it has been found that 
eating fish once a week significantly decreased coronary heart disease mortality rates (He et al., 
2004). Omega-3 fatty acids from fish oil might beneficially influence cardiovascular disease by 
decreasing blood pressure, and atherosclerosis formation (Connor, 2000; Geleijnse et al., 2002; 
Okuda et al., 2005; von Schacky and Harris, 2007). Growing evidence in literature points to the 
benefits of the Mediterranean diet on human health: it has been shown recently that extra-virgin 
olive oil containing diets rich in LCPUFA reduce the risk of  not only cardiovascular disease, but 
also cancer, AD, and PD (Estruch et al., 2013; Sofi et al., 2013). All these findings suggest that 
LCPUFA containing diets resulted in a substantial reduction in the risk of major cardiovascular 
events among high-risk persons and support the benefits of the Mediterranean diet for the 
primary prevention of cardiovascular disease.
Clinical studies
Supplementation studies performed in healthy elderly subjects, and patients with either MCI 
or cerebrovascular disease are very scarce. Table 2 demonstrated that the studies of Yurko-
Mauro et al., Witte et al., and Nilsson et al. are the only ones that show an effect of LCPUFA 
supplementation on cognition in healthy elderly (Nilsson et al., 2012; Witte et al., 2013; Yurko-
Mauro et al., 2010). Yurko-Mauro et al. demonstrated that DHA supplementation during 24 
weeks improved episodic memory in healthy elderly subjects (Yurko-Mauro et al., 2010). Witte et 
al. showed enhanced executive functions in healthy elderly after 26 weeks of supplementation, 
accompanied by improvements in white matter integrity, gray matter volume, and vascular 
parameters (Witte et al., 2013). Nilsson et al. found an improvement in working memory in a 
cross-over study after already 5 weeks of supplementation with n-3 PUFA (Nilsson et al., 2012). 
Stough et al. did not find effects on cognition after DHA supplementation during 90 days, but an 
improvement of visual acuity in elderly subjects with corrected vision was revealed (Stough et 
al., 2012). The studies performed by van de Rest et al. and Dangour et al. failed to show an effect 
of DHA+EPA on cognition in healthy elderly, both on a short (13 or 26 weeks) or long (24 months) 
supplementation period (Table 2) (Dangour et al., 2010; van de Rest et al., 2008). A possible 
explanation may lie in the relatively short duration of supplementation, and in addition starting 
supplementation earlier in life may have a stronger effect. Danthiir et al. describe the trial design 
and methodology of the ongoing study on the influence of n-3 PUFA supplementation in healthy 
elderly (Danthiir et al., 2011). They will supplement a large group of healthy elderly with 1720mg 
DHA and 600mg EPA daily during 18 months. Cognitive performance is assessed every 6 months. 
Other factors, such as dose of administration and mini-mental state examination (MMSE), differ 
between the studies, making it difficult to compare them to each other. In contrast to clinical 
studies on neural development, the clinical studies in normal aging only supplemented the 
subjects with n-3 PUFA. At adult age, ARA is no longer required for growth of the brain and high 
doses will only lead to the formation of pro-inflammatory eicosanoids.
Supplementation of LCPUFA in patients with MCI looks very promising, as (minor) improvements 
in cognition have been shown (Table 2) (Chiu et al., 2008; Lee et al., 2013a; Sinn et al., 2012). There 
are a few studies that have looked into the benefits of n-3 PUFA supplementation in patients with 
a history of cerebrovascular disease (Andreeva et al., 2011; Terano et al., 1999). While Terano et al. 
demonstrated a reduction of depressive symptoms in patients with thrombotic cerebrovascular 
disease, Andreeva et al. found no difference in cognition in patients with a history of cardio- and 
cerebrovascular disease (Andreeva et al., 2011; Terano et al., 1999). 
Overall, duration of supplementation is again essential in setting a proper design for 
these types of studies. In general, the clinical studies performed in healthy elderly and MCI 
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patients indicate that supplementation should persist for at least 6 months. Furthermore, again 
it should be noted that differences in outcomes may occur to large variances in and between 
study populations.
LCPUFA in neurodegeneration
Life expectancy has increased enormously in the last century, from around 50 years to over 
80 due to better medical care and better living conditions.  However, increasing age is also 
the main risk factor for major life-threatening conditions, such as cardiovascular disease 
and neurodegenerative and age-related cognitive disorders. Both cerebrovascular and 
neurodegenerative diseases increase significantly after 60 years of age in almost all populations 
worldwide. Understanding exactly how ageing increases the risk of disease is necessary to fight 
this growing societal problem. The most frequent age related neurodegenerative diseases are 
AD and PD, characterized by the abnormal deposition of insoluble protein aggregates, and 
progressive death of neurons and loss of brain structures, associated with progressive, age-
related decline in neuronal function. 
AD is the most common age related neurodegenerative disorder and is widely recognized 
as the most important cause of dementia, while the second most common form of brain 
degenerative disorder leading to dementia, is caused by cerebrovascular disease. Vascular lesions 
are frequently found to co-exist with AD-type pathologies in older subjects and it is now evident 
that vascular and neurodegenerative lesions intensify each other, accelerating pathological 
mechanisms and increasing the risk that individuals with Alzheimer lesions will exhibit dementia 
(Kalaria, 2010). In agreement with these findings, major risk factors for AD are vascular related risk 
factors like hypertension and atherosclerosis (Wendell et al., 2012; Yarchoan et al., 2012). Future 
preventative interventions should take the proper time-window for intervention into account 
and the multifactorial nature of AD (Qiu, 2012).
A decreased level of plasma DHA is associated with cognitive impairment with aging 
(Conquer et al., 2000; Ikemoto et al., 2001; Kyle et al., 1999). Many animal, epidemiological 
and clinical studies have shown that high DHA consumption is associated with reduced AD 
risk (Bourre, 2007; Freemantle et al., 2006; Green et al., 2007a; Green et al., 2007b; Kiso, 2011; 
Luchtman and Song, 2013; Yurko-Mauro, 2010). In rat, a DHA containing diet enhanced the effects 
of exercise on cognition and BDNF-related synaptic plasticity (Fedorova and Salem, 2006; Wu et 
al., 2008). More recent studies showed that dietary DHA could be protective against β-amyloid 
(Aβ) production, deposition in plaques and cerebral amyloid angiopathy in an aged AD mouse 
model  and increases cerebral blood volume (Hooijmans et al., 2007; Hooijmans et al., 2009). In 
other transgenic AD mouse models DHA also protects against dendritic pathology (Calon et al., 
2004; Cole and Frautschy, 2006).
Both AD patient brain and the 3xTg-AD mouse exhibit reductions in DHA and the DHA derived 
NPD1 (Zhao et al., 2011). As mentioned, it has been shown that NPD1 has anti-inflammatory 
and neuroprotective, but also anti-amyloidogenic bioactivity (Bazan et al., 2011). Large 
multicentre randomized trials should still be executed, because studies performed up until 
now include various populations (for example Mediterranean, Australian, Dutch, and North 
American populations). These geographical differences cause a broad variation of dietary habits 
which may lead to large baseline differences. Many observational studies in elderly indicate 
that development of cognitive decline and dementia can be inhibited via healthy foods and 
dietary supplements (Calon, 2011; Cederholm and Palmblad, 2010; Cole et al., 2009; Jicha and 
Markesbery, 2010; Pauwels et al., 2009; Siegel and Ermilov, 2012). Furthermore, consumption of 
fish is related to lower risk of AD, maybe via inhibition of inflammation and enhancing vascular 
health and countering atherosclerosis (Frisardi et al., 2010; Gu et al., 2010; Scarmeas et al., 2007; 
Scarmeas et al., 2006).
PD is the second most common neurodegenerative disease after AD. It has been 
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estimated that 9 million individuals aged over 50 will have PD worldwide in 2030 (Dorsey et al., 
2007). PD is a complex age related neurodegenerative disorder resulting in movement, balance, 
and fine motor control changes as a consequence of cell death of dopamine-containing neurons 
of the substantia nigra pars compacta (SNpc) (Warner and Schapira, 2003). The dopaminergic 
cell death is induced by oxygen reactive free radicals overproduction and mitochondrial 
dysfunction among other factors. This process can be mimicked by the 1-methyl-4-phenyl-1, 2, 
3, 6-tetrahydropyridine (MPTP) model which affects mitochondria by inhibiting mitochondrial 
complex I or complex III, which induces specifically neuronal cell death in the SNpc (Warner and 
Schapira, 2003).
Currently, the main clinical treatment for PD is dopamine replacement therapy using 
l-dihydroxyphenylalanine (l-DOPA) and/or dopamine receptor agonists (Samii et al., 2004). 
In the early phase of the disease, treatment is generally highly effective, but medication 
becomes increasingly inadequate in controlling motor fluctuations and dyskinesia as the 
disease progresses. Moreover, pharmacotherapy cannot postpone the progression of the loss 
of dopaminergic neurons, and also cannot recover the lost dopaminergic neurons. Deep brain 
stimulation (DBS) is also seen as an alternative treatment suggested earlier in life and not just 
late in life as used nowadays (Desouza et al., 2013; Schupbach et al., 2007; Spieles-Engemann et 
al., 2010). However, still many surgical complications from the DBS procedure are reported such 
as infection, bleeding, stroke, neuropsychiatric adverse effects including depression, aggression, 
apathy, and anxiety (Desouza et al., 2013). Another possible beneficial clinical option for PD 
treatment could be cell transplantation therapy, but development of this therapy is still very 
premature (Nishimura and Takahashi, 2013).
It has been shown that n-3 PUFA have a modulatory effect on BDNF and glial cell-derived 
neurotrophic factor (GDNF) (Tanriover et al., 2010). In line with the positive effect of n-3 PUFA 
on BDNF regulation, is the finding that an ALA deficient diet decreased striatal BDNF content 
in mice (Miyazawa et al., 2010). Moreover, it has recently been shown that BDNF expression 
decreases in n-3 PUFA deficient rats and the upregulation of BDNF and its receptor has been 
recognized as a potential mechanism of action of n-3 PUFA as demonstrated  in MPTP treated 
mice (Bousquet et al., 2009; Rao et al., 2007). Animals with MPTP-induced impaired balance and 
motor coordination showed diminished Parkinsonism symptoms and decreased dopaminergic 
neuronal death when fed a DHA diet (Hacioglu et al., 2012). Furthermore, it has been indicated 
that DHA supplementation may protect dopaminergic neurons in experimental PD models 
by targeting inflammatory signaling pathways and by enhancing the expression of GDNF 
and Neurturin  (member of the same protein family as glial cell-derived neurotrophic factor). 
Both have been shown to benefit the dopaminergic neurons in the substantia nigra which is 
affected in PD (Bousquet et al., 2011; Cardoso et al., 2012; Hacioglu et al., 2012; Ji et al., 2012; 
Ozsoy et al., 2011; Tanriover et al., 2010). DHA supplementation in a nonhuman primate (MPTP) 
model reduces levodopa-induced dyskinesia, suggesting an innovative and safe approach to 
improve the quality of life of PD patients (Mahmoudi et al., 2009). Administration of n-3 PUFA 
could therefore be used as therapeutic strategy against PD via   stimulation of cerebral BDNF 
production, which is supported by the observation of decreased post-mortem levels of BDNF in 
the brains of PD patients, and that neurotrophic factors are not able to cross the BBB (Mori et al., 
1999; Parain et al., 1999).
Higher adherence to the Mediterranean diet consisting of whole grains, fish and olive 
oil and moderate consumption of alcohol is also associated with significant improvement in 
incidence of neurodegenerative disorders.
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Clinical studies
Table 3 shows the LPCUFA supplementation studies that were performed in AD and PD 
patients. Strikingly, these studies show only slight improvement or no effect on cognition after 
supplementation (Boston et al., 2004; Chiu et al., 2008; da Silva et al., 2008; Freund-Levi et al., 2008; 
Freund-Levi et al., 2006; Kotani et al., 2006; Quinn et al., 2010; Scheltens et al., 2012; Yehuda et al., 
1996). Chiu et al. were the only group to show a minor improvement in a clinician’s interview-
based impression of change scale which included caregiver-supplied information (CIBIC-plus). 
Though, no effect on the cognitive subscale of the Alzheimer’s disease assessment scale (ADAS-
cog) could be observed (Chiu et al., 2008). However, this study combined AD patients with 
patients with MCI and the improvement in CIBIC-plus was only found in the combined group. 
The AD patients did not show a difference in ADAS-cog after LCPUFA supplementation (Chiu 
et al., 2008). In a study performed by Freund-Levi et al., 174 AD patients (mean age of 74 years) 
were supplemented daily with 1.7 g DHA and 0.6 g EPA for 12 months, and tested on a number 
of standard cognitive assessments (Table 3) (Freund-Levi et al., 2006). In a subgroup with very 
mild cognitive dysfunction, a significant reduction in the cognitive decline rate was observed 
compared to placebo, suggesting that those with milder cognitive impairment may benefit from 
n-3 PUFA supplementation.
Da Silva et al. were the only group to study supplementation in PD patients and found that 
LCPUFA act as antidepressants in PD patients that were experiencing depression (Table 3) (da 
Silva et al., 2008). Overall, the clinical trials applied relatively short supplementation periods, with 
an exception of the trial performed by Quinn et al. (Quinn et al., 2010). They supplemented mild 
to moderate AD patients with DHA for 18 months, but still did not find an effect on ADAS-cog. 
Two other studies supplementing both DHA and EPA did find slight improvements in cognition 
after only 24 weeks of supplementation (Chiu et al., 2008; Scheltens et al., 2012).   
Studies with transgenic mice and Aβ-infused rats did show improvements in cognition 
after LCPUFA supplementation (Arendash et al., 2007; Arsenault et al., 2011; Calon et al., 
2005; Hashimoto et al., 2006; Hooijmans et al., 2009; Oksman et al., 2006). The duration of 
supplementation in these animal studies is relatively longer compared to the clinical studies. 
This may indicate that the supplementation should start earlier on in clinical studies to obtain 
LCPUFA effects on cognition in AD patients.
Conclusion
The wide range of studies available have shown that LCPUFA are able to influence the brain in 
many ways throughout life (Figure 3). In general, LCPUFA are essential in membrane fluidity and 
their function as inflammatory mediators. They are important at the start of life to support neural 
development and prevent neurodevelopmental disorders, and remain important throughout 
life for membrane fluidity, the prevention of inflammatory states, and cardiovascular health. 
Supplementation studies starting early in life show more potent results than those starting 
during aging or AD. This suggests that it is important to achieve a healthy LCPUFA status early on 
in life and maintain this status throughout life in order to have a beneficial effect. 
The Mediterranean diet fits very well with a healthy LCPUFA status. Not only does it enclose 
a balanced n-6/n-3 ratio, due to the fact that it is rich in fish and lean meat, but it also contains 
other important  nutrients, such as vitamins and antioxidants, originating from fruit, vegetables, 
and whole grains. This in contrast to Western diets that are rich in saturated fats, trans fats, sugar, 
and refined grains. Therefore, implementation of a Mediterranean diet contributes to a healthy 
lifestyle. 
The overall weaknesses in clinical LCPUFA supplementation studies throughout life are 
the relatively short duration of supplementation, variance in populations, and the limitations 
of testing variables. In rodent studies, LCPUFA have shown potential to contribute to a healthy 
life, but in clinical studies they could not yet demonstrate their full potential due to these 
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shortcomings. 
This review shows that LCPUFA have a beneficial effect on health, but the n-6/n-3 ratio is 
most important to establish a healthy and balanced diet. The key message in maintaining this 
healthy LCPUFA status is finding the proper n-6/n-3 balance, with a ratio of about 1/1 – 2/1.
Figure 3: Concluding overview. Schematic overview of findings from clinical studies on LCPUFA 
supplementation in neural development, normal aging, and neurodegeneration. This review has 
shown that there are indications that LCPUFA (mainly a healthy balance n-6/n-3) support and improve 
brain structure and functioning. In neural development there is evidence that LCPUFA might improve 
cognition and visual acuity. Subsequently, LCPUFA are required during the perinatal neuronal (out)
growth when the number of glial cells increase, outgrowth of axons and dendrites takes place, as 
well as the myelination of nerve fibers. During normal aging LCPUFA supplementation may improve 
cognition, decrease (neuro)inflammation, and reduce vascular risk factors. Furthermore, LCPUFA have 
also shown to improve white matter integrity and cerebral blood flow in neurodegeneration.
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Abstract
Maternal intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) is critical during perinatal 
development of the brain. Docosahexaenoic acid (DHA) is the most abundant n-3 PUFA in the 
brain and influences neuronal membrane function and neuroprotection. The present study aims 
to assess the effect of dietary n-3 PUFA availability during the gestational and postnatal period on 
cognition, brain metabolism, and neurohistology in C57BL/6J mice. Female wild type C57BL/6J 
mice at day 0 of gestation were randomly assigned to either an n-3 PUFA deficient diet (0.05% of 
total fatty acids) or an n-3 PUFA adequate diet (3.83% of total fatty acids) containing preformed 
DHA and its precursor α-linolenic acid. Male offspring remained on diet and performed cognitive 
tests during puberty and adulthood. In adulthood, animals underwent 31P MR spectroscopy 
to assess brain energy metabolites. Thereafter, biochemical and immunohistochemical analyses 
were performed assessing inflammation, neurogenesis and synaptic plasticity. Compared to the 
n-3 PUFA deficient group, pubertal n-3 PUFA adequate fed mice demonstrated increased motor 
coordination. Adult n-3 PUFA adequate fed mice exhibited increased exploratory behavior, 
sensorimotor integration, and spatial memory, while neurogenesis in the hippocampus was 
decreased. Selected brain regions of n-3 PUFA adequate fed mice contained significantly lower 
levels of arachidonic acid and higher levels of DHA and dihomo-γ-linolenic acid. Our data 
suggest that dietary n-3 PUFA can modify neural maturation and enhance brain functioning 
in healthy C57BL/6J mice. This indicates that availability of n-3 PUFA in infant diet during early 
development may have a significant impact on brain development.
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Introduction 
Long-chain polyunsaturated fatty acids (LCPUFA) in the human diet are important for maintaining 
health. During evolution in some cultures, LCPUFA dietary intake has changed from an omega-3 
polyunsaturated fatty acids (n-3 PUFA) rich diet to an n-3 PUFA deficient diet (Carlson et al., 2013; 
Muskiet, 2010; Simopoulos, 2011). Within the Western dietary pattern, n-6 PUFA, saturated fatty 
acid (SFA) and trans fatty acids levels have gradually increased, whereas n-3 PUFA levels have 
decreased (Muskiet, 2010). This shift in fatty acid composition is also reflected in human breast 
milk (Ailhaud et al., 2006; Garcia et al., 2011; Makrides et al., 1996; Storck Lindholm et al., 2013). 
LCPUFA play an important role in brain development, especially during the growth spurt 
in the last trimester of pregnancy and the early postnatal period up to 2 years of age (Brenna, 
2011; Gibson et al., 2011; Innis, 2009). Docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid 
(ARA, 20:4n-6) are the most abundant LCPUFA in the brain (Innis, 2009). Placental fatty acids are 
dependent on the maternal supply. After birth, breast milk is the only source of essential fatty 
acids for breast-fed infants.
Deficiency studies in rodents have demonstrated the importance of n-3 PUFA such as 
DHA, eicosapentaenoic acid (EPA, 20:5n-3), and their precursor α-linolenic acid (ALA, 18:3n-3) 
for brain development and cognitive functioning (Fedorova et al., 2009a; Fedorova and Salem, 
2006; McNamara et al., 2009; Moriguchi and Salem, 2003). Research has suggested that an n-3 
PUFA deficiency may lead to a variety of neuronal and psychological abnormalities, such as 
attention-deficit hyperactivity disorder (ADHD), depression, schizophrenia, autism, and anxiety 
(Chalon, 2006; Fedorova et al., 2009a; Fedorova and Salem, 2006; Gustafsson et al., 2010; Lyall et 
al., 2013; Muskiet, 2010; Perera et al., 2012; Yui et al., 2012). N-3 PUFA deficiency in rodents can 
result in hyperactivity, a feature underlying these neuropsychiatric disorders (Levant et al., 2004; 
Moriguchi and Salem, 2003; Umezawa et al., 1995). It has been proposed that n-3 PUFA deficiency 
may affect neurotransmission, especially within the dopaminergic and serotonergic systems, 
as a consequence of altered membrane fluidity and related receptor functions (Chalon, 2006; 
Muskiet, 2010). Furthermore, n-3 PUFA are important for the regulation of synaptic plasticity, and 
learning and memory by their involvement in regulating gene expression and retinoid signaling 
pathways (Cao et al., 2009a; Dyall and Michael-Titus, 2008; Dyall et al., 2010; Kitajka et al., 2004; 
Sidhu et al., 2011).
A sufficient dietary intake of n-3 PUFA is necessary for maintaining a healthy LCPUFA 
status. This is due to the fact that both ALA and linoleic acid (LA, 18:2n-6; the precursor of n-6 
PUFA) compete for the same conversion enzymes, namely delta-5-desaturase and delta-6-
desaturase (Schmitz and Ecker, 2008; Simopoulos, 2008a). A high LA intake interferes with the 
desaturation and elongation of ALA and thereby with the conversion of ALA via EPA to DHA 
(Simopoulos, 2008a). This imbalance in the n-6/n-3 ratio also results in the production of  the n-6 
ARA, leading to the formation of more pro-inflammatory eicosanoids, while the n-3 EPA is the 
precursor of anti-inflammatory eicosanoids (Schmitz and Ecker, 2008; Simopoulos, 2011; Tassoni 
et al., 2008). DHA can also interfere with neuroinflammation, as it is the precursor for resolvins 
and neuroprotectins, such as neuroprotectin D1 (NPD1) (Tapiero et al., 2002; Tassoni et al., 2008). 
NPD1 induces signaling for homeostatic maintenance of cellular integrity and can inactivate 
pro-apoptotic and pro-inflammatory signaling (Schmitz and Ecker, 2008). Therefore, it has been 
proposed that a balanced n-6/n-3 ratio is critical for maintaining a healthy brain and immune 
status.
Clinical studies have shown that (perinatal) LCPUFA supplementation may be beneficial 
for healthy neural development in both preterm and full term infants (Birch et al., 2010; Dunstan 
et al., 2008; Fang et al., 2005; Fewtrell et al., 2004; Henriksen et al., 2008; Isaacs et al., 2011; Janssen 
and Kiliaan, 2014; Makrides et al., 2010; Smithers et al., 2011; van Goor et al., 2011b; Westerberg 
et al., 2011; Willatts et al., 2013). Studies in preterm infants underline the significance of the 
timing of supplementation, because these infants cannot fully benefit from the accumulation 
44
Chapter 3
of LCPUFA starting in the last trimester of gestation. Studies in full term infants show that both 
pre- and postnatal supplementation are able to improve cognition, corresponding with the 
findings in preterm infants that it is important to start supplementation in the last trimester of 
gestation (Birch et al., 2010; Birch et al., 2007; Birch et al., 2000; Dunstan et al., 2008; Helland et 
al., 2003a; Hoffman et al., 2003; Innis and Friesen, 2008; Jensen et al., 2005; Judge et al., 2007a, 
b; Willatts et al., 2013). However, in humans the outcome of infant n-3 PUFA supplementation 
on long-term brain development appears to be subtle (Bouwstra et al., 2006a; Dunstan et al., 
2008; Fewtrell et al., 2002; Firmansyah et al., 2011; Helland et al., 2003a; Hoffman et al., 2003; 
Innis and Friesen, 2008; Jensen et al., 2005; Judge et al., 2007a, b; Lauritzen et al., 2005; Lucas et 
al., 1999; Malcolm et al., 2003; van Goor et al., 2011b; Wurtman, 2008), whereas rodent studies 
have shown more pronounced beneficial effects of n-3 PUFA supplementation (Cao et al., 2009a; 
Carrié et al., 2000b; Coluccia et al., 2009; Fedorova et al., 2009a; Maekawa et al., 2009; Niculescu 
et al., 2011; Wurtman, 2008). This may be explained by the fact that human supplementation 
studies are limited to non-invasive parameters and often encounter difficulties when studying a 
broad lifespan for long-term effects: these studies rarely exceed the infant age. Experiments with 
rodents offer the opportunity to overcome these limitations of human studies, and enable us to 
study the effect of n-3 PUFA availability starting during gestation on brain development in more 
detail throughout life. 
Therefore, the aim of this study was to obtain detailed insights into the mechanisms 
underlying the long-term beneficial effects of n-3 PUFA availability during gestation and 
throughout life in mice. A broad combination of parameters was determined to assess effects on 
behavior, brain structure and function. With behavioral and cognitive tests, changes in cortical 
and hippocampal functionality were studied. Cerebral metabolite status was measured to 
assess energy metabolism and neuronal membrane turnover, immunohistochemistry evaluated 
neurogenesis and synaptic plasticity, and quantitative real-time polymerase chain reaction (qRT-
PCR) was used to study gene expression of inflammatory markers. 
Material and methods
Animals and diets
Mouse C57BL/6J dams (3-4 months old, Harlan Laboratories Inc., Horst, The Netherlands) were 
used for breeding and randomly assigned to either n-3 PUFA deficient (n-3 def; n=10) or n-3 
PUFA adequate (n-3 adq; n=11) diets at the first day of gestation (GD 0). The isocaloric diets were 
based on AIN93m and only differed in n-3 PUFA composition (Table 1) (Fedorova et al., 2009b; 
Greiner et al., 2003; Reeves et al., 1993). As shown in table 1, the n-3 adq diet contained 2.55% ALA 
and 1.28% DHA of total fatty acids, while the n-3 def diet contained 0.05% ALA and 0.00% DHA 
(Research Diets Services, Wijk bij Duurstede, The Netherlands). Diets are comparable to those 
used in other studies so that the results can be easily compared (Fedorova et al., 2009b; Greiner 
et al., 2003; Moriguchi and Salem, 2003). It was demonstrated that n-3 PUFA supplementation 
contributed to increased spatial learning and memory, although the mechanisms involved were 
not elucidated (Fedorova et al., 2009b; Moriguchi and Salem, 2003). Offspring of the dams was 
maintained on the corresponding diet throughout the whole study. To normalize litter sizes, they 
were culled to 3 males and 3 females per dam. Six parallel groups of male offspring were used, 
which were either tested and sacrificed on postnatal day (PND) 30 (n-3 def = 13, n-3 adq = 12) or 
PND 60 (n-3 def = 11, n-3 adq = 12), including cognition and brain biochemistry parameters, or 
used for brain histology at PND 60 (n-3 def = 7, n-3 adq = 9). One male pup from each dam was 
represented in each parallel group for testing and histology (Figure 1). 
Starting from GD 0, the dams were housed individually in Phenotypers (Noldus, 
Wageningen, The Netherlands) and remained there during birth and until weaning of the 
offspring. The male offspring was housed in groups of 3. All mice were housed in the central 
animal facility with temperature controlled at 21 °C, an artificial 12:12h light:dark cycle 
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(lights on at 7:00 am), continuous music playing in the background during the light period, and 
cage enrichment consisting of a plastic shelter and cotton nesting material. Food and water were 
available ad libitum. The experiments were performed according to Dutch federal regulations 
for animal protection and were ethically approved by the Veterinary Authority of the Radboud 
university medical center, Nijmegen, The Netherlands.
Due to some technical problems during the experiments, not all mice could be included for 
statistical analysis for each parameter. For example, some mice were excluded from further 
analysis of phosphorus MR spectroscopy, since the obtained spectra did not meet inclusion 
criteria.
Behavioral and cognitive tests
Dams and pups were monitored in Phenotyper cages for 24 hours per day during PND 0-21 (birth 
until weaning). Combined total activity was measured as well as administration on opening of 
the eyes. Pups were weighed on PND 14, 21, 30, and 60. Behavioral and cognitive tests on the 
male offspring were performed starting at PND 30 (pubertal age) and PND 60 (young adult age) 
(Figure 2). All tests were performed in the same order (open field, rotarod, prepulse inhibition) 
during the light cycle between 8:00 a.m. and 5:00 p.m. The Morris water maze (MWM) was only 
performed at young adult age, after animals had performed the behavioral tests.
Open field
The open field test was performed at PND 30 and PND 60 as a measure for locomotion and 
exploration. The mice were placed individually in a square open field (45 cm × 45 cm × 30 cm) 
with transparent Plexiglas walls. Their activity was recorded for 30 minutes. Locomotion was 
automatically registered with EthoVision XT8.5 (Noldus, Wageningen, The Netherlands), while 
exploration was manually scored. The duration (s) of walking, wall leaning, rearing, sitting, and 
grooming were scored and analyzed as previously described (Hooijmans et al., 2009; Streijger et 
al., 2005).
Figure 1: Schematic overview of the study design. C57BL/6J dams were randomly assigned to n-3 def 
or n-3 adq at GD 0. Offspring was maintained on the corresponding diet throughout the whole study. 
Male littermates were randomly assigned to one out of three parallel groups. One group was tested for 
behavioral and cognitive parameters on PND 30 and subsequently sacrificed for brain biochemistry. 
A parallel group was tested for behavioral and cognitive parameters on PND 60 and subsequently 
underwent 31P MRS and was also sacrificed for brain biochemistry. A third group was used for brain 
histology at PND 60. One male pup from each dam was represented in each parallel group for testing and 
histology. Due to some technical problems during the experiments, not all mice could be included for 
statistical analysis for each parameter.
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 Rotarod
Motor coordination 
was studied using 
the rotarod at PND 
30 and 60. The mice 
were placed on a 
rotating rod (3.18 cm 
in diameter, IITC Inc., 
Woodland Hills, CA, 
United States) and their 
ability to remain on the 
device was recorded 
as latency to fall (s). 
Trials were performed 
at both fixed and 
accelerated speed. All 
trials had a maximum 
duration of 300 s and 
the intertrial interval 
was 20 minutes. First, 
mice were accustomed 
to the task by placing 
them on a stationary drum for a minute followed by a test trial at 10 rpm. Next, the fixed speed 
trials were performed at 10, 15, and 20 rpm. Finally, two trials at accelerating speeds (4-40 rpm) 
followed. 
Prepulse inhibition
The prepulse inhibition test was also performed at PND 30 and 60 to study sensorimotor 
integration as previously described by Streijger et al. (Streijger et al., 2005). Startle reactivity 
was measured in a startle response system, the SR-LAB (San Diego Instruments, San Diego, CA, 
United States). A non-restrictive Plexiglas restrainer (4 cm diameter) on a Plexiglas platform was 
placed inside a ventilated and sound attenuated startle chamber. A high-frequency speaker in 
this chamber produced the various acoustic stimuli and the background noise (set at 70 dB). 
The whole-body startle response of the mouse produced vibrations of the platform, which were 
detected and transduced by a piezoelectric accelerometer mounted underneath the platform, 
which was connected to an automated system.
The testing session started with a 5 minute habituation to the 70 dB background noise. 
Next, three blocks of startle pulses followed. The first block consisted of 5 pulses at 120 dB. 
Subsequently, the mice were presented with 5 blocks that all contained 2 startle pulse alone 
trials (120 dB), 4 prepulse trials, in which 72, 74, 78, or 86 dB startle stimuli are followed by a 
120 dB pulse, and 1 no stimulus trial (70 dB background), in pseudo-randomized order. The last 
block consisted of 5 startle pulse trials at 120 dB again. The (pre)pulses had a duration of 20 ms, 
with a 100 ms interval between the onset of the prepulse and the onset of the pulse. The startle 
response was measured during 50 ms, starting at the onset of the pulse, with an amplitude read-
out expressed in arbitrary units. The intertrial interval range was 10 – 20 s.
MWM
The effect of dietary n-3 PUFA availability on spatial learning and memory was tested using the 
MWM at PND 60.  The young adult mice were placed at different starting positions in a circular 
pool (120 cm diameter) that was filled with water (21-22 °C, made opaque by adding milk 
Figure 2: Time line of the experiment. On GD 0 dams were randomly assigned to n-3 
PUFA adequate or n-3 PUFA deficient diet for the remainder of the experiment. Offspring 
are fed the diets throughout life. Behavioral and cognitive tests on the male offspring 
were performed starting at PND 30 (pubertal age) and PND 60 (young adult age) and 
they were sacrificed for brain biochemistry. Additionally, mice that performed behavior 
and cognition, also underwent 31P MRS before being sacrificed for brain biochemical 
purposes. In a parallel group, brain histology was performed at PND 60.
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powder). The mice were trained to find a submerged platform (8 cm diameter) one centimeter 
below the water surface located in the north-east quadrant of the pool by using distant visual 
cues. The spatial cues were present on the four walls surrounding the pool at a distance of 0.5 m. 
During all trials, the observer was present in the room and always located at the same location 
(behind a curtain surrounding the set-up).
Acquisition phase of MWM
Mice performed 4 acquisition trials (maximal swimming time 120 s; 30 s on platform; intertrial 
interval 60 min) per day during 4 consecutive days. Starting positions were south, north, east, 
and west. All trials were recorded and the latency to find the platform (s) was used as measure 
for spatial learning.
Probe phase
All mice performed a single probe trial on day 5 (1 day after acquisition), in which the platform 
was removed from the pool. They were allowed to swim for 120 s and all trials were recorded and 
analyzed with EthoVision XT8.5 (Noldus, Wageningen, The Netherlands). Time spent searching 
in the target quadrant and the number of platform crossings were used as a measure for spatial 
memory.
31P MRS
At the end of the behavioral testing, the young adult mice underwent phosphorus MR 
spectroscopy (31P MRS) to quantify energy metabolites and phospholipid content in the brain. 
MR measurements were performed on a shielded 7T/300 mm horizontal-bore MR magnet 
Table 1: Composition of experimental diets.
Ingredient Amount (g/100g diet)
n-3 deficient n-3 adequate
Protein: Alacid 710 (vit free casein) 20 20
Carbohydrate: cornstarch 15 15
Sucrose 10 10
Dextrose 19.9 19.9
Maltose-dextrin 15 15
Cellulose 5 5
Salt-mineral mix 3.5 3.5
Vitamin mix 1 1
L-cystine 0.3 0.3
Choline bitartrate 0.25 0.25
TBHQ 0.002 0.002
Fat: Hydrogenated coconut oil 8.1 7.45
Safflower oil 1.9 1.77
Flaxseed oil - 0.48
DHASCO® - 0.3
Fatty acid composition (%):
Total saturated fatty acids 80.8 75.6
Monounsaturated fatty acids 4 4.8
18:2n-6 (LA) 15.1 15.7
18:3n-3 (ALA) 0.05 2.55
20:2n-6 (ARA) 0.05 0.06
22:6n-3 (DHA) - 1.28
n-6/n-3 303 4.1
18:2n-6/18:3n-3 302 6.2
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interfaced to a clinical console (ClinScan, Bruker Biospin, Ettlingen, Germany). A homemade 
probe was designed to fit the mouse head consisting of a ring shaped 31P coil (121.7 MHz) 
for localized 31P MRS and a surface 1H coil (300.4 MHz) for MRI and localized field shimming. 
The coils were positioned with a perpendicular field orientation to avoid coupling. Mice were 
placed in a stereotactic holder to prevent unwanted movement during scanning. They  were 
anaesthetized using 2% isoflurane (Abott, Cham, Switzerland) in a 2:1 O2:N2O mixture and 
body temperature was maintained at about 37 °C with a heated airflow and monitored with a 
rectal optical temperature probe. Respiration of the animal was monitored using a pneumatic 
cushion respiratory monitoring system (Small Animal Instruments Inc, NY, USA). MR images in 
the coronal, transversal, and longitudinal orientation were acquired to visualize the anatomy and 
morphology of the mouse brain. 
Thereafter, first and second order shims were automatically adjusted with FASTMAP from 
a voxel placed over the entire mouse brain (24 x 24 x 24 mm3) (Gruetter, 1993). The 31P spectra 
were acquired using a 3D MRSI sequence with the following parameters: field of view = 24 x 24 x 
24 mm; matrix size= 8 x 8 x 8; voxel size = 3 x 3 x 3 mm3; repetition time (TR) = 1500 ms; BIR-4 45 
degree excitation pulse; acquisition of 2048 data points over spectral width 10000 Hz; averages 
= 192, resulting in a total acquisition time of 1 hour and 52 minutes. The signals of interest 
were: phosphocreatine (PCr), γ- and α- adenosine triphosphate (ATP); inorganic phosphate (Pi); 
phosphomonoesters (PME), and phosphodiesters (PDE).
All spectra were fitted with software package jMRUI 5.0 (http://sermn02.uab.es/mrui/) 
and the metabolites were quantified as ratio compared to the metabolite PCr. For each animal, 
3 to 4 spectra corresponding to voxels inside the brain were selected and their results averaged. 
Immunohistochemistry
Brains were collected at PND 60 from a parallel group of littermates for immunohistochemical 
analysis (see Figure 1). Mice were transcardially perfused with 0.1 M phosphate buffered saline 
(PBS), followed by 4% paraformaldehyde (PF). Next, mice were decapitated and whole brains 
were collected. The brains were post-fixed overnight in 4% PF at 4 °C and thereafter stored in 0.1 
M PBS with 0.01% sodiumazide at 4 °C. Coronal brain sections were cut using a sliding microtome 
(Microm HM 440, Walldorf, Germany) equipped with an object table for freeze sectioning 
at -60 °C gaining 8 series of 30 µm thick sections which were used for immunohistochemical 
purposes (240 μm distance between the sections). The tissue was stained for immature neurons 
(measure for neurogenesis) with antibodies against doublecortin (DCX), for synaptophysin 
immunoreactive presynaptic boutons (SIPBs; measure for synaptic plasticity) with antibodies 
against synaptophysin, and for postsynaptic density (measure for synaptic plasticity) with 
antibodies against postsynaptic density protein 95 (PSD95). 
Immunohistochemistry was performed using standard free-floating labeling procedures, 
using the following protocol. The sections were incubated with the primary antibody overnight 
at room temperature on a shaker table. After incubation, the sections were rinsed three times 
with 0.1 M PBS and incubated with the secondary antibody. After 90 minutes, the sections were 
rinsed three times again and transferred to 0.1 M PBS containing Vector ABC-elite (1:800; Vector 
Laboratories Inc., Burlingame, CA, USA) for another 90 minutes. After rinsing the sections three 
times, visualization of the marker was achieved by incubation with diaminobenzidine-nickel 
(DAB-Ni) solution. Stained sections were mounted on gelatin-coated glass slides, dried overnight 
in a stove at 37 °C, dehydrated in alcohol series, cleared with xylol and mounted in Entellan.
For DCX, polyclonal goat anti-doublecortin (1:4000; Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA) was used as a primary antibody to assess neurogenesis. The secondary 
antibody was donkey anti-goat biotin (1:1500; Jackson ImmunoResearch, West Grove, PA, USA). 
In the synaptophysin staining, we used monoclonal rabbit anti-synaptophysin clone EP1098Y 
(1:10,000; Abcam Inc., Cambridge, UK) as a primary antibody to visualize synaptophysin present 
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in presynaptic boutons. For PSD95, polyclonal rabbit anti-PSD95 (1:2000; Abcam, Cambridge, UK) 
was used as a primary antibody to visualize the postsynaptic density. In both the synaptophysin 
staining and PSD95, the secondary antibody used was donkey anti-rabbit biotin (1:1500; Jackson 
ImmunoResearch, West Grove, PA, USA). 
Stained brain regions were analyzed double blind by 2 independent observers using a 
Zeiss Axioscop microscope equipped with hardware and software of Microbrightfield (Williston, 
VT, USA). Quantified hippocampus regions were based on the mouse brain atlas of Franklin & 
Paxinos (third edition, 2008). 
Quantification doublecortin
DCX positive cells were quantified in three succeeding sections of the hippocampus (-1.70, -2.18 
mm, and -2.46 mm posterior to bregma) for each mouse. Contours were drawn along the borders of 
the hippocampus at 2.5× magnification using the program Stereo Investigator (Microbrightfield, 
Williston, VT, USA). The DCX positive cells in the subgranular zone of the hippocampus were 
manually counted at 40× magnification and the values of the three succeeding sections were 
averaged to obtain a single value for each animal.
Quantification synaptophysin and PSD95
The relevant regions in the hippocampus were digitized using Stereo Investigator. Contours 
of the inner molecular layer (IML), outer molecular layer (OML), stratum radiatum (SR), and 
stratum lucidum (SL) of the hippocampus (-2.18 mm up to -2.46 mm posterior to bregma) were 
drawn at 2.5× magnification. Per region, 2 photographs were taken at 100× magnification. The 
quantification of the staining was performed using the program Image J (National Institute of 
Health, Bethesda, MD, USA). Images were converted to 8-bit gray scale, followed by conversion 
to 16-bit gray scale, next the contrast was enhanced. For synaptophysin, only the SIPBs between 
0.1 μm2 and 4.5 μm2 were considered to be ‘normal’ sized SIPB and included in the analysis 
(Mulder et al., 2007; Rutten et al., 2005). For PSD95, we did not set limits for the particle size.
Biochemistry
Fatty acid analysis
The mice that were tested on behavior on PND 30 and those that were tested on behavior and 
underwent 31P MRS on PND60 were transcardially perfused with 0.1 M PBS. Subsequently, mice 
were decapitated and whole brains were collected and snap frozen in liquid nitrogen. The brains 
were stored at -80 °C up until analysis. The left cerebral hemispheres and erythrocytes collected 
from blood were processed to analyze fatty acid composition at (early) adult age. Brain tissue 
was divided into 4 regions; brain stem, cortex, subcortical region, and cerebellum. Samples 
were kept at -80 C until analysis.  Preparation and analysis of fatty acid methyl esters (FAME) 
Table 2: qRT-PCR primers.
Primers (mouse) Forward Reverse
GAPDH 5’-AGGTCGGTGTGAACGGATTTG-3’ 5’-TGTAGACCATGTAGTTGAGGTCA-3’
IL-1β 5’-GCAACTGTTCCTGAACTCAACT-3’ 5’-ATCTTTTGGGGTCCGTCAACT-3’
IL-6 5’-CAAGTCGGAGGCTTAATTACACATG-3’ 5’-ATTGCCATTGCACAACTCTTTTCT-3’
TNF-α 5’-CAGACCCTCACACTCAGATCATCT-3’ 5’-CCTCCACTTGGTCCTTTGCTA-3’
CD36 5’-ATGGGCTGTGATCGGAACTG-3’ 5’-GTCTTCCCAATAAGCATGTCTCC-3’
MCP-1 5’-CCCAATGAGTAGGCTGGAGA-3’ 5’-TCTGGACCCATTCCTTCTTG-3’
synaptophysin 5’-TCTTTGTCACCGTGGCTGTGTT-3' 5’-TCCCTCAGTTCCTTGCATGTGT-3' 
DCX 5’-GATGTCAACCGGGAAAGCAC-3’ 5’-GTGGAACCACAGCAACTTTTC-3’
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was performed with a one-step homogenation/methylation procedure as described previously 
(Zhou et al., 2008). Briefly, about 50 mg of tissue was treated simultaneously with an aqueous 
and an organic solution that extract, separate and methylate fatty acids. FAME were quantified 
with a 5890 Series II gas chromatograph (Hewlett-Packard, Palo Alto,CA) equipped with a BPX70 
fused silica column (25 m x 0.22 mm i.d. × 0.25 mm film; SGE Inc, Austin,TX). FAME structures 
were positively identified by covalent-adduct chemical ionization tandem mass spectrometry on 
a Saturn 2000 ion trap mass spectrometer (Varian, Inc., Walnut Creek,CA). An equal weight FAME 
mixture was used daily to measure response factors that were applied to the day’s analyses. The 
concentration of the fatty acids is expressed as μg fatty acid per mg wet tissue weight.
qRT-PCR
The cortex of the right hemispheres of the brains collected at PND 30 and 60 were analyzed for 
inflammatory markers and synaptic plasticity with qRT-PCR. The subcortical area of the right 
hemispheres collected at PND 30 and 60 was analyzed for neurogenesis with qRT-PCR. Brain 
tissue was analyzed for interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), cluster of 
differentiation 36 (CD36), and monocyte chemoattractant protein-1 (MCP-1), synaptophysin, 
and DCX.
Brain tissue was collected in 1 ml cold Trizol (Invitrogen, Paisley, UK) and homogenized 
using a dispersing machine (ultra-Turrax, IKA Werke GmbH & Co. KG, Staufen, Germany). After 
chloroform extraction and isopropyl alcohol precipitation, RNA was dissolved in 25 μl RNase-
free diethylpyrocarbonate (DEPC)-treated water. The RNA concentration of the tissue was 
measured with a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific Inc, Wilmington, 
DE, USA). First strand cDNA synthesis was performed using 1 μg RNA dissolved in a 10 μl solution 
containing RNase-free DEPC-treated water, 2 μl 5× iScript reaction mix and 0.5 μl iScript reverse 
transcriptase (iScript cDNA synthesis kit, Bio-Rad Laboratories B.V., Hercules, CA, USA) at 25 °C for 
5 minutes, at 42 °C for 30 minutes and at 85 °C for 5 minutes and cooled down to 4 °C. The cDNA 
samples were stored at -80 °C.
qRT-PCR was performed in a total volume of 10 μl buffer solution containing 2 μl of 
template cDNA (diluted 1:10), 5 μl 2× Power SYBR Green Master mix (Applied Biosystems, 
Foster City, CA, USA), 2.92 μl RNase-free DEPC-treated water and 0.04 μl of each primer (100 
μM). Primers for glyceraldehyde 3-phosphate dehydrogenase (GAPDH), IL-1β, IL-6, TNF-α, CD36, 
MCP-1, synaptophysin, and DCX were designed using Vector Primer Express software (Applied 
Biosystems) (Table 2). The optimal temperature cycling protocol was determined to be 95 °C for 
10 minutes followed by 40 reaction cycles at 90 °C for 15 seconds and at 60 °C for 1 minute, using 
a StepOnePlus real time PCR system (Applied Biosystems, Foster City, CA, USA). Subsequently, 
the melt curve temperature protocol was determined to be 95 °C for 15 seconds, 60 °C for 20 
seconds, and 90 °C for 15 seconds 
with a slope of 0.6 °C. Absolute 
quantities were determined using 
standard curves, and the validity 
of the results was confirmed by 
including appropriate negative 
controls. The quantity of cDNA was 
calculated for each sample with 
StepOne Software version 2.2.2. To 
evaluate differences, relative gene 
expression ratios were calculated 
according to the comparative CT 
method (also referred to as the 
2-ΔCT method) (Schmittgen and 
Figure 3: Locomotion in the open field. Activity (total walking 
distance) was measured over a 30 minute period. *p≤0.05.
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Livak, 2008). Relative CT values were calculated by subtracting the CT value of the housekeeping 
gene GAPDH from the CT values of IL-1β, IL-6, CD36, MCP-1, TNF-α, synaptophysin, and DCX. For 
each primer, two independent qRT-PCR runs were performed, and the means of their relative 
values were used for statistical analysis.
Statistical analyses
Data are expressed as mean ± SEM and were analyzed with SPSS for Windows 20.0 software 
(SPSS Inc., Chicago, IL, USA). The 
repeated measures ANOVA was 
used for the open field parameters 
(with the repeated measure: 10 
minute intervals), the first and 
last block of pulse-alone trials in 
the prepulse inhibition (with the 
repeated measure: time), and the 
acquisition phase of the MWM 
(with the repeated measure: 
acquisition days). A Student’s t-test 
was performed for the parameters 
of the open field (total time), 
rotarod, prepulse inhibition, MWM 
parameters in the probe phase, 
energy metabolites measured with 
31P MRS, immunohistochemistry, 
and biochemistry. For readability 
reasons, F-values and degrees of 
freedom are not displayed in the 
text. Statistical significance was set 
at *p≤0.05 and #0.05<p<0.075.  
Results
Cognitive tests
There were no differences between 
the two dietary groups in general 
developmental parameters such as 
opening of the eyes or activity of 
the litter in the Phenotypers (data 
not shown). Activity of the dam 
with litter increased over time for 
both diet groups (data not shown). 
Dietary intervention had no effects 
on body weight of the two groups 
throughout the study (data not 
shown). 
Open field 
The open field was used to 
assess locomotion (total walking 
distance) and exploration (walking, 
wall leaning, rearing, sitting) and 
Figure 4: Exploration in the open field. Different open field parameters 
were measured in a 30 minute period. A n-3 adq diet increased time 
spent walking on PND 60 compared to PND 30. Furthermore, n-3 adq 
increased time spent walking compared to n-3 def on PND 60. B n-3 adq 
diet decreased time spent grooming on PND 60 compared to PND 30. 
Additionally, n-3 adq decreased time spent grooming compared to n-3 
def on PND 60. C n-3 adq diet increased time spent leaning on PND 60 
compared to PND 30. *p≤0.05.
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grooming for 30 minutes. 
In the open field no effects of diets could be detected on locomotion at both PND30 and PND60. 
However, the young adult mice fed n-3 adq diet displayed a higher total walking distance 
(p=0.016) than pubertal mice (Figure 3). This effect was not found in the n-3 def diet. 
Furthermore, we observed no dietary effects in exploratory behavior in pubertal mice in 
the total 30 minutes. However, young adult mice on the n-3 adq diet spent more time walking 
(p=0.031) and less time grooming (p=0.027) than pubertal mice fed the n-3 adq diet (Figure 
4A and B). Moreover, they showed more time wall leaning (p=0.033) and walking (p=0.024), 
but less time grooming (p=0.027) than their n-3 def fed littermates in across the 30 minutes of 
the test (Figure 4A-C). Subsequently, we observed that the n-3 adq fed young adult mice spent 
more time walking than their n-3 def fed littermates (p=0.024; Figure 4A). Lastly, the n-3 adq fed 
mice demonstrated less time grooming (p=0.027) than their n-3 def littermates over 30 minutes 
(Figure 4B). 
Rotarod 
The rotarod is designed to 
assess motor coordination. Mice 
performed a motor task on a 
rotating rod at fixed speeds or 
acceleration and the latency to fall 
was recorded. 
No dietary effect was observed 
at fixed speeds (10, 15, 20 rpm) in 
both pubertal and young adult 
mice (data not shown). However, 
n-3 adq fed pubertal mice 
demonstrated a higher latency to 
fall (p=0.001) compared to n-3 def 
fed pubertal mice at accelerated 
speed (4-40 rpm) (Figure 5). Young 
adult mice showed no diet effect at 
accelerated speed (data not shown). Yet, the n-3 adq fed mice on PND 60 display a lower latency 
to fall than n-3 adq fed mice on PND 30 (p=0.011, Figure 5). Comparing performances in all 
groups, the n-3 adq fed mice at pubertal age performed best among all groups.
Figure 5: Latency to fall in the rotarod. On PND30, n-3 adq diet increased 
latency to fall at acceleration compared to n-3 def. On PND 60, n-3 adq 
diet displayed a decreased latency to fall compared to PND 30. *p≤0.05.
Figure 6: Startle response in the prepulse inhibition test. Mice were exposed to acoustic pulses, and the startle 
amplitude at 120 dB of the mice was measured at the start and at the end of the experiment. A The mice displayed an 
overall habituation effect on PND 30. B On PND 60, there was also a habituation, and additionally a diet effect. *p≤0.05, 
**p≤0.01.
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Prepulse inhibition 
The prepulse inhibition test studies sensorimotor integration by measuring the startle response 
in mice that are administered acoustic pulses with or without a preceding softer prepulse. 
At both ages, no dietary effects could be detected (data not shown). However, an age effect 
was found in the n-3 def diet; mice fed the n-3 def diet at PND 60 demonstrated a stronger 
prepulse inhibition than at 
PND 30, which was not the 
case in n-3 adq fed mice. 
A habituation effect to the 
stimuli was observed in 
pubertal mice (p<0.001, 
Figure 6A) and in the young 
adult mice (p=0.004, Figure 
6B). However, at young 
adult age, this habituation 
effect was stronger in the 
n-3 adq fed mice than 
in the n-3 def fed mice. 
Both diet groups showed 
a stronger habituation at 
PND 60 compared to PND 
30 (p=0.009). 
MWM 
In the MWM task, spatial 
learning is tested in the 
acquisition phase where 
the mice have to find a 
hidden platform. Spatial 
memory is assessed in a 
subsequent trial where the 
platform is removed from 
the pool. 
The MWM was only 
performed at PND 60. 
In the acquisition phase 
both diet groups showed 
a learning effect (p=0.002), 
but there was no significant 
difference between the two 
diet groups (p>0.05, Figure 
7A). In the probe phase 
we focused on the first 30 
seconds of the trial. The n-3 
adq fed mice spent more 
time in the target quadrant 
than the n-3 def fed mice 
(p=0.007, Figure 7B) and 
also showed more platform 
crossings (p=0.029, Figure 
Figure 7: Morris water maze learning and memory in young adult mice (PND 60). 
Spatial learning was measured in a 4-day acquisition phase, by determining the latency 
to find a hidden platform in the NE target quadrant. Spatial memory was tested in a 
probe phase in which the percentage of time spent in the target quadrant and the total 
number of platform crossings (of the previous location of the platform) was measured. 
A MWM acquisition: both diets show a learning curve. B MWM probe target quadrant: 
n-3 adq diet increased time spent in the NE quadrant. The dotted line represents the 
25% chance level of finding the target quadrant. The n-3 def mice performed below 
25% chance level while n-3 adq performed at 25% chance level. C MWM probe 
platform crossings: n-3 adq increased platform crossings. *p≤0.05.
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7C) over the area where the platform used to be located. The n-3 def fed mice performed below 
25% chance level (p=0.004) while the n-3 adq fed mice performed at 25% chance level.
31P MRS 
After performing the MWM, the mice underwent 31P MRS to measure the content of the main 
phosphorylated metabolites in the brain at PND 60. The metabolite levels (PCr, γ- and α-ATP; Pi; 
PME, and PDE) showed no differences between the diets for all metabolites in the mice (data not 
shown).
Immunohistochemistry 
Immature neurons were visualized in young adult mice with a polyclonal antibody against DCX. 
DCX positive cells were counted in the subgranular zone of the hippocampus as a measure 
for neurogenesis (Figure 8A and B). Calculation of the DCX-positive cells in the hippocampus 
demonstrated significantly less DCX- positive cells in the subgranular zone of n-3 adq fed young 
adult mice compared to n-3 def fed mice (p=0.048, Figure 8C). 
The amount of presynaptic boutons (size ranges from 0.1 μm2 to 4.5 μm2) was visualized 
with a monoclonal antibody against synaptophysin. Whereas, postsynaptic density was 
visualized with a polyclonal antibody against PSD95 in the hippocampus of young adult mice 
to reflect synaptic function. No significant diet effect in presynaptic (SIPB) and postsynaptic 
densities in the IML, OML, SL, and SR of the hippocampus were observed (data not shown).
Biochemistry
Fatty acid analysis 
Fatty acid analysis of erythrocytes confirmed increased levels of DHA in n-3 adq fed animals at 
young adult age as compared to n-3 def fed animals (p<0.01, Table 3). Analysis of all four brain 
Figure 8: Doublecortin immunohistochemical 
staining performed on brain sections of young 
adult mice (PND 60). A Representative image of 
the doublecortin-positive cells in the hippocampus. 
Image taken using a 2.5× objective. Scale bar 500 μm. 
B Representative image of the doublecortin positive 
cells in the subgranular zone of the hippocampus. 
Image taken using a 20× objective. Scale bar 100 
μm. C Amount of doublecortin positive cells in the 
subgranular zone of the hippocampus. *p≤0.05.
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regions demonstrated lower levels of ARA (p<0.01) and higher levels of dihomo-γ-linolenic acid 
(DGLA) (p<0.01) and DHA (p<0.01) in n-3 adq fed mice as compared to n-3 def fed mice (Table 3). 
qRT-PCR 
Analysis of gene expression of inflammatory markers (IL-1β, IL-6, TNF-α, CD36, MCP-1), and 
synaptophysin in the cortical region of the brains of both pubertal and young adult mice was 
performed with qRT-PCR. Analysis of doublecortin expression as a measure of neurogenesis was 
quantified in the subcortical region of the brains of pubertal and young adult mice. No significant 
differences were detected between n-3 adq and n-3 def fed animals at pubertal or young adult 
age for the expression of inflammatory markers (data not shown). The n-3 adq fed animals 
demonstrated a trend for increased synaptophysin mRNA expression (synaptic plasticity) in the 
cortex at pubertal age (p=0.054), but no longer in adulthood (Figure 9). Furthermore, the n-3 adq 
fed mice displayed a decrease in synaptophysin mRNA expression on PND 60 compared to PND 
30 (p=0.001). No diet effects were detected in DCX mRNA expression of the subcortical region at 
either PND 30 or 60 (data not shown).
Discussion
The present study aimed to investigate the influence of dietary n-3 PUFA availability during 
the development of C57BL/6J mice on behavior, cognition, cerebral metabolism, and brain 
plasticity using behavioral and cognitive tests, 31P MRS, immunohistochemistry, and biochemical 
Table 3: Fatty acid analysis of erythrocytes and brain tissue at (young) adult age.
n-3 deficient % n-3 adequate % p-value
Eryhtrocytes n=10 n=9
ARA 12.41±1.31 9.13±0.94 NS
DGLA 1.24±0.14 1.35±0.07 NS
DHA <0.001±0.00 6.80±0.97 ≤0.01
DPA 1.55±0.28 0.13±0.03 ≤0.01
Brain stem n=9 n=7
ARA 7.07±0.17 5.22±0.40 ≤0.01
DGLA 0.42±0.03 0.83±0.09 ≤0.01
DHA 4.86±0.31 8.84±1.10 ≤0.01
DPA 4.33±0.31 0.07±0.01 ≤0.01
Cortex n=10 n=9
ARA 10.03±0.31 7.97±0.45 ≤0.01
DGLA 0.38±0.04 0.64±0.04 ≤0.01
DHA 6.09±0.59 15.88±1.03 ≤0.01
DPA 8.43±0.29 0.39±0.11 ≤0.01
Subcortical region n=10 n=9
ARA 10.25±0.12 8.36±0.12 ≤0.01
DGLA 0.42±0.02 0.72±0.02 ≤0.01
DHA 6.77±0.27 14.48±0.26 ≤0.01
DPA 7.02±0.46 0.31±0.03 ≤0.01
Cerebellum n=10 n=9
ARA 6.94±0.15 5.19±0.18 ≤0.01
DGLA 0.41±0.01 0.62±0.04 ≤0.01
DHA 5.43±0.28 9.90±0.61 ≤0.01
DPA 4.22±0.47 0.17±0.08 ≤0.01
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approaches. An overview of the main results is shown in Table 4. Overall, significant effects 
on motor coordination, exploratory behavior, sensorimotor integration, spatial memory, 
and neurogenesis were observed. These findings indicate that dietary intake of both ALA 
and preformed DHA during early development has a significant impact on neural and brain 
development as well as on cognition and behavior.
Regarding behavioral and cognitive outcomes, n-3 PUFA availability had no effects 
on locomotion, although total walking distance and activity of the pups increased as they 
reached weaning age (PND 21). This observation is in agreement with other studies (Carrié et 
al., 2000a; Coluccia et al., 2009; Enslen et al., 1991; Nakashima et al., 1993). Significantly more 
exploratory behavior, reflected by more time spent walking and wall leaning, was found in 
the open field in the n-3 adequate fed mice at adult age, but not at pubertal age. Carrié et al. 
demonstrated increased locomotion and an increase in the exploratory parameter rearing in 
n-3 PUFA supplemented adult female mice compared to control mice (Carrié et al., 2000b). 
However, Coluccia et al. observed no difference in rearing between n-3 PUFA supplemented and 
control rats at both pubertal and adult age (Coluccia et al., 2009). In yet another study, rearing 
and horizontal movement were decreased in n-3 PUFA deprived rats (Enslen et al., 1991). These 
studies define exploratory parameters purely as rearing or sometimes vertical movement when 
drawing their conclusions on exploration. In the current study no dietary effect in the time spent 
rearing could be observed, but indeed an increase in time spent on wall leaning in animals with 
an adequate n-3 PUFA intake was demonstrated, which is also a vertical movement. Additionally, 
n-3 PUFA adequate fed young adult mice also displayed more walking, which is considered as 
an exploratory horizontal movement (Enslen et al., 1991). Furthermore, grooming has been 
suggested as a measure for anxiety, because mice are known to display grooming under stressful 
conditions (O’Leary et al., 2013). We observed less grooming in the adequate n-3 PUFA group at 
adult age, but not in puberty, while the n-3 PUFA deficient mice did not display age differences. 
This indicates that n-3 PUFA supplementation may decrease anxiety-related behavior, however, 
no specific tests of anxiety were included in the current study.
In the prepulse inhibition test of the acoustic startle reflex, a habituation effect to the 
120 dB pulses was found in pubertal and young adult mice. At young adult age, this habituation 
effect was significantly stronger in animals with adequate n-3 PUFA intake. This reflects 
improved habituation to startle stimuli and therefore our data point to an improvement of 
cortical development by adequate n-3 PUFA intake (Geyer and Dulawa, 2001). Fedorova et 
al. also measured prepulse inhibition in 8 week old mice on n-3 PUFA deficient and n-3 PUFA 
supplemented diets (Fedorova et al., 2009a). In that study, the n-3 PUFA supplemented mice 
showed a stronger inhibition to the acoustic pulses than mice on the deficient diet. Additionally, 
a habituation process was observed in supplemented, but not in deficient animals, which is in 
line with the results of this present study. In this experiment, we observed a stronger habituation 
process in our n-3 PUFA adequate mice. In a schizophrenia rat model, LCPUFA have been shown 
to be able to ameliorate the impaired prepulse inhibition (Maekawa et al., 2009). Schizophrenia is 
Figure 9: Synaptophysin mRNA expression 
measured with qRT-PCR in the cortical region 
of the brain in pubertal (PND 30) and young 
adult mice (PND 60). On PND30, n-3 adq 
diet increased expression of synaptophysin 
compared to n-3 def. On PND 60, n-3 adq 
decreased synaptophysin expression compared 
to PND30. *p≤0.05, #0.05<p<0.075.
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a condition that mostly develops during early adulthood and has been associated with LCPUFA 
deficiency (Levant et al., 2004; Moriguchi and Salem, 2003; Umezawa et al., 1995). These data 
suggest that LCPUFA supplementation supports dopaminergic neurotransmission processes, 
by improving membrane fluidity. More testing at time points later in life could provide more 
information on the full potency of LCPUFA. It has been reported that high levels of n-3 PUFA were 
associated with a negative effect on neural development by prolonging auditory brain stem 
conduction times and a delay in auditory startle reflex in rodents (Haubner et al., 2007; Saste et 
al., 1998).  These studies show the importance of dosage, but indirectly also stress the relevance 
of the n-6/n-3 ratio, which deserves further attention. 
In the current study, n-3 PUFA adequate mice displayed a higher latency to fall in the 
accelerating rotarod test at pubertal age, but not at young adult age.  A higher latency reflects 
improved performance, since the animals were able to stay longer on the rotarod. The n-3 PUFA 
deficient mice did not demonstrate differences between puberty and adulthood. The increased 
rotarod latency in n-3 PUFA adq mice suggests that the n-3 PUFA adequate diet was associated 
with an accelerated development of motor coordination. In contrast to our results, Collucia et al. 
showed that n-3 PUFA supplementation in both juvenile and adult rats improved performance 
in the rotarod at fixed but not accelerating speeds (Coluccia et al., 2009). During development, 
Purkinje cells are innervated by multiple climbing fibers. Around PND 21, elimination of synapses 
occurs, leading to mono-innervation of Purkinje cells (Bearzatto et al., 2005). Bearzatto et al. 
compared three common wild type mouse strains and suggested a delay in the elimination of 
multiple climbing fibers innervating the Purkinje cells in adult C57BL6/J mice (Bearzatto et al., 
2005). Our findings have led us to postulate that the possible delay in elimination of multiple 
climbing fibers in C57BL6/J mice as described by Bearzatto et al. might be shortened by adequate 
dietary n-3 PUFA availability. As a result, the plateau in the development of motor coordination 
may be reached already before adulthood.
The results of the MWM test indicate that spatial memory at PND 60 was improved in n-3 
Table 4: Summary of the main results found in the behavioral and cognitive tests in pubertal and young adult mice 
that on an n-3 PUFA adequate diet throughout life.
Effect of n-3 PUFA adequate diet PND 30 PND 60
Open field Behavior and activity NS Increased exploration
Decreased anxiety
Rotarod Motor coordination Increased motor coordination NS
Prepulse inhibition Sensorimotor integration 
Habituation
NS
NS
NS
Increased habituation
Morris water maze Learning and memory n.a. Increased memory
31P MRS Cerebral metabolites n.a. NS
DCX expression Subcortical region NS NS
Immature neurons Hippocampus n.a. Fewer immature neurons
Synaptophysin 
expression
Cortex Increased synaptic plasticity NS
Presynaptic boutons Hippocampus n.a. NS
Postsynaptic density Hippocampus n.a. NS
Inflammatory markers Cortex NS NS
Fatty acid analysis Brain 
Erythrocytes 
n.a.
n.a.
Increased DGLA
Increased DHA
Decreased ARA
Increased DHA
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PUFA adq animals, but spatial learning remained unaffected. Several studies have stated the 
probable relation of learning and memory functions with brain fatty acid status (Fedorova and 
Salem, 2006; Moriguchi and Salem, 2003). Moriguchi et al. showed that n-3 PUFA deficiency in 
second and third generation deprived adult rats caused an impairment in performing the MWM 
task (Moriguchi et al., 2000). The second generation n-3 adequate fed rats showed improved 
spatial learning and memory as compared to the deficient rats, and the effect was even stronger 
in the third generation. Yet, Carrié et al. found no effects on spatial learning or memory in adult 
female mice demonstrated in both an n-3 PUFA deficiency model as well as in an n-3 PUFA 
supplementation study (Carrié et al., 2000a; Carrié et al., 2000b). A study performed by Kavraal 
et al. underlined the importance of n-3 PUFA availability starting early on at gestation in rats 
(Kavraal et al., 2012). In that study, both dams and offspring were supplemented with n-3 PUFA, 
and offspring was also supplemented with n-3 PUFA from gestation and throughout life. However, 
in contrast to our results, an increase in spatial learning was demonstrated, whereas there was 
no significant effect on spatial memory. The limitation of that study was that the supplemented 
diet was compared to a standard rat chow, which contained 1.9% ALA, preventing complete n-3 
PUFA depletion (Kavraal et al., 2012). These studies show the importance of choosing the right 
starting point for supplementation and composition of diets. 
In the present study, 31P MRS demonstrated no effects of n-3 PUFA availability on 
phosphorylated energy and lipid metabolites. As neurogenesis was decreased in n-3 PUFA 
adequate animals, a change in the PME levels reflecting membrane formation was expected. 
A clinical 31P MRS study in epilepsy patients showed that n-3 PUFA supplementation reduced 
membrane phospholipid breakdown, whereas it improved brain energy metabolism (Puri et 
al., 2007). However, a post mortem observational study of schizophrenia patients revealed no 
changes in phospholipid metabolism measured by 31P MRS (Pearce et al., 2009). Studies using 
1H MRS have further elucidated the effect of n-3 PUFA supplementation on cerebral metabolite 
status (McNamara et al., 2009; McNamara et al., 2013b).  McNamara et al. demonstrated a 
decrease of myo-inositol in the prefrontal cortex of n-3 PUFA deficient adult rats (McNamara et 
al., 2009). It is hypothesized that this reduction may be caused by impaired astrocyte maturation 
and deficits in osmotic regulation. Another study using 1H MRS revealed that ethyl-EPA has the 
ability to protect the human brain from early psychosis by increasing glutathione levels in the 
temporal lobes and increasing glutamate/glutamine levels in the left hippocampus (Berger et 
al., 2008). These studies indicate that 1H MRS may provide in a more sensitive method to detect 
effects on cerebral metabolite status that would help to understand the changes in behavioral 
and cognitive tests in the present experimental setup, such as improvement of spatial memory 
in the MWM and neuronal functionality as reflected by decreased neurogenesis. Furthermore, 
we were only able to measure whole brain metabolite status with our 31P MRS method. Possibly, 
measurements distinguishing between different brain regions such as hippocampus and cortex 
would be more sensitive to detect metabolite changes. 
The qRT-PCR data on neurogenesis revealed no diet effect on DCX mRNA expression in 
the subcortical area (containing hippocampus and subcortical structures. This may have led to 
a weakening of possible effects in DCX mRNA expression). Another explanation may be that 
n-3 PUFA already exert their effect before puberty. Strikingly, immunohistochemical staining for 
doublecortin demonstrated decreased hippocampal neurogenesis in n-3 PUFA adequate fed 
young adult mice. To our knowledge, this is the first study to show diminished neurogenesis in 
young adult mice due to altered n-3 PUFA availability during development. Contrarily, several 
studies have illustrated an increase of neurogenesis after LCPUFA supplementation (Crupi et 
al., 2012; Maekawa et al., 2009; Niculescu et al., 2011). Niculescu et al. assessed hippocampal 
neurogenesis of n-3 PUFA supplemented mice at the end of the lactation period (PND 19) and 
detected an increase in cell proliferation (Niculescu et al., 2011). In another study, dietary LCPUFA 
supplementation led to increased neurogenesis in juvenile rats (Maekawa et al., 2009). Dietary 
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DHA has been suggested to promote neurogenesis and synaptogenesis during embryonic 
development (Cao et al., 2009a). It should be noted that these studies were performed at an 
earlier age than the immunohistochemical stainings in our experiment. Additionally, n-3 PUFA 
supplementation counteracted the reduction of hippocampal neurogenesis in an immune 
deprived mouse model (Crupi et al., 2012). Combined, these data suggest that n-3 PUFA 
availability may promote earlier neurogenesis, possibly already before pubertal age. 
In the current study, immunohistochemical stainings for synaptophysin and PSD95 
showed no effect on pre- and postsynaptic density, respectively, indicating that synaptogenesis 
remained unaffected in adulthood. However, our results obtained by qRT-PCR indicate that 
synaptic plasticity may be increased at pubertal age in the cortex, while it remains unaffected 
at adult age. Several studies demonstrated an increased expression of pre- and postsynaptic 
proteins after n-3 PUFA supplementation, hinting at increased synaptogenesis either early 
on in life or during ageing (Cao et al., 2009a; Crupi et al., 2012; Wurtman, 2008). Our data on 
synaptophysin expression led us to hypothesize that synaptogenesis is stimulated at adolescent 
age on an n-3 PUFA adequate diet, and reaches a plateau before adult age. We postulate 
that neurogenesis may already be accelerated before puberty, as our data show unaffected 
DCX mRNA expression during puberty and adulthood. Our immunohistochemistry data on 
hippocampal neurogenesis strengthen the idea that n-3 PUFA induce a plateau in neurogenesis 
before adulthood. In line with these results, the n-3 PUFA adequate animals showed enhanced 
performance on the rotarod in puberty, but not in adulthood. At young adult age, n-3 PUFA 
adequate fed mice still demonstrated improved spatial memory in the MWM. Additional gene 
expression analysis (for example cAMP response element binding protein: involved in long-term 
potentiation, or peroxisome proliferator-activated receptor and retinoid X receptor: involved in 
regulating synaptic plasticity, and learning and memory) may further support our findings.
In the present study, only DHA levels in erythrocyte membrane were affected by the dietary 
intervention, while all brain regions tested displayed decreased levels of ARA and increased 
levels of DHA and DGLA as well. This decrease in ARA might be explained by the competition 
of n-3 and n-6 PUFA for the conversion enzymes delta-5 and delta-6 desaturase, which favor 
the conversion of n-3 PUFA (Schmitz and Ecker, 2008; Simopoulos, 2008a). Another explanation 
could be a competition in tissue uptake, due to the administration of preformed DHA (Brenna 
et al., 2009). These changes in n-3 and n-6 PUFA are in the same range as observed in previous 
studies in rats (Moriguchi et al., 2000; Moriguchi and Salem, 2003). The results acquired in the 
current study underline the importance of brain fatty acid status during development. Besides, 
the expression of inflammatory markers remained unaffected by n-3 PUFA availability during 
development. N-3 PUFA supplementation has been shown to decrease neuroinflammation in 
immune deprived and aged mice (Crupi et al., 2012; Labrousse et al., 2012). It is not likely that the 
young, healthy C57BL/6J mice used in our experiments are prone to inflammation at this stage in 
life, which is supported by the fact that n-3 PUFA availability did not affect inflammatory markers. 
In summary, the current study indicates that adequate dietary n-3 PUFA levels early 
in life improve neural development in the cerebellar cortex during puberty, as reflected by 
improved motor coordination. Additionally at adult age, we observed cortical and hippocampal 
changes with increased habituation in the prepulse inhibition, increased exploratory behavior 
and decreased anxiety in the open field, increased spatial memory in the MWM, a decrease 
in neurogenesis and unaltered synaptogenesis in immunohistochemistry. qRT-PCR revealed 
that n-3 PUFA increased synaptogenesis in the cortex at pubertal age, but did not change 
neurogenesis in the subcortical area. The overall level of cerebral phosphorylated metabolites 
as measured by in vivo 31P MRS was not altered by n-3 PUFA. Expression of inflammatory markers 
also remained unaffected in both puberty and young adulthood. Finally, we demonstrated that 
dietary modifications led to increased n-3 PUFA and decreased n-6 PUFA in cerebral fatty acid 
status, and increased DHA in erythrocyte membranes. 
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We postulate that perinatally administered dietary n-3 PUFA have the potential to improve 
cortical and hippocampal development and enhance cognitive functioning. While the present 
study focused on dietary n-3 PUFA availability in a healthy mouse model, it already yields a range 
of beneficial effects in brain functioning. Overall, our findings indicate that ensuring adequate 
dietary n-3 PUFA levels starting early in life may support optimal neural development in healthy 
full term infants. Furthermore, our results implicate that it would be interesting to study the effect 
of a sufficient n-3 PUFA intake in disorders caused by an n-3 PUFA deficiency more extensively.
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Abstract
Evidence suggests that flavanol consumption can beneficially affect cognition in adults, 
but little is known about the effect of flavanol intake early in life. The present study aims to 
assess the effect of dietary flavanol intake during the gestational and postnatal period on 
brain structure, cerebral blood flow (CBF), cognition, and brain metabolism in C57BL/6J mice. 
Female wild-type C57BL/6J mice were randomly assigned to either a flavanol supplemented 
diet or a control diet at gestational day 0. Male offspring remained on the corresponding diets 
throughout life and performed cognitive and behavioral tests during puberty and adulthood 
assessing locomotion and exploration (Phenotyper and open field), sensorimotor integration 
(Rotarod and prepulse inhibition), and spatial learning and memory (Morris water maze, MWM). 
Magnetic resonance spectroscopy and imaging at 11.7T measured brain metabolism, CBF, and 
white and grey matter integrity in adult mice. Biochemical and immunohistochemical analyses 
evaluated inflammation, synaptic plasticity, neurogenesis, and vascular density. Cognitive and 
behavioral tests demonstrated increased locomotion in Phenotypers during puberty after 
flavanol supplementation (p=0.041) but not in adulthood. Rotarod and prepulse inhibition 
demonstrated no differences in sensorimotor integration. Flavanols altered spatial learning in 
the MWM in adulthood (p=0.039), while spatial memory remained unaffected. Additionally, 
flavanols increased diffusion coherence in the visual cortex (p=0.014) and possibly the corpus 
callosum (p=0.066) in adulthood. Mean diffusion remained unaffected, a finding that corresponds 
with our immunohistochemical data showing no effect on neurogenesis, synaptic plasticity, 
and vascular density. However, flavanols decreased CBF in the cortex (p=0.001) and thalamus 
(p=0.009) in adulthood. Brain metabolite levels and neuroinflammation remained unaffected by 
flavanols. These data suggest that dietary flavanols results in subtle alterations in brain structure, 
locomotor activity and spatial learning. Comparison of these data to published findings in aging 
or neurodegeneration suggests that benefits of dietary flavanols may increase with advancing 
age and in disease.
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Introduction
Nutrition plays an important role in developing and maintaining a healthy brain. For example, 
there is increasing evidence that dietary polyphenols can support brain health. Polyphenols 
are fruit and plant constituents that are well-known for their antioxidant properties. A class 
of polyphenols that has been associated with improved cognition are flavonoids (Corcoran et 
al.; Ghosh and Scheepens, 2009; Hollenberg et al., 2009; Rendeiro et al., 2009; Spencer, 2009). 
Studies indicate that flavonoid consumption can beneficially affect normal cognitive function 
and cerebral blood flow in adults (Francis et al., 2006; Sorond et al., 2008; Vauzour, 2012). 
In our current study, we focus on flavanols, a group of flavonoids that are present in 
apple and grape seed extract. Flavanols are the most abundant flavonoids in the human diet 
and are mostly provided by fruits (such as apple and grapes), cocoa, tea, wine, nuts, and beans 
(Arola-Arnal et al., 2013). The daily intake of flavanols such as catechins and proanthocyanidins is 
estimated at 18-50 mg/day in humans, while intake of the flavonol quercetin has been estimated 
to be 20-35 mg/day (Manach et al., 2005). These substances have the ability to improve health 
by exerting cardioprotective, anti-inflammatory, and antioxidant effects (Arola-Arnal et al., 2013; 
Vauzour, 2012). The most well-known biological actions of flavanols are their antioxidant effects 
as shown in in vitro conditions. Due to donation of a hydrogen atom from hydroxyl groups to 
reactive oxygen species (ROS), phenoxyl radicals arise which can be stabilized by reactions with 
other radicals and stabilized oxygen species (Gomez-Pinilla and Nguyen, 2012). After ingestion, 
the largest portion of dietary flavonoids are metabolized in the small and large intestine, in the 
liver, and in cells (Rendeiro et al., 2012). They form substrates for phase I and II enzymes and 
are de-glucosylated and further metabolized into glucuronides, sulphates, and O-methylated 
derivatives (Rendeiro et al., 2012). In order to be able to influence brain health directly, flavonoids 
or their metabolites must pass the blood-brain barrier (BBB). The ability of structures to cross 
the BBB depends on their systemic availability and lipophilicity (Faria et al., 2014; Rendeiro et al., 
2012). As a result, theoretically the O-methylated metabolites would be more potent to pass the 
BBB than sulphates and glucuronides, which has been shown in in vitro studies (Rendeiro et al., 
2012; Vauzour, 2012; Youdim et al., 2003). 
While the effects of flavonoid supplementation have been studied in normal aging 
and neurodegenerative models, little is known about their influence during development. In 
neurodegeneration, flavonoids have shown to exert neuroprotective properties such as the 
modulation of neuroinflammation and improvement of cognition (Vauzour, 2012). It has been 
shown that flavonoids modulate neuronal signaling pathways involved in synaptic plasticity 
and neurogenesis (Spencer, 2010; Vauzour, 2012). In vivo, flavonoids are able to affect these 
pathways by activation of cyclicAMP-response element binding (CREB) receptors and brain 
derived neurotrophic factor (BDNF), mechanisms that are involved in memory acquisition and 
consolidation (Spencer, 2010). Potential effects in neural development may be expected, but this 
has not been studied yet. 
In the current study, the impact of flavanol availability during gestation and the postnatal 
period was assessed in mice to understand the mechanisms underlying potential long-term 
beneficial effects throughout life. A broad spectrum of parameters was investigated in order 
to evaluate effects on brain structure and function. Changes in cortical and hippocampal 
functionality were studied with behavioral and cognitive tests. Proton magnetic resonance 
spectroscopy (1H MRS) was used to assess brain metabolism, while cerebral blood flow (CBF) was 
measured with arterial spin labeling (ASL), and diffusion tensor imaging (DTI) was performed 
to study brain integrity. Neurogenesis, synaptic plasticity and capillary density were evaluated 
immunohistochemically, and quantitative real-time polymerase chain reaction (qRT-PCR) was 
used to study gene expression of inflammatory markers, synaptic plasticity and angiogenesis.
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Material and methods
Animals and diets
C57BL/6J mouse dams (3-4 months old, Harlan Laboratories Inc., Horst, the Netherlands) were 
used for breeding. The dams obtained the control diet upon arrival in the Central Animal 
Facility (Radboud university medical center, Nijmegen, the Netherlands) and were randomly 
assigned to the control diet (n=14), or a flavanol supplemented diet (apple + grape seed extract; 
apple+GSE), n=11) at the first day of gestation (GD 0). The diets were isocaloric and based on 
AIN93m; they only differed in flavonoid concentrations (Table 1A and B; Research Diets Services, 
Wijk bij Duurstede, the Netherlands) (Reeves et al., 1993). Offspring of all dams were maintained 
on the corresponding diets throughout the whole experiment. Litter sizes were normalized by 
culling the litters to 3 males and 3 females per dam. Nine parallel groups of male offspring were 
tested, the groups were either tested and sacrificed on postnatal day (PND) 30 (control n=11, 
apple+GSE, n=13) or PND 60 (control n=9, apple+GSE, n=10), including behavioral testing and 
brain biochemistry parameters, or used for brain histology at PND 60 (control n=11, apple+GSE, 
n=11) (Figure 1). 
The dams were housed individually in Phenotypers (Noldus, Wageningen, the Netherlands) 
from GD 0 onwards and remained there during delivery of the pups until weaning of the offspring. 
After weaning, male offspring were housed in groups of 3 in individually ventilated cages. Only 
male offspring were used in these experiments to avoid influence of hormonal fluctuations 
in the female offspring. All mice were housed in the Preclinical Imaging Centre (PRIME) in the 
central animal facility with temperature controlled at 21 °C, an artificial 12:12h light:dark cycle 
(lights on at 7:00 a.m.), continuous music playing in the background during the light period, and 
cage enrichment consisting of a plastic shelter and cotton nesting material. Food and water were 
available ad libitum. The experiments were performed according to Dutch federal regulations 
for animal protection and were ethically approved by the Veterinary Authority of the Radboud 
university medical center. Data of some mice were excluded from further analysis of magnetic 
resonance (MR) spectroscopy and imaging due to movement errors (i.e. obtained spectra did not 
meet inclusion criteria). 
Behavioral and cognitive tests
Dams and pups were monitored in Phenotyper cages (EthoVision XT 8.5, Noldus, Wageningen, 
the Netherlands) for 24 hours a day during PND 0 – 21 (from birth until weaning). Locomotor 
activity of the litters was monitored as well as opening of the eyes. The offspring were weighed 
on PND 14, 21, 30, and 60. Male offspring performed behavioral and cognitive tests starting on 
PND 30 (puberty) and PND 60 (young adulthood) (Figure 1). Tests were performed in the same 
order (Phenotypers open field, rotarod, prepulse inhibition) during the light period between 
8:00 a.m. and 5:00 p.m. The Morris water maze (MWM) was only performed in young adulthood, 
after the animals had exerted the other behavioral tests.
 
Phenotypers
Locomotor activity was measured in Phenotypers at PND 30 and PND 60. Mice were individually 
monitored in Phenotyper cages during 24 hours.
 
Open field 
Locomotion and explorative behavior was evaluated in the open field at PND 30 and PND 60 as 
previously described (Jansen et al., 2013a; Jansen et al., 2014; Janssen et al., 2015). Locomotion 
was automatically recorded with EthoVision XT8.5 (Noldus, Wageningen, The Netherlands), 
while exploration was manually scored and analyzed as described previously (Hooijmans et al., 
2009; Streijger et al., 2005). 
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Rotarod
The Rotarod was performed to study motor coordination at PND 30 and 60 (for more detailed 
information see (Janssen et al., 2015)). Mice were placed on a rotating drum and their ability to 
remain on the rotating drum was recorded as latency to fall (s). 
Prepulse inhibition
The prepulse inhibition test was performed at PND 30 and 60 to evaluate sensorimotor 
integration as previously described (Janssen et al., 2015; Streijger et al., 2005). The whole-body 
startle response of the mouse was measured during three blocks of startle pulses. 
Morris water maze
Spatial learning and memory was tested in the MWM at PND 60 (for more detailed information 
see (Jansen et al., 2013a; Jansen et al., 2014; Janssen et al., 2015)). The young adult mice were 
trained to find a submerged platform located in the north-east quadrant of the pool by using 
distant visual cues. The acquisition phase was used as a measure for spatial learning, while the 
probe phase evaluated spatial memory. 
Figure 1: Schematic overview of the study design and timeline of the experiment. C57BL/6J 
dams were randomly assigned to remain on a control diet or switch to an apple+GSE supplemented 
diet on GD 0. Offspring were maintained on the corresponding diets throughout the whole study. 
Male littermates were randomly assigned to one  of three parallel groups. One group was tested for 
behavioral and cognitive parameters (24h activity, open field, Rotarod, and prepulse inhibition) on 
PND 30 and subsequently sacrificed for brain biochemistry. A parallel group was tested for behavioral 
and cognitive parameters (24h activity, open field, Rotarod, prepulse inhibition, and MWM) on PND 60 
and subsequently underwent MR imaging and spectroscopy (ASL, 1H MRS, and DTI) and was sacrificed 
afterwards for brain biochemistry. A third group was sacrificed at PND 60 for brain histology. One male 
pup from each dam was represented in each parallel group for testing.
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Compound 2:1 Apple:Grape Seed mix
Compound (mg) / Extract (g)
Catechin 21.06
Epicatechin 40.24
Epigallocatechin 0.19
Epicatechin gallate 3.44
Quercetin 0.93
Quercetin 3 glucoside 16.14
Procyanidin B1 17.65
Procyanidin B2 32.27
Other Procyanidins 9.74
Other Procyanidins 1.64
Table 1B: Flavonoid composition of extract.
We used a 2:1 ratio of apple: grape seed extract. The apple extract used was 
Diana 9080 (Diana Naturals Inc, Rennes, France) and the grape seed extract 
was Ajinomoto 20R (Ajinomoto Omnichem, Louvain-la-Neuve, Belgium). The 
combined extract was incorporated into the diets at 9.3g/kg of the total diet 
(as referenced in Table 1A).
Ingredient Amount (g/kg diet)
Control Apple+GSE
Cornstarch 397.486 388.186
Casein (alcohol extracted) 200 200
Maltose 132 132
Sucrose 100 100
Soybean oils (no additives) 28 28
Hydrogenated coconut oil (no additives) 42 42
Cellulose BW 200 50 50
Mineral mix (AIN-93-mix) 35 35
Vitamin-mix (AIN-93-mix) 10 10
L-cystine 3 3
Choline bitartrate (4.1% choline) 2.5 2.5
TBHQ 0.014 0.014
Flavanols ND 9.3
Flavonoid composition (µg/g):
Catechin ND 243.61±7.13
Epicatechin ND 478.26±5.84
Epigallocatechin ND 2.24±0.13
Epicatechin gallate ND 18.87±0.14
Procyanidin B1 ND 146.16±4.63
Procyanidin B2 ND 144.53±0.29
Quercetin ND 13.58±0.16
Quercetin 3 glucoside ND 68.48±0.30
Table 1A: Composition of diets.
Both diets were isocaloric and based on AIN93M (Reeves et al., 1993). 
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MR measurements
After behavioral and cognitive testing on PND 60, mice were measured on an 11.7T BioSpec 
Avance III small animal MR system (Bruker BioSpin, Ettlingen, Germany) equipped with an 
actively shielded gradient set of 600 mT/m and operated by Paravision 5.1 software. A circular 
polarized volume resonator was used for signal transmission and an actively decoupled mouse 
brain quadrature surface coil with integrated combiner and preamplifier was used for signal 
reception (Bruker BioSpin). Mice were placed in a stereotactic holder to immobilize the head 
and prevent unwanted movement during scanning. During the MR measurements, mice were 
anaesthetized with isoflurane (Nicholas Primal (I) Limited, London, United Kingdom; 3.5% for 
induction and 1.8% for maintenance) in a 2:1 oxygen and N2O mixture through a nose cone. 
Body temperature was measured using a rectal optimal temperature probe and maintained at 
37 °C with heated airflow. Respiration of the mouse was monitored using a pneumatic cushion 
respiratory monitoring system (Small Animal Instruments Inc., NY, United Stated). Gradient echo 
(GE) images in the axial, sagittal, and coronal orientation were acquired to visualize the anatomy 
and morphology of the mouse brain (see Table 2A for details).
ASL
Cerebral blood flow was measured under resting conditions using an ASL method with flow-
sensitive alternating inversion recovery (FAIR) (Kim, 1995; Kwong et al., 1991).  A spin-echo planar 
imaging sequence preceded by a 180° hyperbolic secant (sech80) RF inversion pulse was used. 
The inversion slab thickness was 6 mm and the slice margin was 1.5 mm. Twenty-five images with 
increasing inversion times (40 ms – 3000 ms) were obtained for the T1 calculations. Inversion 
recovery data from the imaging slice were acquired after selective inversion interleaved with 
non-selective inversion (see Table 2A for details). For each mouse, FAIR images were processed 
and analyzed as described previously (Zerbi et al., 2014a). Regional perfusion was evaluated in 
the cerebral cortex, hippocampus, and thalamus according to the mouse brain atlas of Franklin 
& Paxinos (third edition, 2008).
Table 2A: Imaging parameters ASL, DTI.
Anatomical scans ASL DTI
Method Gradient echo FAIR-ASL SE-EPI
Echo time (TE) 5 ms 11.8 ms 21.4 ms
Repetition time (TR) 630 ms 13.75 s 7.75 s
Image matrix 512 x 512 128 x 128 128 x 128
Field of view (FOV) 40 x 40 mm 30 x 30 mm 20 x 20 mm
Spatial resolution 0.078 x 0.078 x 0.034 mm/pixel 0.234 x 0.234 x 1 mm/pixel 0.156 x 0.156 x 0.5 mm/pixel
Acquisition time ~8 min ~12 min ~18 min
Table 2B: imaging parameters 1H MRS.
Anatomical scans
Method Single voxel
Echo time (TE) 10.905 ms
Repetition time (TR) 2500 ms
T1 6.31 ms
T2 4.59 ms
Signal averages 800
Acquisition time ~27 min
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1H MRS 
Metabolite concentrations in the hippocampus were determined by 1H MRS (Jansen et al., 
2013a) in a single voxel of 1 x 1 x 2 mm, positioned unilaterally in the right hippocampus 
guided by anatomical images. Water-suppressed 1H MRS spectra were acquired with a point-
resolved spectroscopy sequence (PRESS) with a short echo time (TE) (see Table 2B for details). 
Quantification of metabolite concentrations was performed with LCModel™ software (Linear 
Combination Model, S. Provencher, Oakville, Canada) as described previously (Jansen et al., 
2013a). As a criterium for a reliable metabolite signal fit a Cramér-Rao lower bound (CRLB) ≤ 
20% was used (Cavassila et al., 2001). Ten metabolites fulfilled this criterium: N-acetylaspartate 
(NAA), glycerophosphocholine (GPC), myo-Inositol (mI), taurine (Tau), glutamate (Glu), 
glutamine (Gln), choline + glycerophosphocholine + phosphocholine (tCho), N-acetylaspartate 
+ N-acetylaspartateglutamate (NAA+NAAG), myo-Inositol + glycine (mI+Gly), glutamate + 
glutamine (Glu+Gln).
DTI 
Diffusion of water was measured by the protocol originating from Harsan et al. and modified 
by Zerbi et al. (Harsan et al., 2010; Zerbi et al., 2014a; Zerbi et al., 2013). In short, 31 axial slices 
covering the whole brain were acquired with by spin-echo planar imaging (SE-EPI). B0 shift 
compensation, navigator echoes and an automatic correction algorithm to limit the occurrence 
of ghosts and artefacts were implemented. Encoding b-factors of 0 s/mm2 (b0 images; 5x) and 
1000 s/mm2 were used and diffusion-sensitizing gradients were applied along 30 non-collinear 
directions in three-dimensional space (see Table 2A for details). Pre-processing was performed as 
previously described (Zerbi et al., 2013). Maps of mean diffusivity (MD) and fractional anisotropy 
(FA) were evaluated for diet differences with a region of interest (ROI) approach. Eight white and 
grey matter tracts were selected bilaterally across the brain according to the mouse brain atlas 
of Franklin & Paxinos (third edition, 2008). These regions include the corpus callosum (CC), fornix 
(F), optic tract (OT), hippocampus (HC), motor cortex (MC), somatosensory cortex (SSC), auditory 
cortex (AUC), and visual cortex (VC).
Biochemistry
qRT-PCR
Mice that were tested on behavior on PND 30 and those that were tested on behavior and 
underwent MR imaging and spectroscopy on PND60 were transcardially perfused with 0.1 M 
phosphate buffered saline (PBS). Subsequently, mice were decapitated and whole brains were 
collected and snap frozen in liquid nitrogen. The brains were stored at -80 °C until further 
analysis. The right hemisphere was divided into 4 regions; brain stem, cortex, subcortical region, 
and cerebellum. Samples were kept at -80 C until analysis.
The subcortical areas (containing hippocampus) of the right hemispheres of the brains 
collected at PND 30 and 60 were analyzed for inflammatory markers, synaptic plasticity, and 
angiogenesis with qRT-PCR. Inflammatory markers included interleukin-1β (IL-1β), IL-6, tumor 
necrosis factor-α (TNF-α), cluster of differentiation 36 (CD36), and monocyte chemoattractant 
protein-1 (MCP-1) (Table 3). Synaptophysin was used as a measure for synaptic plasticity and 
vascular endothelial growth factor (VEGF) was used to assess angiogenesis (Table 3).
qRT-PCR was performed as previously described by Janssen et al. (Janssen et al., 2015). To 
evaluate differences, relative gene expression ratios were calculated according to the comparative 
CT method (also referred to as the 2-ΔCT method) (Schmittgen and Livak, 2008). Relative CT 
values were calculated by subtracting the CT value of the housekeeping gene GAPDH from the 
CT values of IL-1β, IL-6, CD36, MCP-1, and TNF-α. For each primer, two independent qRT-PCR runs 
were performed, and the means of their relative values were used for statistical analysis.
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Enzyme-linked immunosorbent assay (ELISA)
Mature BDNF concentration in the left hemispheres of the brains collected at PND 30 and 60 was 
measured with a commercially available high-sensitivity enzyme-linked immunosorbent assay 
(Promega Corporation, Madison, WI, USA) according to the manufacturer’s instruction.
Immunohistochemistry
Brains were collected at PND 60 from the parallel group of littermates for immunohistochemical 
analysis (Figure 1). Mice were transcardially perfused with 0.1M phosphate buffered saline 
(PBS; room temperature), followed by 4% paraformaldehyde (PF; 4°C). Subsequently, mice were 
decapitated and whole brains were collected. The brains were post-fixated overnight in 4% PF at 
4 °C and thereafter stored in 0.1M PBS with sodiumazide at 4 °C. Coronal brain sections were cut 
using a sliding microtome (Microm HM 440, Walldorf, Germany) equipped with an object table 
for freeze sectioning at -60 °C gaining 8 parallel series of 30 µm thick sections. These sections 
were used for immunohistochemical purposes (240 µm distance between the sections). The 
tissue was stained for immature neurons (measure for neurogenesis) with antibodies against 
doublecortin (DCX), for postsynaptic density (measure for synaptic plasticity) with antibodies 
against postsynaptic density protein 95 (PSD95), for glucose transporters (measure for capillary 
density) with antibodies against glucose transporter 1 (GLUT-1), and for activated microglia 
(measure for neuroinflammation) with antibodies against ionized calcium-binding adapter 
molecule 1 (Iba1) (Figure 2).
Immunohistochemistry was performed using standard free-floating labeling procedures, 
using the protocol described by (Jansen et al., 2012; Jansen et al., 2014; Janssen et al., 2015). For 
DCX, polyclonal goat anti-doublecortin (1:4000; Santa Cruz Biotechnology Inc., Santa Cruz, CA, 
USA) was used as a primary antibody to assess neurogenesis. In the Iba1 staining, polyclonal 
goat anti-Iba1 (1:1500, Abcam, Cambridge, United Kingdom) was used as a primary antibody to 
assess neuroinflammation. The secondary antibody for both DCX and Iba1 was donkey anti-goat 
biotin (1:1500; Jackson ImmunoResearch, West Grove, PA, USA). For PSD95, polyclonal rabbit 
anti-PSD95 (1:2000; Abcam, Cambridge, UK) was used as a primary antibody to visualize the 
postsynaptic density. In the GLUT-1 staining, polyclonal rabbit anti-GLUT-1 (1:10,000; Chemicon 
International Inc., Temecula, CA, United States) was used as a primary antibody to assess capillary 
density. The secondary antibody used for both PSD95 and GLUT-1 was donkey anti-rabbit biotin 
(1:1500; Jackson ImmunoResearch, West Grove, PA, USA). 
Stained brain regions were analyzed double blind by 2 independent observers using a 
Zeiss Axioscop microscope equipped with hardware and software of Microbrightfield (Williston, 
VT, USA). Quantified hippocampus regions were based on the mouse brain atlas of Franklin & 
Paxinos (third edition, 2008).
Table 3: qRT-PCR primers (Janssen et al., 2015).
Primers (mouse) Forward Reverse
GAPDH 5’-AGGTCGGTGTGAACGGATTTG-3’ 5’-TGTAGACCATGTAGTTGAGGTCA-3’
CD36 5’- ATGGGCTGTGATCGGAACTG-3’ 5’-GTCTTCCCAATAAGCATGTCTCC-3’
IL-1β 5’-GCAACTGTTCCTGAACTCAACT-3’ 5’-ATCTTTTGGGGTCCGTCAACT-3’
IL-6 5’-CAAGTCGGAGGCTTAATTACACATG-3’ 5’-ATTGCCATTGCACAACTCTTTTCT-3’
MCP-1 5’-CCCAATGAGTAGGCTGGAGA-3’ 5’-TCTGGACCCATTCCTTCTTG-3’
TNF-α 5’-CAGACCCTCACACTCAGATCATCT-3’ 5’-CCTCCACTTGGTCCTTTGCTA-3’
synaptophysin 5'- TCTTTGTCACCGTGGCTGTGTT-3' 5'-TCCCTCAGTTCCTTGCATGTGT-3'
VEGF 5’-GGAGATCCTTCGAGGAGCACTT-3’ 5’-GGCGATTTAGCAGCAGATATAAGAA-3’
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Quantification doublecortin
DCX positive cells were quantified in three succeeding sections of the hippocampus (-1.70, -2.18 
mm, and -2.46 mm posterior to bregma) for each mouse. Contours were drawn along the borders of 
the hippocampus at 2.5× magnification using the program Stereo Investigator (Microbrightfield, 
Williston, VT, USA). The DCX positive cells in the subgranular zone of the hippocampus were 
manually counted at 40× magnification and the values of the three succeeding sections were 
averaged to obtain a single value for each animal.
Quantification PSD95
The relevant regions in the hippocampus were digitized using Stereo Investigator. Contours of 
the inner molecular layer (IML), outer molecular layer (OML), stratum radiatum (SR), and stratum 
lucidum (SL) of the hippocampus, and the sensory and visual cortex (-2.18 mm up to -2.46 mm 
posterior to bregma) were drawn at 2.5× magnification (Figure 3B). Photographs were taken at 
100× magnification. The quantification of the staining was performed using the program Image 
J (National Institute of Health, Bethesda, MD, USA). Images were converted to 8-bit grey scale, 
followed by conversion to 16-bit grey scale, next the contrast was enhanced and the amount 
of tissue stained was measured with a threshold-based approach. We did not set limits for the 
particle size.
Figure 2: Immunohistochemistry in young adult mice. Representative images of (A) DCX staining (2.5× objective), (B) 
PSD95 staining (2.5× objective). Black = visual cortex, white = sensory cortex, yellow = stratum radiatum, blue = inner 
molecular layer, red = outer molecular layer, green = stratum lucidum, (C) Iba1 staining (5× objective), and (D) GLUT-1 
staining (5× objective). Scale bars represent 500 µm.
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Quantification  Iba1 and GLUT-1
Relevant regions in the hippocampus were digitized using Stereo Investigator. Photographs 
of the whole hippocampus (-2.18 mm up to -2.46 mm posterior to bregma) were taken at 5x 
magnification. The quantification of the staining was performed using the program Image J. 
Images were converted to 8-bit grey scale, contours of the CA1, CA3, and DG were drawn, and the 
amount of tissue stained was measured with a threshold-based approach. Measurement of Iba1 
and GLUT-1 density was defined as the area covered by either Iba1 or GLUT-1 immunoreactivity 
per mm2 of the total area of the region measured. 
Statistics
Data are expressed as mean ± SEM and were analyzed with SPSS for Windows 20.0 software 
(SPSS Inc., Chicago, IL, USA). The repeated measures ANOVA was used for the first and last 
block of pulse-alone trials in the prepulse inhibition (with the repeated measure: time), and the 
acquisition phase of the MWM (with the repeated measure: acquisition days). A Student’s t-test 
was performed for the parameters of the open field (total time), rotarod, prepulse inhibition, 
MWM parameters in the probe phase, parameters of MR imaging, immunohistochemistry, and 
biochemistry. For readability reasons, F-values and degrees of freedom are not displayed in 
the text. Statistical outliers were removed from the dataset for further analysis and statistical 
significance was set at p≤0.05 and a trend at 0.05<p≤0.07.  
Results
There were no differences between the two dietary groups in general developmental parameters 
such as opening of the eyes or litter activity in the Phenotypers (data not shown). Activity 
of the dam with litter increased over time for both dietary groups (data not shown). Dietary 
intervention had no effect on body weight in the two groups on PND 30 (control 16.03±0.86; 
apple+GSE 15.06±1.09), PND 60 (control 23.07±0.58; apple+GSE 22.88±0.74) or at PND 60 in the 
parallel group for immunohistochemistry (control 24.52±0.84; apple+GSE 23.45±0.55). 
Behavioral and cognitive tests
Phenotypers
At pubertal age (PND 30), the apple+GSE fed mice displayed increased mean walking velocity 
during 24 hours in the Phenotypers (p=0.041; Figure 3A). The total walking distance only showed 
a tendency for increased walking in apple+GSE fed mice (p=0.060; Figure 3B). In young adulthood 
(PND 60), the mice did not demonstrate differences in 24h activity in the Phenotypers. We also 
Figure 3: 24h activity in Phenotypers. Mice were placed in Phenotypers for 24 hours to measure locomotor activity. 
A Apple+GSE fed pubertal mice demonstrated increased mean walking velocity. Both diets showed increased mean 
walking velocity when comparing adulthood to puberty. B Apple+GSE fed pubertal mice showed a tendency (p=0.060) 
for increased total walking distance. Both diets showed increased total walking distance when comparing adulthood to 
puberty. *p≤0.05, **p≤0.01, and #p≤0.07.
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observed increased activity over time between PND 30 and 60 in both control (total walking 
distance p=0.000, mean walking velocity p=0.000) and apple+GSE (total walking distance 
p=0.001, mean walking velocity p=0.006) fed mice (Figure 3A and B).
Open field
At pubertal age, there were no differences observed between the diets on any of the parameters 
(locomotion, behavior, and regional preferences). However, the young adult mice on apple+GSE 
diet showed increased grooming (p=0.033), but no differences in any other parameter (Figure 
4A).When comparing pubertal and young adult mice, we found that young adult control fed 
mice demonstrated increased time spent walking compared to pubertal mice (p=0.000), this 
effect was not significant in apple+GSE fed mice (p=0.061; Figure 4B). Age comparisons also 
showed that young adult control fed mice spent decreased time grooming (p=0.002), while 
young adult apple+GSE fed mice did not (Figure 4A). The control fed mice displayed increased 
locomotion in adulthood compared to puberty (total walking distance p=0.004, mean walking 
velocity p=0.004; Figure 5A and B). However, this aging effect was not observed in the apple+GSE 
fed mice. 
Figure 4: Behavior in the open field. Locomotion, behavior, and regional preferences were measured in the open field. 
A Apple+GSE fed young adult mice displayed increased time spent grooming in the open field. Furthermore, young 
adult control fed mice demonstrated decreased time spent grooming compared to their pubertal littermates. B Young 
adult control fed mice demonstrated increased time spent walking compared to their pubertal littermates. A tendency 
(p=0.061) for the same aging effect was shown in apple+GSE fed mice. *p≤0.05, **p≤0.01, and #p≤0.07.
Figure 5: Locomotion in the open field. Locomotion was measured in the open field. A Young adult control fed mice 
showed increased total walking distance in the open field, this effect was not demonstrated in the apple+GSE fed mice. 
B Young adult control fed mice displayed increased mean walking velocity in the open field, this effect was not shown in 
the apple+GSE fed mice. **p≤0.01.
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Rotarod
Motor coordination as measured with the Rotarod did not differ between the diet groups neither 
during puberty nor in young adulthood. However, young adult control fed mice demonstrated 
a decreased latency to fall compared to pubertal mice (p=0.016; Figure 6). This effect was not 
observed in apple+GSE fed mice.
Prepulse inhibition
Sensorimotor integration as measured in the prepulse inhibition test remained unaffected by 
apple+GSE diet in pubertal mice. Furthermore, a habituation effect to the 120dB pulses was 
determined (p=0.000), but no diet effect could be observed (Figure 7). In young adulthood, 
the mice did not display differences in prepulse inhibition. Surprisingly, the mice also did not 
demonstrate a habituation to the 120dB pulses. Both young adult control fed mice and apple+GSE 
fed mice showed a decreased habituation effect compared to their pubertal littermates (control 
p=0.002, apple+GSE p=0.002; Figure 7).  
MWM
The young adult mice were also tested in the Morris water maze. All groups showed a learning 
curve during the acquisition phase (p=0.000; Figure 8). However, the learning curve in the 
apple+GSE fed mice deviated from control (p=0.039) fed mice. The apple+GSE group started 
with a higher escape latency on day 1. But while control fed mice only showed a significant 
learning effect from day 1 to day 2 (p=0.040), the apple+GSE fed mice also showed a learning 
effect from day 2 to day 3 (day 1–2: p=0.004; day 2–3: p=0.023). Spatial memory was not affected 
by apple+GSE diet (data not shown).
Figure 6: Motor function in the Rotarod. Young 
adult control fed mice demonstrated a decreased 
latency to fall compared to their pubertal control 
fed littermates. No differences were observed in 
the apple+GSE fed mice. *p≤0.05.
Figure 7: Startle response in the prepulse inhibition test. Mice were exposed to acoustic pulses, and the startle 
amplitude at 120 dB of the mice was measured at the start and the end of the experiment. A The mice displayed an 
overall habituation effect to the acoustic pulses on PND 30. B No differences were observed on PND 60, but both diets 
showed a decreased habituation effect in adulthood compared to puberty. **p≤0.01.
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MR measurements
ASL
After the behavioral tests on PND 60, the cerebral blood flow was measured with ASL (Figure 
9A and B). In the apple+GSE fed mice, the CBF was decreased in the cortex (p=0.001) and the 
thalamus (p=0.009; Figure 9C). No effect on CBF was found in the hippocampus. 
1H MRS
1H MRS was used to measure tissue levels of cerebral metabolites that represent neuronal 
integrity, occurrence of proceses associated with inflammation, membrane turnover, energy 
metabolism, osmoregulation, and neurotransmitters. No differences between the diet groups 
were observed in cerebral metabolites (data not shown). 
Figure 8: Morris water maze learning in young adult mice (PND 60). Spatial learning was measured in a 4-day 
acquisition phase, by determining the latency to find a hidden platform in the NE target quadrant. All groups showed a 
learning curve during the acquisition phase (a**). However, the learning curve in the apple+GSE fed mice deviated from 
control  fed mice (b*). The apple+GSE group started with a higher escape latency on day 1. Apple+GSE fed mice also 
showed a learning effect from day 1 to 2 (c**) and day 2 to day 3 (d*), while control fed mice only showed a significant 
learning effect from day 1 to day 2 (e*). *p≤0.05, **p≤0.01. 
Figure 9: Cerebral blood flow 
in young adult mice. CBF 
was measured in the cortex, 
hippocampus, and the thalamus 
using ASL in control (A) and 
flavanol (B) fed young adult mice. 
C Apple+GSE fed young adult mice 
demonstrated decreased CBF in the 
cortex and the thalamus. **p≤0.01.
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DTI
Grey and white matter diffusion coherence was measured with DTI. The apple+GSE groups 
displayed a significant increased diffusion anisotropy in the visual cortex (p=0.014) and a trend 
in the corpus callosum (p=0.066; Figure 10). No differences between the diet groups were 
observed in mean diffusivity in all selected ROIs.
Biochemistry
qRT-PCR
After finalizing cognitive and motor function tests and imaging, brains of the mice were collected 
for biochemical analysis after perfusion with 0.1M PBS. We measured inflammatory markers, 
synaptic plasticity, and angiogenesis in the subcortical region (includes hippocampus) of the 
right hemispheres with qRT-PCR in pubertal and young adult mouse brains. 
Synaptic plasticity did not change after apple+GSE supplementation, nor did angiogenesis. IL-
1β expression showed a tendency for a decrease in the apple+GSE fed mice at both pubertal 
(p=0.067) and young adult age (p=0.065; Figure 11. Expression of the other inflammatory 
markers (CD36, IL-6, MCP-1, and TNF-α) did not show any differences.
ELISA
BDNF concentrations were measured with ELISA in the left hemispheres of the pubertal and young 
adult mouse brains. BDNF concentration was not affected by apple+GSE supplementation in 
neither pubertal nor young adult mice (Figure 12). However, BDNF levels increased in adulthood 
compared to puberty in both control fed mice (p=0.000) and apple+GSE fed mice (p=0.002).
Figure 10: Diffusion coherence in 
young adult mice. Apple+GSE fed 
young adult mice displayed increased 
diffusion anisotropy in the visual cortex 
and a tendency to increased activity 
in the corpus callosum.   *p≤0.05 and 
#p≤0.07.
Figure 11: Neuroinflammation. Both pubertal (A) and young adult (B) apple+GSE fed mice showed a tendency for 
decreased IL-1β gene expression. #p≤0.07.
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Immunohistochemistry
Brain tissue of young adult mice was stained for immature neurons (measure for neurogenesis) 
with doublecortin, postsynaptic density (measure for synaptic plasticity) with PSD95, and 
glucose transporter 1 (measure for capillary density) with GLUT-1. No differences in any of the 
parameters were found (data not shown).
Discussion
Overall, dietary flavanol supplementation in early life led to increased locomotor activity and 
a tendency for decreased neuroinflammation during puberty. In adulthood, we demonstrated 
increased grooming behavior, altered spatial learning and increased white matter integrity. 
Furthermore, CBF was decreased and we found a tendency for decreased neuroinflammation 
during adulthood. See Table 4 for an overview of the main results of the present study.
Both pubertal and young adult apple+GSE fed mice displayed increased locomotor 
activity in the Phenotypers. Barros et al. have shown that anthocyanins, a different class of 
flavonoids, also have the ability to increase locomotion (Barros et al., 2006). It has been suggested 
that locomotion was increased due to improved motor function (Barros et al., 2006; Joseph et al., 
1999; Joseph et al., 1998). Our Rotarod data do not support this theory though, as we did not find 
an effect of flavanol supplementation on motor function.  
Our PPI results, both in adult control and apple+GSE fed mice, were comparable to other 
studies from literature (Fedorova et al., 2009a; Foldi et al., 2011; Matsuo et al., 2010). While the 
pubertal mice showed a habituation response to the 120 dB pulses, the young adult mice 
failed to do so. This is in contrast to other studies showing a habituation response in adulthood 
(Fedorova et al., 2009a; Janssen et al., 2015). An explanation might be that the habituation 
response is decreased due to hearing loss. C57BL/6J mice are prone to early onset hearing loss, 
but not starting at such an early age (Johnson et al., 1997; Yu et al., 2011). This makes it unlikely 
that hearing loss caused the absence of the habituation effect. Similarly, impairment of prepulse 
inhibition has been observed in schizophrenia models (Dashti et al., 2013; Singer et al., 2013). 
However, the C57BL/6J mouse model is not known to be prone for schizophrenia. It has been 
reported that spatial memory in schizophrenia models was also impaired, which is also not the 
case in the present study (Singer et al., 2013). Therefore, our finding may need further research.
Spatial learning and memory may be affected by flavanol supplementation. Other studies 
on models for ageing have demonstrated that flavanols can improve both spatial learning and 
memory (Rendeiro et al., 2009; Rendeiro et al., 2013; Rodrigues et al., 2013; Sasaki et al., 2013; 
Zeng et al., 2012). In our study, all young adult mice showed a learning effect in the MWM, but 
the learning curve of the apple+GSE fed animals differed from the control diet. The apple+GSE 
fed mice showed a higher escape latency on day 1, and a learning effect from day 1 to day 2 
(as in control), and also from day 2 to day 3 finishing with the same escape latency on day 4 
as the control group. Therefore, the apple+GSE fed animal showed a different learning curve 
Figure 12: BDNF concentration. Mature BDNF 
levels were measured and demonstrated no 
diet effect of apple+GSE supplementation. 
Measurement do show an aging effect with 
significantly increased mBDNF concentration 
when comparing young adult mice to their 
pubertal littermates in both diets. **p≤0.01.
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than controls but both groups reached optimal performance by day 4. In the probe phase of the 
MWM, we did not find differences between the groups. Thus, while flavanols might contribute to 
spatial learning, they do not influence spatial memory. 
The young adult mice did not display differences in cerebral metabolism, as measured 
with 1H MRS in the hippocampus. This indicates that neuronal function and inflammation are 
not affected by flavanol supplementation in this young healthy mouse model. NAA, for example, 
functions as a neuronal marker as it is produced by healthy neurons (Govindaraju et al., 2000). We 
did not find changes in NAA concentration indicating that neural function was not affected by 
flavanol supplementation. Doublecortin (a marker for neurogenesis) and BDNF (a neurotrophin) 
concentrations also showed no effect of flavanol supplementation. MI acts as a glial marker and 
can be used as a marker for neuroinflammation (Govindaraju et al., 2000). We did not find changes 
in mI concentration with 1H MRS, suggesting that neuroinflammation remained unaffected after 
flavanol supplementation. This is supported by our data collected with qRT-PCR for expression 
of inflammatory markers and IHC staining for Iba1 which both did not show significant effects 
on neuroinflammation. 
Surprisingly, apple+GSE fed animals demonstrated decreased CBF in the cortex and 
thalamus, but not the hippocampus. There is little supporting literature for this effect, since most 
studies describe increased CBF after flavanol supplementation (Francis et al., 2006; Nehlig, 2013; 
Shah et al., 2010; Sorond et al., 2008). Quercetin, for example, has shown to not only protect 
Table 4: Summary of main results.
Effect of Apple+GSE diet PND 30 PND 60
Phenotyper Locomotor activity Increased 24h activity 
(p=0.041)
NS
Open field Behavior and activity NS Increased grooming (p=0.033)
Rotarod Motor coordination NS NS
Prepulse inhibition Sensorimotor integration
Habituation
NS
NS
NS
NS
Morris water maze Learning and memory n.a. Altered spatial 
learning (p=0.039)
ASL Cerebral blood flow n.a. Decreased CBF: 
cortex (p=0.001) and 
thalamus (p=0.009)
1H MRS Cerebral metabolites n.a. NS
DTI Grey and white 
matter integrity
n.a. Increased diffusion anisotropy 
visual cortex (p=0.014); 
tendency increased 
diffusion anisotropy corpus 
callosum (p=0.066)
Immature neurons Hippocampus n.a. NS
Synaptic plasticity Hipppcampus
Subcortical region
n.a.
NS
NS
NS
Inflammatory markers Hippocampus
Subcortical region
n.a.
Tendency increased 
IL-1β (p=0.067)
NS
Tendency decreased 
IL-1β (p=0.065)
Vascular density Hippocampus
Subcortical region
n.a.
NS
NS
NS
BDNF Subcortical region NS NS
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against microvascular damage, but also against white matter damage in a hypoperfusion rat 
model (Takizawa et al., 2003). While most studies use a specific flavanol component, we used 
a mixture of flavanols which may a reason for the discrepancy in results. Possibly, there is an 
interaction between components that is responsible for our findings. Furthermore, there are 
studies indicating that flavanols may inhibit angiogenesis (Tian et al., 2014; Zhao et al., 2013). We 
hypothesized that decreased CBF in an optimal (young healthy mice) state would be accompanied 
by an increase in GLUT-1 expression to assure a sufficient glucose transport across the blood-
brain barrier. Furthermore, VEGF expression would be decreased due to reduced angiogenesis. 
However, we did not find an effect of flavanol supplementation on VEGF expression, indicating 
that angiogenesis remained unaffected in adulthood. Additionally, the GLUT-1 staining was 
used as a measure for capillary density, but also did not reveal differences in GLUT-1 expression, 
suggesting that capillary density also remained unaffected. It has also been suggested that CBF 
is regulated by glutamate (Attwell et al., 2010). 1H MRS measurements did not display changes in 
glutamate concentration and therefore do also not explain the decrease found in CBF. Therefore, 
an explanation to our results may be that alterations in blood pressure occur, ultimately leading 
to a decrease in CBF. Flavanols are mainly known to have blood pressure lowering properties, 
but epigallocatechine gallate (EGCG) for example demonstrated both vasorelaxant (Alvarez 
et al., 2006; Chen et al., 2000; Lorenz et al., 2009) and vasoconstrictive properties (Sanae et al., 
2002; Shen et al., 2003) in ex vivo studies. This effect appears to be dose-dependent, as the 
vasoconstrictive properties were only apparent at low doses (Shen et al., 2003). Wightman et al. 
also found a reduced CBF in healthy volunteers after a single dose of 135 mg EGCG (Wightman et 
al., 2012). This low dose of EGCG resulted in decreased CBF in the frontal cortex during cognitive 
task performance (Wightman et al., 2012). Further research is necessary to explore these dose-
dependent effects and underlying mechanisms.
In the apple+GSE fed animals we demonstrated a trend for increased diffusion anisotropy 
in the corpus callosum as measured with DTI. Increased white matter fiber coherence could 
lead to improved cognition and motor function, but currently we only observed mild changes 
in spatial learning in the MWM of the apple+GSE fed mice. Furthermore, we found increased 
FA in the visual cortex. However, we did not find any changes in synaptic plasticity in the 
visual cortex as measured in the PSD95 staining. Mean diffusivity, as a measure for grey matter 
integrity, remained unaffected by flavanol supplementation, a finding that corresponds to 
our immunohistochemical data that show no effect on neurogenesis, synaptic plasticity, and 
capillary density. We would expect that the changes found in spatial learning, would be reflected 
by structural changes in the hippocampus. 
The brains of young adult mice were stained immunohistochemically for neurogenesis, 
synaptic plasticity, and capillary density. There were no differences observed in neurogenesis 
and capillary density after flavanol supplementation. We neither found differences in synaptic 
plasticity in the other regions of the dentate gyrus, nor in the visual and sensory cortex. Flavanols 
have been shown to support synaptic plasticity during ageing, which leads us to hypothesize 
that while flavanols do not have an impact during development, they show minor indications 
of a protective effect during ageing (Gomez-Pinilla and Nguyen, 2012; Hu et al., 2008; Rendeiro 
et al., 2009; Zeng et al., 2012). These results also support the findings in the behavioral tests, that 
flavanols do not have a major effect on cognition or motor function. 
Last, we performed qRT-PCR to measure inflammatory markers and synaptic plasticity in the 
brains of young adult mice. We found a trend for decreased IL-1β gene expression in apple+GSE. 
All other inflammatory markers (CD36, IL-6, MCP-1, and TNF-α) did not show differences between 
the diet groups. It should be noted that IL-6, TNF-α, and IL-1β were barely detectable in all dietary 
groups, indicating that young C57BL/6J mice do not experience inflammation. Taken together, 
these data suggest that flavanols only have a minor influence on inflammatory processes in a 
healthy young mouse model. Studies on ageing (AD) and flavanols have shown anti-inflammatory 
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effects of flavanols (Esposito et al., 2014; Lee et al., 2013b; Nishizawa et al., 2011; Vauzour, 2013). 
The qRT-PCR for synaptophysin expression did not demonstrate changes in synaptic plasticity, 
supporting our findings in the PSD95 staining that flavanols do not affect synaptic plasticity 
during neurodevelopment.
Several studies have shown that flavanols are metabolized by the body after administration 
(de Boer et al., 2005; Faria et al., 2014). For this reason, it is important to evaluate the biodistribution 
of flavanols and its metabolites in both dams and offspring. In the current study, we are not able 
to distinguish if any of the found effects can be accounted to flavanols or to their metabolites. 
However, we have shown that both methylated and non-methylated metabolites of catechin and 
epicatechin were detectable at postnatal day 14, in brains and plasma of both dams and pups 
fed the same dietary supplements (unpublished results). These data suggest that flavonoids 
undergo biodegradation and that their metabolites may be absorbed in brain and plasma. 
The formation of these metabolites will most likely depend on mouse microbiota composition 
which may still had been in development in early life, but that has not been determined in the 
current study. It is known from studies in humans that microbiota composition has a high inter-
individual heterogeneity, thus microbiota-mediated polyphenol conversion may differ among 
individuals and related health effects (Bolca et al., 2013; van Duynhoven et al., 2011). 
Furthermore, the dose of flavanols also appears to be very important. As mentioned 
before, low doses may exert opposite effects compared to high doses of flavanols (Lorenz et 
al., 2009; Shen et al., 2003). We should also keep in mind that supplementation of a mixture of 
flavanols as used in this study may act differently than a single component.
All in all, the present study demonstrates that supplementation with dietary flavanols 
early in life may exert mild effects on activity, spatial learning, cerebral blood flow, and brain 
structural integrity during neural development. The changes observed appear to be very subtle 
in the healthy mouse model used. Comparison of these data to published findings in aged 
or neurodegenerating animals suggests that benefits of dietary flavanols may increase with 
advancing age and might be more pronounced in a challenged animal model. 
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Abstract
Apolipoprotein E4 (ApoE), one of three common isoforms of ApoE, is a major risk factor for 
late-onset alzheimer disease (AD). ApoE-deficient mice, as well as mice expressing human 
ApoE4, display impaired learning and memory functions and signs of neurodegeneration. 
Moreover, ApoE  protects against high-fat (HF) diet induced  neurodegeneration by its role in 
the maintenance of the integrity of the blood-brain barrier. The influence of a HF diet on the 
progression of AD-like cognitive and neuropathological changes was assessed in wild-type (WT), 
human ApoE4 and ApoE-knockout (ApoE-/-) mice to evaluate the modulatory role of ApoE in this 
process. From 12 months of age, female WT, ApoE4, and ApoE-/- mice were fed either a standard 
or a HF diet  (19% butter, 0.5% cholate, 1.25% cholesterol) throughout life. At 15 months of age 
mice performed the novel object recognition task and the Morris water maze, evaluating short-
term memory, and spatial learning and memory respectively. No significant differences were 
found in short term memory. ApoE-/- showed increased spatial learning compared to WT mice 
(p=0.009). HF diet improved spatial learning in WT mice (p=0.045), but did not affect ApoE4 
and ApoE-/- mice. Immunohistochemical analyses of the hippocampus demonstrated increased 
neuroinflammation (CD68) in the cornu ammonis 1 (CA1) region in ApoE4 (p=0.001) and in 
ApoE-/- (p=0.032) mice on standard diet. HF diet tended to increase CD68 in the CA1 in WT mice 
(p=0.052), while it decreased in ApoE4 (p=0.009), but ApoE-/- remained unaffected. A trend 
towards increased neurogenesis (DCX) was found in both ApoE4 (p=0.052) and ApoE-/- mice 
(p=0.068). In conclusion, these data suggest that HF intake induces different effects in WT mice 
compared to ApoE4 and ApoE-/- with respect to markers for cognition and neurodegeneration. 
We propose that HF intake inhibits the compensatory mechanisms of neuroinflammation and 
neurogenesis in aged female ApoE4 and ApoE-/- mice.
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Introduction 
Apolipoprotein E4 (ApoE4) is a major genetic risk factor for Alzheimer disease (AD). Carriers 
of ApoE4 have a much higher prevalence and earlier age of onset of Alzheimer disease (AD) 
than non-carriers, There are 3 common APOE isoforms: ApoE2, ApoE4 and ApoE3 which is the 
most prevalent  (Knouff et al., 1999; Stojakovic et al., 2004). While ApoE4 seems to stimulate AD 
pathogenesis, ApoeE2 appears to protect against AD pathology (Kim et al., 2009). Besides being 
a risk factor for AD, ApoE4 is also associated with an increased risk of cardiovascular disease. 
Because of its relatively high affinity for very low density lipoproteins, it leads to a more pro-
atherogenic lipoprotein profile compared to ApoE3 (Mahley et al., 2006; Spinney, 2014; Tanzi 
and Bertram, 2001). Cardiovascular disease, type 2 diabetes mellitus, hypertension and a high fat 
intake at middle age all have been identified as risk factors for cerebrovascular disease including 
AD. All of these factors can be aggravated by a sedentary lifestyle and a high-fat intake (de la 
Torre, 2004; Grammas et al., 2002; Kalaria et al., 2012; Skoog and Gustafson, 2006). Atherosclerosis 
similar to hypertension, is a process that precedes dementia symptoms by many years. Both 
hypertension and atherosclerosis cause impairments in  blood flow and in blood brain barrier 
function,  as do hypoperfusion and  blood vessel wall pathology which may initiate the underlying 
neurodegenerative processes leading to cognitive impairment and ultimately AD (de la Torre, 
2012; Grammas et al., 2002; Kalaria et al., 2012; Muller et al., 2007; Skoog and Gustafson, 2006). A 
decline in regional cerebral blood flow (rCBF) over time in human nondemented ApoE4 carriers 
compared to noncarriers was shown (Thambisetty et al.). Another study showed that decreased 
CBF in patients with metabolic syndrome, a collection of cardiovascular risk factors including 
high triglyceride and low HDL cholesterol levels is associated with impaired cognition (Birdsill 
et al., 2013). Additionally, Zerbi et al. have shown that ApoE4 and ApoE knockout mouse models 
display reduced CBF (Zerbi et al., 2014b).
ApoE is expressed in most tissues in the body, with the brain producing the second highest 
amount after the liver, predominantly in astrocytes [8]. As in the rest of the body, in the brain 
ApoE plays a critical role in cholesterol transport, during development, synaptic remodelling, 
regeneration after injury and inflammatory responses. In vitro studies have also demonstrated 
that ApoE4 leads to a reduced cholesterol synthesis by astrocytes and neurons in comparison 
with ApoE3 (Jansen et al., 2009; Michikawa et al., 2000; Rapp et al., 2006). ApoE4 may therefore 
contribute to the development of AD in various manners, including modulation of cerebral 
lipid homeostasis, vascular function and cerebral  blood flow. However, it was indicated that sex 
differences occur in neurodegeneration and cardiovascular disease (Levi and Michaelson, 2007; 
Rijpma et al., 2013). Therefore, the focus of the current study will be on the effect of a high-fat 
diet in female mice.
ApoE-deficient and human ApoE4-knockin mice have shown cognitive impairment and 
vascular changes (Knouff et al., 1999).  ApoE-deficient mice and also, to a lesser extent, human 
ApoE4 knock-in mice display a pro-atherogenic lipoprotein profile leading to atherosclerosis. 
When fed a high fat diet, ApoE-deficient mice display signs of a dysfunctional blood-brain 
barrier and neurodegeneration. (Jansen et al., 2013b; Libby et al., 2013; Piedrahita et al., 1992). 
In the present study, we tested the hypothesis that female ApoE4 and ApoE-deficient mice are 
vulnerable for high-fat diet induced neurodegeneration and cognitive impairment. Clarity in 
underlying mechanisms may support the development of a dietary approach in the prevention 
of AD, in particularcarriers of ApoE4.
Material and methods 
Animals and diets
Female ApoE4-knockin mice were obtained from Taconic Transgenic Models (Hudson, NY, USA). 
These mice were created by targeting the murine APOE gene for replacement with the human 
APOE4 alleles (4/4) in 129P2/OlaHsd-derived E14TG2a ES cells and injecting the targeted cells 
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into blastocysts. Resultant chimeras were backcrossed to C57BL/6J for 8 generations. The line 
was derived by embryo transfer and is maintained by incrossing homozygous mice.
ApoE deficient female mice (B6,129P2-Apoetm1Unc/J) were obtained from Jackson Laboratories 
(Bar Harbor, ME, USA). The mice were created by targeting the APOE gene in 129P2/OlaHsd-
derived E14TG2a ES cells and injecting the targeted cells into blastocysts. Resultant chimeras 
were backcrossed to C57BL/6J for 11 generations. This line was derived by embryo transfer and 
is maintained by incrossing homozygous mice (Piedrahita et al., 1992).
The C57BL/6J wild-type female mice, used as control mice in the present study, were the 
non-transgenic wild-type littermates of a colony of AβPPswe-PS1dE9 mice originally obtained 
from Johns Hopkins University (Bar Harbor, ME, USA) and subsequently established in our 
lab at Radboud university medical center, Nijmegen, the Netherlands (Jankowsky et al., 2004; 
Jankowsky et al., 2001). At 12 months of age, the female mice were randomly assigned to either 
a standard rodent chow diet (3.3% fat, ssniff Spezialdiäten GmbH, Soest, Germany: CTRL), or a 
high fat cholesterol enhanced diet (19% butter, 0.5% cholate, 1.25% cholesterol: HF) (Mulder et 
al., 2001) and fed for the remainder of the experiments. Starting at 15 months of age, the mice 
underwent cognitive tasks. Afterwards, they were sacrificed by transcardial perfusion with 0.1M 
phosphate buffered saline (PBS) and brains were collected for immunohistochemical purposes. 
Mice were weighed at the start of the cognitive task and on the day that they were sacrificed. 
Throughout the experiments, animals were housed in groups of 6-8 per cage in a 
controlled environment at the central animal facility of the Radboud university medical center. 
Room temperature was controlled at 21 °C, with an artificial 12:12h light:dark cycle (lights on at 
7:00 a.m.), continuous music was playing in the background during the light period, and cage 
enrichment consisted of a plastic shelter and cotton nesting material. Food and water were 
available ad libitum. The experiments were performed according to Dutch federal regulations 
for animal protection and were ethically approved by the Veterinary Authority of the Radboud 
university medical center. In total, 5 ApoE-/- (3 on CTRL and 2 on HF diet) died during the 
experiment from undisclosed causes. The experiments were performed according to Dutch 
federal regulations for animal protection and were ethically approved by the Veterinary Authority 
of the Radboud university medical center (Permit Number: RU-DEC 2009-182). All efforts were 
made to minimize suffering of the animals.
Cognitive tasks
Novel object recognition task (NORT)
The NORT was performed to assess short term memory. The apparatus consisted of a square 
arena (45 cm × 45 cm × 30 cm) with transparent Plexiglas walls. The different objects were (1) 
a black aluminium cylinder with a roughened surface (diameter 7 cm, height 10 cm), (2) a dark 
transparent glass cube (5 cm × 5 cm × 5.5 cm), (3) a ceramic egg (diameter 4 cm, height 6 cm), 
and (4) a set-up of 3 Duplo™ blocks stacked as a pyramid (6.32 cm × 6.32 cm × 4.52 cm). The mice 
were not able to move any of the objects. The order of objects used per subject per session was 
determined using a randomization scheme.
In the habituation phase, the mouse was allowed to explore the empty arena in 4 min 
trials, twice a day, for two days. On the third day, the NORT started. The mouse was presented two 
similar objects in the first trial (T1) and was allowed to explore for 4 min. Subsequently, the mouse 
was returned to the home cage until the second trial. After a predetermined delay interval, the 
mouse was returned to the arena for a second 4 min trial (T2). Now the arena contained two 
dissimilar objects: the familiar object and a new object. The experimental phase was performed 
on 4 consecutive days, each day with a different predetermined delay interval of 0.5h, 1h, 2h, 
and 6h. The time spent exploring the objects was recorded manually. Sitting on an object was 
not considered as exploratory behavior. The discrimination index (d2) in T2 was calculated as a 
measure for object memory:
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Morris water maze (MWM)
The MWM was used to assess spatial learning and memory. The mouse was placed at different 
starting positions in a circular pool (diameter 104 cm) that was filled with water (21-22 °C, made 
opaque by adding milk powder). The mouse was trained to find the platform (diameter 8 cm) 
which was submerged 1 cm below the water surface and located in the north-east quadrant of 
the pool by using distant visual cues. The visual cues were present on the four walls surrounding 
the pool at a distance of 0.5 m. During all trials, the observer was present in the room and always 
located at the same position (behind a curtain surrounding the set-up).
Acquisition phase 
The mouse performed 4 acquisition trials (maximal swimming time 120 s; 30 s on platform; inter-
trial interval 60 min) per day during 4 consecutive days. Starting positions were south, north, 
east, and west. All trials were recorded and latency to find the platform (s) was used as a measure 
for spatial learning.
Probe phase
The mouse performed a single probe trial at the end of day 4 of acquisition, in which the 
platform was removed from the pool. The mouse was allowed to swim freely for 120 s and trials 
were recorded and analyzed at 30 and 120 s with EthoVision XT 7.0 (Noldus, Wageningen, the 
Netherlands). The time spent searching in the target quadrant (north-east) and the number of 
platform crossings were used as a measure for spatial memory.
Immunohistochemistry
Brains were collected for immunohistochemical analysis. Mice were transcardially perfused with 
0.1M PBS and subsequently, brains were collected and cut midsagitally. The left hemisphere was 
used for immunohistochemistry and the right hemisphere for biochemistry. The left hemisphere 
was post-fixed overnight in 4% paraformaldehyde at 4 °C and thereafter stored in 0.1M PBS with 
0.01% sodiumazide at 4 °C. After cryoprotection with 30% sucrose, the hemisphere was cut in 
coronal sections with a sliding microtome (Microm HM 440, Walldorf, Germany) equipped with 
an object table for freeze sectioning at -60 °C gaining 6 parallel series of 40 µm thick sections (240 
µm distance between the sections). The sections were used to visualize and quantify immature 
neurons (measure for neurogenesis) with antibodies against doublecortin (DCX), to determine 
postsynaptic density (measure for synaptic plasticity) with antibodies against postsynaptic 
density protein 95 (PSD95), glucose transporters (measure for vascular density) with antibodies 
against glucose transporter 1 (GLUT-1), and microglia (measure for inflammation) with antibodies 
against cluster of differentiation 68 (CD68).
Immunohistochemistry was performed using standard free-floating labeling procedures, 
using the following protocol. Sections were incubated overnight with the primary antibody on 
a shaker table at room temperature (RT). After this incubation, sections were rinsed three times 
with 0.1M PBS and afterwards incubated with the secondary antibody. After 90 minutes, sections 
were rinsed three times again and transferred to 0.1M PBS containing Vector ABC-elite (1:800; 
Vector Laboratories Inc., Burlingame, CA, USA) for another 90 minutes. After rinsing three times, 
the sections were incubated with diaminobenzidine-nickel (DAB-Ni) solution to visualize the 
marker. Last, stained sections were mounted on gelatin-coated glass slides, dried overnight in a 
stove at 37 °C, dehydrated in alcohol series, cleared with xylol and mounted in Entellan.
For DCX, polyclonal goat anti-doublecortin (1:3,000; sc-8066; Santa Cruz Biotechnology 
Inc., Santa Cruz, CA, USA) was used as a primary antibody to assess neurogenesis. The secondary 
antibody was donkey anti-goat biotin (1:1,500; Jackson ImmunoResearch, West Grove, PA, USA). 
In the PSD95, polyclonal rabbit anti-PSD95 (1:2,000; ab18258; Abcam Inc., Cambridge, UK) as a 
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primary antibody to visualize the postsynaptic density. The secondary used was donkey anti-
rabbit biotin (1:1,500; Jackson ImmunoResearch, West Grove, PA, USA). For GLUT-1, polyclonal 
rabbit anti-GLUT-1 (1:20,000; AB1340; Chemicon International Inc., Temecula, CA, USA) was used 
as a primary antibody and donkey anti-rabbit biotin (1:1,500; Jackson ImmunoResearch, West 
Grove, PA, USA) was used as a secondary antibody. In the CD68, polyclonal rat anti-CD68 (1:15,000; 
ab53444; Abcam Inc., Cambridge, UK) as a primary antibody to visualize the postsynaptic density. 
The secondary used was donkey anti-rat biotin (1:1,500; Jackson ImmunoResearch, West Grove, 
PA, USA).
Quantification doublecortin
DCX positive cells were quantified in three succeeding sections of the hippocampus (-1.70, -2.18 
mm, and -2.46 mm posterior to bregma) for each mouse (Franklin and Paxinos, 2008). Contours 
were drawn along the borders of the hippocampus at 2.5× magnification using the program 
Stereo Investigator (Microbrightfield, Williston, VT, USA). The DCX positive cells in the subgranular 
zone of the hippocampus were manually counted at 40× magnification and the values of the 
three succeeding sections were averaged to obtain a single value for each animal.
Quantification PSD95
The relevant regions in the hippocampus were digitized using Stereo Investigator. Contours of 
the visual and sensory cortex and the inner molecular layer (IML), outer molecular layer (OML), 
stratum radiatum (SR), and stratum lucidum (SL) of the hippocampus (-2.18 mm up to -2.46 
mm posterior to bregma) were drawn at 2.5× magnification (Franklin and Paxinos, 2008). Per 
region, 2 photographs were taken at 100× magnification. The quantification of the staining was 
performed using the program Image J (National Institute of Health, Bethesda, MD, USA). Images 
were converted to 8-bit gray scale, followed by conversion to 16-bit gray scale, next the contrast 
was enhanced and the amount of tissue stained was measured with a threshold-based approach. 
We did not set limits for the particle size.
Quantification  GLUT-1 and CD68
Relevant regions in the hippocampus were digitized using Stereo Investigator. Photographs 
of the whole hippocampus (-2.18 mm up to -2.46 mm posterior to bregma) were taken and 
contours of the CA1, CA3, and DG were drawn at 5x magnification (Franklin and Paxinos, 2008). 
The quantification of the staining was performed using the program Image J. Images were 
converted to 8-bit gray scale and the amount of tissue stained was measured with a threshold-
based approach. Measurement of GLUT-1 and CD68 density was defined as the area covered by 
either GLUT-1 or CD68 immunoreactivity per mm2 of the total area of the region measured.
Statistical analyses
Data are expresses as mean ± standard error of the mean with SPSS for Windows 20.0 software 
(SPSS Inc., Chicago, IL ,USA). The set-up of the present study was designed to determine the effect 
of diets and the extent to which ApoE4 and ApoE-/- mice develop cognitive deficits. Therefore, the 
statistical analyses was performed separately for ApoE4 and ApoE-/- mice (ApoE4 versus WT and 
ApoE-/- versus WT).
The repeated measures ANOVA was used for the acquisition phase of the MWM. A univariate 
ANOVA was used for analysis of the DCX staining. The probe phase of the MWM, the ORT, and 
stainings for PSD95, GLUT-1 and CD68 were analyzed with a multivariate ANOVA. If the Bonferroni 
post hoc test indicated a significant interaction between genotype and diet (and trial day in the 
MWM), the data were split for the concerning factor and analyzed again. For readability reasons, 
F-values and degrees of freedom are not displayed in the text. Statistical outliers were removed 
from the dataset. Statistical significance was set at * p≤0.05 and a trend at # 0.05<p<0.07.
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Results 
The effect of the high fat intake on body weight was assessed prior to cognitive testing when the 
mice were 15 months old. A high fat diet led to an increased body weight in both the ApoE4 and 
WT mice (Figure 1; p<0.001), but not in the ApoE-/- mice. After the cognitive testing period, body 
weight of the WT and ApoE-/- mice both on standard and on HFD remained unchanged (p>0.05), 
while body weight of the HF fed ApoE4 mice had further increased (p=0.002). There were no 
differences in brain weight immediately after brain collection (p>0.05, Table 1).
Cognitive tasks
NORT
Short term memory was assessed in the NORT. No differences were observed between the 3 
groups (ApoE4 compared to WT and ApoE-/- compared to WT) nor was there any effect of the HF 
diet (p>0.05; data not shown). 
MWM
Mice were subjected to the MWM to examine spatial learning and spatial memory (Figure 2). 
The increased body weights in the wild-type and ApoE4 mice, caused by the HF diet, did not 
affect mean swimming velocity or total swimming distance (p>0.05). For this reason, we did not 
correct for body weight in the statistical analysis. In the acquisition phase, all groups displayed a 
learning effect (Figure 2A and B; p<0.001). Furthermore, HF fed WT mice displayed a decreased 
Table 1: Brain weights for immunohistochemistry.
Values represent mean ± SEM
WT ApoE4 ApoE-/-
CTRL diet 0.49 ± 0.01 0.43 ± 0.02 0.48 ± 0.02
HF diet 0.43 ± 0.02 0.49 ± 0.01 0.44 ± 0.02
Figure 1: Body weight during the experimental phase. HF diet increased body weight pre- 
and post-testing in both ApoE4 and WT mice compared to the CTRL diet, but not in ApoE-/-. 
Furthermore, the body weight increase due to HF diet was significantly stronger in ApoE4 
compared to WT. 
WT CTRL n=8, WT HF n=8, ApoE4 CTRL n=8, ApoE4 HF n=8, ApoE-/- CTRL n=5, ApoE-/- HF n=6.  
*p≤0.05
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escape latency compared to the animals on standard diet (p=0.045). ApoE-/- mice demonstrated 
a decreased escape latency compared to WT mice (p=0.009). We did not observe significant 
differences in the probe phase of the MWM at 30 and 120 s (p>0.05).
Immunohistochemistry
DCX
The DCX staining was used as an indicator of neurogenesis. The data suggest a genotype effect 
as we observed a trend for increased adult neurogenesis in ApoE4 and ApoE-/- mice (Figure 3; 
ApoE4 vs WT p=0.052, ApoE-/- vs WT p=0.068). No diet effects were detectable (p>0.05). 
 
Figure 3: DCX-positive cells in the DG. ApoE4 and 
ApoE-/- mice display a trend for increased adult 
neurogenesis compared to WT mice (p=0.052 and 
p=0.068 respectively). 
Values represent mean±SEM; WT CTRL n=4, WT HF 
n=6, ApoE4 CTRL n=4, ApoE4 HF n=7, ApoE-/- CTRL 
n=4, ApoE-/- HF n=7. #0.05<p<0.07
Figure 2A: MWM acquisition ApoE4 versus WT. Both 
groups displayed a learning effect (p=0.000). HF fed 
mice showed improved spatial learning compared to 
CTRL diet (p=0.045).
Figure 2B: MWM acquisition ApoE-/- versus WT. Both 
groups displayed a learning effect (p=0.000). ApoE-/- 
demonstrated improved spatial learning compared 
to WT mice (p=0.009). There was no difference in 
spatial learning between diets.
WT CTRL n=6, WT HF n=7, ApoE4 CTRL n=8, ApoE4 
HF n=8, ApoE-/- CTRL n=6, ApoE-/- HF n=6. *p≤0.05
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CD68
CD68 expression is used as a measure for neuroinflammation as, in the brain, it reflects the 
presence of microglia (Figure 5). We demonstrated a genotype × diet interaction in the 
CA1 (p=0.001), CA3 (p=0.024), and DG (p=0.047) when comparing ApoE4 to WT. When fed a 
standard diet, the ApoE4 mice showed significantly more inflammation in the CA1 than WT mice 
(p=0.001). We observed the same pattern in the CA3 and the DG although these results were 
not significant (p>0.05). A HF diet decreased CD68 immunoreactivity in the CA1 of ApoE4 mice 
(p=0.009). When comparing ApoE-/- to WT, we also demonstrated a genotype × diet interaction 
in the CA1 (p=0.010) and CA3 (p=0.023). ApoE-/- mice on standard diet showed significantly 
increased inflammation in the CA1 when compared to WT mice (p=0.032). The HF diet did not 
affect inflammation in ApoE-/- mice. Furthermore, significantly increased inflammation in the DG 
for ApoE-/- mice was observed (p=0.029). In contrast, HF fed WT mice displayed a trend towards 
an increase in inflammation in the CA1 (p=0.052).
PSD95
PSD95 staining was analyzed as an indicator for synaptic plasticity in the visual and sensory 
cortex, and the IML, OML, SR and SL of the hippocampus. No genotype or diet effects were found 
for synaptic plasticity (p>0.05, data not shown). 
GLUT-1
GLUT-1 density is used as a measure for capillary density as it reflects the glucose transport across 
the BBB. We did not observe significant differences in capillary density, as determined by GLUT-1 
staining, caused by either genotype or diet (p>0.05, data not shown).
Figure 4: CD68 immunoreactivity.  In the CA1, we observed a genotype × diet interaction  (p=0.001), there was a 
trend for increased inflammation in WT after HF supplementation  (p=0.052). Inflammation in ApoE4 mice significantly 
decreased after HF supplementation  (p=0.009). ApoE4 mice on CTRL demonstrated increased inflammation compared 
to WT mice on CTRL  (p=0.001). ApoE-/- compared to WT mice showed a genotype × diet interaction (p=0.010). ApoE-/- on 
CTRL demonstrated increased inflammation when compared to WT mice on CTRL (p=0.032).
In the CA3, a genotype × diet interaction was observed  (p=0.024) but no significant effect on inflammation caused by 
genotype or diet when comparing ApoE4 to WT mice. Furthermore, ApoE-/- compared to WT mice showed a genotype × 
diet interaction (p=0.023). No significant effects on inflammation caused by genotype or diet were found though.
In the DG, we observed a genotype × diet interaction (p=0.047) when comparing ApoE4 to WT mice. There was a trend 
for increased inflammation in ApoE4 mice on CTRL diet compared to WT mice on CTRL (p=0.063). In addition, ApoE-/- 
displayed increased inflammation when compared to WT mice (p=0.029).
WT CTRL n=5, WT HF n=7, ApoE4 CTRL n=7, ApoE4 HF n=5, ApoE-/- CTRL n=4, ApoE-/- HF n=6. *p≤0.05, #0.05<p<0.07
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Discussion 
Overall, our data suggest increased signs of neurodegeneration in ApoE4 mice and in ApoE-/- 
mice in comparison with WT mice. A HF diet reduces signs of neurodegeneration in both ApoE4 
mice and, to a lesser extend, in ApoE-/- mice, while it increases it in WT mice.
Our data show that the NORT does not reveal any differences in short term memory 
performance in 15 months old female ApoE4, ApoE-/- and WT mice. All groups displayed a 
spatial learning effect in the MWM task, with the ApoE-/- performing better than the WT mice. A 
beneficial effect of a HF diet on acquisition of the MWM task was observed in the WT mice, while 
no effect of HF diet was observed in ApoE4 and ApoE-/- mice. 
In the current study, the ApoE-/- mice displayed better spatial learning in the MWM 
when compared to WT mice. Previously, male ApoE-/- have been shown to display impaired 
performance in the MWM in comparison with WT mice, but their performance improved under 
certain (stressful) conditions (Champagne et al., 2002; Grootendorst et al., 2001; Grootendorst et 
al., 2002; Oitzl et al., 1997). In contrast with our observations impaired performance in the MWM 
was observed in female ApoE-/- mice at advanced  age (>14 months) (Grootendorst et al., 2004), 
but not in younger animals. Results from a study by Champagne et al. indicate that male ApoE-/- 
mice are not able to learn the procedural component of how to get to the platform as opposed 
to knowing where the platform is located (Champagne et al., 2002). This deficit was much larger 
in older (12 months old) than in younger (3 months old) ApoE-/- mice. These older male mice also 
displayed deficits in their ability of knowing where the platform is located. Yin et al. have shown 
similar age-related deficits for male ApoE4 mice (Yin et al., 2014). In the current study, it appears 
that female ApoE-/- are impaired in the procedural component of knowing where the platform is 
located. Other studies have shown spatial memory deficits in male ApoE4 mice and even more 
in ApoE4 female mice which have been attributed to estrogen (Bour et al., 2008; Raber et al., 
1998). However, the females in our study have already reached (post-)menopausal stages where 
androgen levels are comparable to those of male mice (Rijpma et al., 2013; Suckow et al., 2001). In 
addition, Andrews-Zwilling et al. have shown that female ApoE4 mice display an age-dependent 
decrease in hilar GABAergic interneurons, correlating with the extent of ApoE4-induced learning 
and memory deficits in aged mice (Andrews-Zwilling et al., 2010). As stress was shown to affect 
performance in the MWM, the results may be complicated by the stress induced by the forced 
swimming. Additionally, differences in the temperature of the water may affect performance. 
Therefore, the Barnes maze may be a less stressful alternative test for ApoE-/- mice for assessment 
of  spatial learning and memory.
ApoE is known for its anti-inflammatory effect. Addition of exogenous ApoE and its 
mimetics down-regulate activation of microglia and peripheral macrophages in vitro (Dorey et al., 
2014). The absence of ApoE and also the ApoE4 isoform are therefore associated with secretion 
of inflammatory factors and increased neurinflammation (Dorey et al., 2014). ApoE4 enhances 
neuroinflammation either due to dysregulation of the nuclear factor-κB signaling cascade or 
due to an increase in cytokine levels (Dorey et al., 2014; Ophir et al., 2005). The HF diet increases 
the number of microglia in WT mice exclusively. Strikingly, the ApoE-/- animals showed increased 
neuroinflammation when fed standard rodent chow, but a decrease when fed a HF diet. The 
same was found in ApoE4 mice. 
We hypothesized that the HF diet would decrease neurogenesis and synaptic plasticity 
in ApoE4 and ApoE-/- animals due to decreased levels of brain-derived neurotrophic factor 
(Dhungana et al., 2013; Molteni et al., 2002). However, on a control diet the ApoE-/- mice and also 
to a lesser extend in the ApoE4 mice already displayed a tendency for increased DCX expression. 
Increased DCX levels leads to more neurons, however we do not know if these neurons are 
actually surviving and/or functional. This may indicate that a repair mechanism for neurogenesis 
and synaptic plasticity is active in the control diet, but that this is no longer effective on HF diet. 
Our data are in line with results from Jansen et al. who have previously shown increased adult 
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neurogenesis in aged male ApoE-/- mice (Jansen et al., 2013b).
ApoE-containing lipoprotein particles secreted by astrocytes are supportive of 
synaptogenesis and maintenance of synaptic connections (Levi et al., 2003). Therefore, synaptic 
plasticity might be decreased in  mice deficient for ApoE. Though, we did not find alterations 
in synaptic plasticity, as indicated by PSD95 staining, in both ApoE4 and ApoE-/- mice as 
compared to WT mice. This finding suggests that the proposed compensation mechanism 
for neurodegeneration appears to be sufficient at this age. A HF diet did not detectably affect 
synaptic plasticity in any of the groups. It has previously been shown that ApoE4 expression 
leads to reduced cerebral vascularization that is accompanied by thinner vessel walls and 
decreased glucose uptake (Alata et al., 2015). Under  suboptimal conditions the number of GLUT-
1 transporters may increase to ensure sufficient glucose transport.  Strikingly, we found no effects 
in the number of GLUT-1 transporters in the hippocampus of both ApoE4 and WT mice after HF 
supplementation. In addition, ApoE-/- also did not show any differences in the number of GLUT-1 
transporters compared to WT mice. In line with these findings, Alata et al. were also not able to 
show a difference in GLUT-1 expression in ApoE4 compared to WT mice (Alata et al., 2015).
Overall, our data suggest that HF intake induces a different effect in WT versus ApoE4 and 
ApoE-/- mice with respect to markers for neurodegeneration and cognition. We propose that HF 
intake inhibits the compensatory mechanisms of neuroinflammation and neurogenesis in aged 
female ApoE4 and ApoE-/- mice. Underlying mechanisms for neurogenesis, synaptic plasticity 
and neuroinflammation need to be elucidated in order to develop the dietary management for 
APOE4-carriers.
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A wide range of studies have shown that nutrients are able to affect the brain in many ways 
throughout life. Omega-3 polyunsaturated fatty acids (n-3 PUFA) such as docosahexaenoic 
acid (DHA) and eicosapentaenoic acid (EPA) have been shown to have beneficial effects on 
cardiovascular health and brain function (Bang et al., 1971; Bang et al., 1980; Estruch et al., 
2013; Hoevenaar-Blom et al., 2012; Hooijmans et al., 2009; Jansen et al., 2014). In recent years, 
it has become clear that the Mediterranean diet, which contains high levels of long-chain 
polyunsaturated fatty acids (LCPUFA) and low levels of saturated and trans-fatty acids, contributes 
in maintaining a healthy brain (Estruch et al., 2013; Feart et al., 2009; Gardener et al., 2011; 
Hooijmans et al., 2009; Jansen et al., 2014). This diet includes a balanced n-6/n-3 ratio, due to the 
fact that it is rich in fish, lean meat, and olive oils, but it also contains other important nutrients, 
such as vitamins, antioxidants and polyphenols, originating from fruits, vegetables, and whole 
grains (Feart et al., 2009; Gardener et al., 2011; Hoevenaar-Blom et al., 2012). This in contrast to 
Western diets that are rich in saturated fats, trans fats, sugar, and refined grains (Hooijmans et al., 
2009; Jansen et al., 2012; Kanoski and Davidson, 2011). 
In this thesis, we aimed to determine the influence of several nutrients on neural 
development and neurodegeneration. We studied the effect of perinatal availability of LCPUFA 
(chapter 3) and flavanols from fruits (chapter 4) on neural development in C57Bl/6J mice. 
Furthermore, we studied the effect of a cholesterol enhanced diet, mimicking a bad Western 
diet, on neurodegeneration in mouse models at risk for atherosclerosis and Alzheimer’s disease 
(AD) (chapter 5).
LCPUFA
LCPUFA have been shown to act beneficial in obtaining and maintaining a healthy brain. They 
are important already at the start of life supporting neural development, and preventing 
neurodevelopmental disorders.  Throughout life LCPUFA remain important for membrane fluidity, 
synaptic plasticity, neurogenesis, as anti-inflammatory mediators, and for cardiovascular health 
(Hooijmans et al., 2009; Jansen et al., 2014; O’Connor et al., 2001; van Goor et al., 2011b; Westerberg 
et al., 2011; Wurtman, 2008; Zerbi et al., 2014a). Supplementation studies in animals, starting 
early in life, show more potent influence on these mechanisms than those starting during aging 
or in AD mouse models (Carrié et al., 2000b; Fedorova and Salem, 2006; Hooijmans et al., 2009; 
Jansen et al., 2014; Maekawa et al., 2009; Niculescu et al., 2011). This suggests that it is important 
to achieve an optimal LCPUFA status early on in life and maintain this status throughout life to 
attain beneficial effects. In our review (chapter 2) we showed that LCPUFA have beneficial effects 
on brain health, such as increased neurogenesis and decreased neuroinflammation. A healthy 
and balanced diet is not only established by a sufficient intake of n-3 PUFA; the n-6/n-3 ratio is 
most important for an efficient conversion of n-3 and n-6 PUFA. The key message in maintaining 
this healthy LCPUFA status is finding the proper n-6/n-3 balance, with an optimal ratio of about 
1/1 – 2/1 (Hjorth and Freund-Levi, 2012; Innis, 2008; Simopoulos, 2008b, 2011; van Goor et al., 
2010; Wall et al., 2010).
In chapter 3, we aimed to investigate the influence of dietary n-3 PUFA availability during 
the development of C57BL/6J mice on behavior, cognition, cerebral metabolism, and brain 
plasticity. Our findings indicate that dietary intake of both α-linolenic acid (ALA) and preformed 
DHA during early development has a significant impact on neural and brain development as well 
as on cognition and behavior.
N-3 PUFA availability stimulated cognition and behavior in pubertal and young 
adult C57Bl/6J mice. Motor coordination increased already during puberty due to n-3 PUFA 
supplementation, but did not improve in young adulthood. This suggests that the n-3 PUFA 
adequate diet induced accelerated development of motor coordination already early in life 
before adulthood. During development, Purkinje cells are innervated by multiple climbing 
fibers, but around postnatal day (PND) 21 (juvenile age) many synapses are eliminated, leading 
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to mono-innervation of the Purkinje cells (Bearzatto et al., 2005). It has been suggested that a 
delay in the elimination of multiple climbing fibers innervating the Purkinje cells occurs in adult 
C57Bl/6J mice when compared to other mouse strains (Bearzatto et al., 2005). This results in poor 
motor performance of the C57Bl/6J mice at juvenile age (Bearzatto et al., 2005). The findings in 
our studies indicate that this possible delay in C57BL/6J might be shortened by adequate dietary 
n-3 PUFA availability, and a plateau in the development of motor coordination may already be 
reached before adulthood. In young adulthood, we observed increased sensorimotor integration, 
improved spatial memory, and exploratory behavior in the n-3 PUFA fed mice. Sensorimotor 
integration increased in young adult C57Bl/6J mice on an adequate n-3 PUFA intake as well. 
This was reflected in the prepulse inhibition test by improved habituation to startle stimuli and 
therefore may indicate an improved cortical development by adequate n-3 PUFA intake (Geyer 
and Dulawa, 2001). LCPUFA have been shown to ameliorate the impaired prepulse inhibition 
in a schizophrenia rat model (Maekawa et al., 2009). Schizophrenia is a condition that mostly 
develops during early adulthood and has been associated with LCPUFA deficiency (Levant et 
al., 2004; Moriguchi et al., 2001; Umezawa et al., 1995) and it is characterized by alterations in 
dopaminergic neurotransmission (McNamara and Carlson, 2006). These data suggest that 
LCPUFA supplementation may support dopaminergic neurotransmission processes by its ability 
to improve membrane fluidity (Levant et al., 2004). It has been reported that high levels of n-3 
PUFA are associated with a negative effect on neural development by prolonging auditory brain 
stem conduction times and a delay in auditory startle reflex in rodents (Haubner et al., 2007; 
Saste et al., 1998).  These studies show the importance of dosage and indirectly underline the 
relevance of the n-6/n-3 ratio. Several studies have stated the probable relation of learning 
and memory functions with brain fatty acid status (Fedorova and Salem, 2006; Moriguchi et al., 
2001). However, results on spatial learning and memory remain somewhat inconsistent (Carrié 
et al., 2000a; Carrié et al., 2000b; Kavraal et al., 2012; Moriguchi et al., 2000). The main distinction 
between the studies appear to be the starting point of supplementation or deprivation and 
the dosage of the diets. This underlines the importance of choosing the right starting point 
for supplementation and composition of the diet. No specific anxiety tests were performed in 
the study described in chapter 3, but we did find increased exploratory behavior in n-3 PUFA 
adequate fed C57Bl/6J mice in the open field. On the contrary, no differences were found in time 
spent in the corners, indicating that there are no signs of anxiety in this parameter. However, 
other studies have shown decreased anxiety after n-3 PUFA supplementation in the open field 
task (Clouard et al., 2015; Moriguchi et al., 2001; Perez et al., 2013; Vinot et al., 2011). 
We performed phosphorus magnetic resonance spectroscopy (31P MRS) in young adult 
C57Bl/6J mice to study phosphorylated energy and lipid metabolites in the brain. Although 
we found decreased neurogenesis in the hippocampus of n-3 PUFA adequate fed mice with 
immunohistochemistry, no changes  in membrane formation could be detected  with 31P MRS. 
Membrane turnover was reflected by phosphomonoesters (building blocks for membranes) 
and phosphodiesters (breakdown products of membranes) and showed no changes in our 
experiment. We were only able to measure whole brain metabolite status with the 31P MRS 
method, making it difficult to detect subtle changes in specific brain regions. Measurements 
in separate brain regions such as hippocampus and cortex may be a more sensitive method to 
detect metabolite changes.
To our knowledge, we are the first to show diminished neurogenesis in young adult mice 
as effect of increased n-3 PUFA availability during development. Our immunohistochemical 
data on hippocampal neurogenesis strengthen the idea that n-3 PUFA induce a plateau in 
neurogenesis before adulthood. In line with these results, the n-3 PUFA adequate animals showed 
enhanced performance on the rotarod in puberty, but not in adulthood. At young adult age, n-3 
PUFA adequate fed mice still demonstrated improved spatial memory in the Morris water maze 
(MWM). Our data obtained by quantitative real-time PCR (qRT-PCR) support our hypothesis, as 
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doublecortin (DCX) mRNA expression remains unaffected during both puberty and adulthood. 
Several studies have shown increased neurogenesis after LCPUFA supplementation already 
before pubertal age (Crupi et al., 2012; Maekawa et al., 2009; Niculescu et al., 2011). All together, 
these data suggest that n-3 PUFA may promote accelerated neurogenesis, possibly even before 
puberty. Additional gene expression analysis (for example cyclicAMP response element binding 
protein (CREB)): involved in long-term potentiation, or peroxisome proliferator-activated 
receptor and retinoid X receptor: involved in regulating synaptic plasticity, and learning and 
memory) may further support our findings.
Our results obtained via qRT-PCR indicate that synaptic plasticity may be increased in n-3 
PUFA fed mice at pubertal age in the cortex, while it remains unaffected at adult age. Several 
studies demonstrated an increased expression of pre- and postsynaptic proteins after n-3 PUFA 
supplementation, hinting at increased synaptogenesis either early on in life or during aging (Cao 
et al., 2009a; Crupi et al., 2012). Our data on synaptophysin expression led us to hypothesize 
that synaptogenesis is stimulated at adolescent age on a n-3 PUFA adequate diet, and reaches a 
plateau before adult age. 
The results in chapter 3 led us to hypothesize that perinatally administered dietary n-3 
PUFA have the potential to improve cortical and hippocampal development and enhance 
cognitive functioning. While our study focused on dietary n-3 PUFA availability in a healthy 
mouse model, it already yields a range of beneficial effects in brain functioning. Our findings 
indicate that ensuring adequate dietary n-3 PUFA levels starting early in life may support optimal 
neural development in healthy full term infants. Furthermore, our results implicate that it would 
be interesting to study the effect of a sufficient n-3 PUFA intake in disorders caused by an n-3 
PUFA deficiency more extensively. Therefore, based on our findings we would advise a balanced 
LCPUFA intake throughout life, starting already directly after conception. For pregnant women, 
this translates into the intake of three LCPUFA rich (containing fatty fish) portions a week starting 
in the early stages of pregnancy. This may help in preventing disorders caused by LCPUFA 
deficiency, such as autism spectrum disorders and ADHD. Future studies may help to specify the 
beneficial effects for their children throughout life in more detail.
Flavanols
The effects of flavonoid supplementation have been studied in normal aging and 
neurodegenerative models, but little is known about their influence during development. In 
neurodegeneration, flavonoids have shown to exert neuroprotective properties such as the 
modulation of neuroinflammation and improvement of cognition (Vauzour, 2012). It has been 
shown that flavonoids modulate neuronal signaling pathways involved in synaptic plasticity and 
neurogenesis (Spencer, 2010; Vauzour, 2012). In vivo, flavonoids are able to affect these pathways 
by activation of CREB receptors and brain derived neurotrophic factor (BDNF), mechanisms that 
are involved in memory acquisition and consolidation (Spencer, 2010). Flavonoids possibly affect 
neural development, but this has not been studied yet. 
In chapter 4, we aimed to study the impact of flavanol availability during gestation and 
the postnatal period on brain structure, circulation, cognition, and metabolism in C57Bl/6J mice. 
Our study demonstrates that supplementation with dietary flavanols early in life may exert mild 
beneficial effects on locomotor activity, spatial learning, cerebral blood flow, and brain structural 
integrity during neural development.
We observed effects of flavanol supplementation in locomotor activity during both 
puberty and young adulthood in C57Bl/6J mice. The flavanol supplemented mice displayed 
increased locomotion, which has been explained as an effect of improved motor function 
(Barros et al., 2006; Joseph et al., 1999; Joseph et al., 1998). However, we did not observe effects 
of flavanol supplementation on motor coordination as measured in the Rotarod. Sensorimotor 
integration was not affected by flavanol supplementation at either pubertal or young adult 
100
Chapter 6
age. Surprisingly, we observed a decreased habituation response on both diets in the prepulse 
inhibition test during adulthood. Since the C57Bl/6J mice are not prone to hearing loss at young 
adult age (Johnson et al., 1997; Yu et al., 2011), nor to schizophrenia (Dashti et al., 2013; Singer 
et al., 2013), our finding needs further research to find a logical explanation. Spatial learning 
and memory may be affected by flavanol supplementation. However, flavanols did not influence 
spatial learning or memory in our experiment. 
In this study, the flavanol supplemented diet did not affect cerebral metabolism 
in the hippocampus of young adult C57Bl/6J mice as  investigated with proton magnetic 
resonance spectroscopy (1H MRS). These results are supported by our data collected with 
immunohistochemistry, enzyme-linked immunosorbent assay (ELISA), and qRT-PCR. 
flavanol supplementation did not affect markers for neurogenesis, neurotrophin, and 
neuroinflammation.  
Surprisingly, flavanol supplemented C57Bl/6J demonstrated decreased cerebral blood 
flow (CBF) in the cortex and thalamus, but not the hippocampus in adulthood. There is little 
supporting literature for this effect, since most studies describe increased CBF after flavanol 
supplementation (Francis et al., 2006; Nehlig, 2013; Shah et al., 2010; Sorond et al., 2008). An 
explanation for our results may be that alterations in blood pressure occur, ultimately leading 
to a decrease in CBF. Flavanols are mainly known to have blood pressure lowering properties, 
but epigallocatechine gallate (EGCG) for example, demonstrated both vasorelaxant (Alvarez 
et al., 2006; Chen et al., 2000; Lorenz et al., 2009) and vasoconstrictive properties (Sanae et al., 
2002; Shen et al., 2003) in ex vivo studies. This effect appears to be dose-dependent, as the 
vasoconstrictive properties were only apparent at low doses (Shen et al., 2003). Wightman et al. 
also found a reduced CBF in healthy volunteers after a single dose of 135 mg EGCG (Wightman et 
al., 2012). This low dose of EGCG resulted in decreased CBF in the frontal cortex during cognitive 
task performance (Wightman et al., 2012). Further research is necessary to explore these dose-
dependent effects and underlying mechanisms.
In the flavanol supplemented young adult mice, we demonstrated a trend for increased 
fractional anisotropy in the corpus callosum as measured with diffusion tensor imaging (DTI). 
Increased white matter integrity  could lead to improved cognition and motor function, 
but currently we only observed mild changes in spatial learning in the MWM of the flavanol 
supplemented mice. Moreover, we found increased fractional anisotropy in the visual cortex. 
Though, we did not find any changes in synaptic plasticity in the visual cortex measured with 
immunohistochemistry. Mean diffusivity, as a measure for grey matter integrity, remained 
unaffected by flavanol supplementation, a finding that corresponds to our immunohistochemical 
data that showed no effect on neurogenesis, synaptic plasticity, and capillary density. We would 
expect that the changes found in spatial learning, would be reflected by structural changes in 
the hippocampus. Flavanols have been shown to support synaptic plasticity during aging, which 
leads us to hypothesize that while flavanols do not have an impact during development, they 
show minor indications of a protective effect during aging (Gomez-Pinilla and Nguyen, 2012; 
Hu et al., 2008; Rendeiro et al., 2009; Zeng et al., 2012). These results also support the findings in 
the behavioral tests, suggesting that flavanols do not have a major effect on cognition or motor 
function. 
Last, our qRT-PCR data suggest that flavanols only have a minor influence on inflammatory 
processes in a healthy young mouse model. Studies on aging (AD) and flavanols have shown anti-
inflammatory effects of flavanols (Esposito et al., 2014; Lee et al., 2013b; Nishizawa et al., 2011; 
Vauzour, 2013). Synaptic plasticity was not affected during neurodevelopment as measured with 
qRT-PCR and immunohistochemistry.
In chapter 4, we were not able to distinguish if any of the found effects can be accounted 
to flavanols or to their metabolites. Additionally, the dose of flavanols appears to be very 
important. As mentioned before, low doses may exert opposite effects compared to high doses 
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of flavanols (Lorenz et al., 2009; Shen et al., 2003). We should keep in mind that supplementation 
of a mixture of flavanols as used in this study may exert  different effects  compared to  single 
component suplementation, due to antagonistic effects.   
All in all, our study demonstrates that supplementation with dietary flavanols early in 
life may exert mild effects on activity, spatial learning, cerebral blood flow, and brain structural 
integrity during neural development. The changes observed appear to be very subtle in the 
healthy mouse model used. Comparison of published findings with our data suggests that 
benefits of dietary flavanols may increase with advancing age and might be more pronounced 
in a challenged animal model. Based on these findings, we would advise a sufficient intake of 
flavonoid containing fruits in pregnant women. Future studies may help to further specify the 
beneficial effects in their children throughout life.
Cholesterol & ApoE
In chapter 5, we hypothesized that ApoE4 and ApoE deficient mice are vulnerable to high-fat 
diet induced neurodegeneration and cognitive impairment. From 12 months of age, female mice 
(ApoE4 and ApoE-/-) were fed either a standard diet or a high-fat diet  throughout life. At 15 months 
of age, short-term memory and spatial learning and memory was assessed. Our experiments 
show that short term memory was not affected by a high-fat diet. Furthermore, all groups 
displayed spatial learning in the MWM. ApoE-/- mice performed the task better than WT mice. 
High-fat fed mice demonstrated improved spatial learning compared to standard diet. ApoE4 
and ApoE-/- mice showed a tendency for increased neurogenesis, while neurogenesis remained 
unaffected by the high-fat diet. Synaptic plasticity and capillary density were not significantly 
affected by the high-fat diet. From these results, it appears that HF intake induces a different 
effect in WT versus ApoE4 and ApoE-/- mice with respect to markers for neurodegeneration, 
and behavior. A high-fat diet did not lead to signs of neurodegeneration, but rather appears to 
protect WT mice from neurodegeneration. Furhtermore, high-fat intake inhibits the observed 
compensatory mechanism of neuroinflammation and neurogenesis in aged female ApoE4 and 
ApoE-/- mice. 
ApoE-/- have been shown to perform better in the MWM under certain (stressful) 
circumstances (Champagne et al., 2002; Grootendorst et al., 2001; Grootendorst et al., 2002; Oitzl 
et al., 1997). However, results from a study by Champagne et al. indicate that male ApoE-/- mice 
are not able to learn the procedural component of how to get to the platform as opposed to 
knowing where the platform is located. This deficit was much larger in older (12 months old) 
than in younger (3 months old) ApoE-/- mice. These older male mice also displayed deficits in 
their ability of knowing where the platform is located. Yin et al. have shown similar age-related 
deficits for male ApoE4 mice (Yin et al., 2014). In our experiment, female ApoE-/- mice displayed 
an impaired ability for spatial memory. They show an impairment in knowing where the platform 
is located. However, the females in our study have already reached (post-)menopausal stages 
where androgen levels are comparable to those of male mice (Rijpma et al., 2013; Suckow et 
al., 2001). In addition, Andrews-Zwilling et al. have shown that female ApoE4 mice display an 
age-dependent decrease in hilar GABAergic interneurons, correlating with the extent of ApoE4-
induced learning and memory deficits in aged mice (Andrews-Zwilling et al., 2010). As stress was 
shown to affect performance in the MWM, the results may be complicated by the stress induced 
by the forced swimming. Additionally, differences in the temperature of the water may affect 
performance. Therefore, the Barnes maze may be a less stressful alternative test for ApoE-/- mice 
for assessment of  spatial learning and memory.
CD68 expression is used as a measure for neuroinflammation as it reflects the expression 
of microglia in the brain. ApoE is known to exert anti-inflammatory effects. It was shown by 
Dorey et al. that addition of exogenous ApoE and ApoE derived peptides down-regulate 
activation of microglia and peripheral macrophages in vitro (Dorey et al., 2014). The absence of 
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ApoE and also the ApoE4 isoform are therefore associated with secretion of inflammatory factors 
and increased neurinflammation (Dorey et al., 2014). ApoE4 enhances neuroinflammation 
either via dysregulation of the nuclear factor-κB signaling cascade or caused by an increase in 
cytokine levels (Dorey et al., 2014; Ophir et al., 2005). The high-fat diet increases the number of 
microglia in WT mice exclusively. Strikingly, the ApoE-/- animals showed a tendency for increased 
neuroinflammation when fed standard rodent chow, but not when fed a high-fat diet. Thus, we 
hypothesize that the high-fat diet in the ApoE-/- model may trigger a possible compensation 
mechanism. 
We expected that the high-fat diet would decrease neurogenesis and synaptic plasticity 
in ApoE4 and ApoE-/- animals due to decreased levels of brain-derived neurotrophic factor 
(Dhungana et al., 2013; Molteni et al., 2002). Contrarily, ApoE-/- mice and to a lesser extend ApoE4 
mice already displayed a tendency for increased DCX expression on a control diet. Increased 
DCX levels lead to more neurons, however we do not know for sure if these neurons are actually 
surviving and/or functional. This may indicate that a repair mechanism for neurogenesis and 
synaptic plasticity is active when the mice are on control diet. Supplementation of the high fat 
diet challenges this repair mechanism, making it no longer effective. Jansen et al. have previously 
shown increased adult neurogenesis in aged male ApoE-/- mice (Jansen et al., 2013b). With 1H 
MRS, it is possible to measure the concentration of NAA, a marker for healthy neurons, and this 
method may provide more clarity about the condition of the newly formed neurons (Jansen 
et al., 2013b). Furthermore, other MR imaging techniques such as functional connectivity and 
diffusion tensor imaging would give more insight into neuronal functioning.
Cholesterol is released from ApoE-containing lipoprotein particles and is used for support 
of synaptogenesis and maintenance of synaptic connections (Levi et al., 2003). Thus, we would 
expect that synaptic plasticity is decreased in ApoE-/- mice due to decreased cholesterol release. 
However, we did not find indications for alterations in synaptic plasticity in both ApoE4 and 
ApoE-/- mice. This suggests that the proposed compensation mechanism for neurodegeneration 
still appears to be sufficient in these aged female mice. Yet, high-fat supplementation did not 
affect synaptic plasticity. 
Glucose transport 1 (GLUT-1) is responsible for the glucose transport across vessel walls. 
Hence, it is used as a marker capillary density and indication of blood vessel wall health. It was 
shown that ApoE4 expression leads to reduced cerebral vascularization that is accompanied 
by thinner vessel walls and decreased glucose uptake (Alata et al., 2015). We expect that in a 
suboptimal state (hypercholesterolemia or even neurodegeneration) the number of GLUT-
1 transporters would have increased to ensure sufficient glucose transport (compensation 
mechanism). In contrast, the GLUT-1 staining did not demonstrate alterations in the number of 
GLUT-1 transporters in the hippocampus after high-fat supplementation. Additionally, ApoE-/- 
did not show any differences in the number of GLUT-1 transporters indicating that the proposed 
compensation mechanism was possibly no longer effective. In line with these findings, Alata et 
al. were also not able to show a difference in GLUT-1 expression in ApoE4 mice (Alata et al., 2015).
In short, the results of chapter 5 suggest that high-fat supplementation induces different 
effects in WT versus ApoE4 and ApoE-/- mice with respect to markers for neurodegeneration 
and cognition. We propose that high-fat intake inhibits the compensatory mechanisms of 
neuroinflammation and neurogenesis in aged female ApoE4 and ApoE-/- mice. Hence, we 
would advise to limit the intake of cholesterol and saturated fatty acids to protect from 
hypercholesterolemia, atherosclerosis, and subsequent neurodegeneration in APOE4 carriers. 
Underlying mechanisms for neurogenesis, synaptic plasticity and neuroinflammation need to 
be elucidated in order to develop a more detailed dietary management for APOE4 carriers.
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Concluding remarks
In chapter 2, we summarized that LCPUFA have a beneficial effect on a healthy brain, wherein 
the n-6/n-3 ratio is essential when establishing a healthy and balanced diet. The key message 
in maintaining this healthy LCPUFA status is finding the proper n-6/n-3 balance, with a ratio of 
about 1/1 – 2/1.
In chapter 3, we postulate that perinatally administered dietary n-3 PUFA have the potential 
to improve cortical and hippocampal development and enhance cognitive functioning. While 
our study focused on dietary n-3 PUFA availability in a healthy mouse model, it already yields 
a range of beneficial effects in brain functioning. Overall, our findings indicate that ensuring 
adequate dietary n-3 PUFA levels starting early in life may support optimal neural development 
in healthy full term infants. Furthermore, our results implicate that it would be interesting to 
study the effect of a sufficient n-3 PUFA intake in n-3 PUFA deficient pregnant females and in 
disorders caused by underlying n-3 PUFA deficiency more extensively. 
The results in chapter 4 indicate that supplementation with dietary flavanols early in 
life may exert mild beneficial effects on activity, spatial learning, cerebral blood flow, and brain 
structural integrity during neural development. The changes observed appear to be very subtle 
in the healthy mouse model used. Comparison of these data to published findings in aged 
or neurodegenerating animals suggest that benefits of dietary flavanols may increase with 
advancing age and might be more pronounced in a challenged animal model. Additionally, 
dietary flavanols may have a beneficial effect on neural development in pregnant females and 
infants with a deficiency.  
And last, in chapter 5  we suggest that high-fat supplementation induces different 
effects in WT versus ApoE4 and ApoE-/- mice with respect to markers for neurodegeneration 
and cognition. We propose that high-fat intake inhibits the compensatory mechanisms of 
neuroinflammation and neurogenesis in aged female ApoE4 and ApoE-/- mice. Hence, limited 
intake of cholesterol and saturated fatty acids seems to protect from hypercholesterolemia, 
atherosclerosis, and subsequent neurodegeneration in APOE4 carriers. Underlying mechanisms 
for neurogenesis, synaptic plasticity and neuroinflammation need to be elucidated in order to 
develop a more detailed dietary management for APOE4 carriers.
Overall, in this thesis we demonstrated the influence of n-3 PUFA and flavanols on neural 
development. Especially n-3 PUFA were confirmed to have a beneficial effect on brain 
functioning starting at an early age. Flavanols have shown a potentially positive influence on 
brain structure and functioning, though the changes were very subtle in our healthy mouse 
model. Mouse models at risk for atherosclerosis and AD appear to be protected from AD-like 
neurodegenerative changes. High-fat intake inhibits this compensatory mechanism. On the other 
hand, high-fat intake provides WT mice with a compensatory mechanism for neurodegeneration 
and neuroinflammation. 
All in all, this thesis underlines the importance of a healthy and balanced diet throughout 
life. We have shown that n-3 PUFA and flavanols support neural development starting during 
pregnancy and may even be more important in at risk pregnancies. Infants suffering from 
disorders caused by nutrient deficiencies may benefit from a balanced diet even more. The 
beneficial effects of n-3 PUFA and flavanols support a healthy brain throughout life and may 
protect from neurodegeneration in later life. While cholesterol is required for membrane synthesis 
and the formation of bile acids and steroid hormones, a high-fat diet does not support healthy 
aging of the brain when at risk for atherosclerosis and AD. The key message in obtaining and 
maintaining a healthy brain is finding a proper balance in nutrients such as n-3 PUFA, flavanols 
and cholesterol.
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Summary
Nutrition plays an important role in the development and maintenance of a healthy brain. It 
has been shown that nutrients such as lipids and polyphenols influence the health status of 
the brain. Current diets are associated with large cultural differences in health. For example, a 
typical Western diet is characterized by a high-fat intake and increases the risk of obesity and 
cognitive impairment. On the contrary, a Mediterranean diet is based on fish, olive oil, fruits, nuts, 
vegetables and whole grains and decreases the risk of cardiovascular disease and contributes 
to a healthy brain. Studies suggest that nutrients supporting healthy cardiovasculature 
are also responsible for a healthy brain. Nutrients related to atherosclerosis have also been 
associated with neurodegeneration and cognitive impairment. In this thesis, we focused on the 
influence of n-3 PUFA and flavonoids on neural development, and the influence of cholesterol 
in neurodegeneration in genetic risk factors for cardiovascular impairments and Alzheimer’s 
disease.
In chapter 2, we have reviewed the involvement of LCPUFA from early development onto aging 
of the brain. We showed that LCPUFA have beneficial effects on a healthy brain by increasing the 
formation of neurons and decreasing inflammation of the brain. A healthy and balanced diet is 
not only established by a sufficient intake of n-3 PUFA. The n-6/n-3 ratio is most important for an 
efficient conversion of n-3 and n-6 PUFA. The key message in maintaining this healthy LCPUFA 
status is finding the proper n-6/n-3 balance, with an optimal ratio of about 1/1 – 2/1.
In chapter 3, we aimed to obtain detailed insights into the mechanisms underlying the long-term 
beneficial effects of n-3 PUFA availability during gestation and throughout life in mice. A broad 
combination of parameters was determined to assess effects on behavior, brain structure and 
function. Our findings indicate that dietary intake of both ALA and preformed DHA during early 
development has a significant impact on neural and brain development as well as on cognition 
and behavior. N-3 PUFA availability stimulated cognition and behavior in pubertal (PND 30) and 
young adult (PND 60) C57Bl/6J mice. Motor coordination increased already during puberty due 
to n-3 PUFA supplementation, but did not improve in young adulthood. These results suggest 
that n-3 PUFA induced an acceleration in the development of motor coordination. In young 
adulthood, we observed increased sensorimotor integration, improved spatial memory, and 
signs of exploratory behavior in the n-3 PUFA fed mice. No specific anxiety tests were performed 
in the study described in chapter 3, but we did find increased exploratory behavior in n-3 
PUFA adequate fed C57Bl/6J mice in the open field. On the contrary, no signs of anxiety were 
demonstrated in the open field. 31P MRS was performed in young adult C57Bl/6J mice to study 
energy metabolism and lipid metabolites in the brain. Although we found decreased neurogenesis 
in the hippocampus of n-3 PUFA adequate fed mice with immunohistochemistry, no changes 
in membrane formation could be detected  with 31P MRS. Membrane turnover was reflected 
by phosphomonoesters (building blocks for membranes) and phosphodiesters (breakdown 
products of membranes) and showed no changes in our experiment. To our knowledge, we are 
the first to show diminished neurogenesis in young adult mice as an effect of increased n-3 PUFA 
availability during development. Our immunohistochemical data on hippocampal neurogenesis 
strengthen the idea that n-3 PUFA induce a plateau in neurogenesis before adulthood. In line 
with these results, the n-3 PUFA adequate animals showed enhanced performance on the 
rotarod in puberty, but not in adulthood. At young adult age, n-3 PUFA adequate fed mice still 
demonstrated improved spatial memory in the MWM. Data obtained by qRT-PCR support our 
hypothesis, as DCX mRNA expression remains unaffected during both puberty and adulthood. 
Furthermore, these data indicate that synaptic plasticity may be increased in n-3 PUFA fed 
mice at pubertal age in the cortex, while it remains unaffected at adult age. This has led us to 
hypothesize that synaptogenesis is stimulated at adolescent age on a n-3 PUFA adequate diet, 
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and reaches a plateau before adult age. Based on the results in chapter 3, we postulate that 
perinatally administered dietary n-3 PUFA may support optimal development of the brain in 
healthy full term infants. Additionally, n-3 PUFA may also provide beneficial effects in disorders 
caused by an n-3 PUFA deficiency. We would advise a balanced LCPUFA intake throughout life. 
For pregnant women, this translates into the intake of three LCPUFA rich (containing fatty fish) 
portions a week starting in the early stages of pregnancy. This may help in preventing disorders 
caused by LCPUFA deficiency, such as autism spectrum disorders and ADHD.
In chapter 4, we evaluated the impact of flavanol availability during gestation and the postnatal 
period in mice to understand the mechanisms underlying potential long-term beneficial effects 
throughout life. The effects of flavonoid supplementation have been studied in normal aging 
and neurodegenerative models, but little is known about their influence during development. 
In neurodegeneration, flavonoids have shown to exert neuroprotective properties. A broad 
spectrum of parameters was investigated in order to assess effects on brain structure and 
function. Flavanol supplemented mice displayed increased locomotion, but motor coordination 
remained unaffected. The flavanol diet did not affect cerebral metabolism as measured with 1H 
MRS. Markers for neurogenesis, neurotrophin, and neuroinflammation also showed no effect 
of flavanol supplementation. Surprisingly, flavanol supplemented C57Bl/6J  demonstrated 
decreased CBF in the cortex and thalamus, but not the hippocampus in adulthood. There is little 
supporting literature for this effect, since most studies describe increased CBF after flavanol 
supplementation. An explanation to our results may be that alterations in blood pressure occur, 
ultimately leading to a decrease in CBF. Additionally, some flavanols, such as epigallocatechine 
gallate, have demonstrated both vasorelaxant and vasoconstrictive properties. Further research 
is necessary to explore dose-dependent effects and underlying mechanisms. We found no major 
structural changes in the brain as measured with DTI. In this experiment, we were not able to 
distinguish if any of the found effects can be accounted to flavanols or to their metabolites. 
We should keep in mind that supplementation of a mixture of flavanols as used in this study 
may act differently than a single component, due to antagonistic effects. All in all, our study 
demonstrates that supplementation with dietary flavanols early in life may exert mild effects 
on activity, spatial learning, cerebral blood flow, and brain structural integrity during neural 
development. The changes observed appear to be very subtle in the healthy mouse model 
used. Comparison of these data to published findings in aged or neurodegenerating animals 
suggests that benefits of dietary flavanols may increase with advancing age and might be more 
pronounced in a challenged animal model. Based on these findings, we would advise a sufficient 
intake of flavonoid containing fruits in pregnant women. Future studies may help to further 
specify the beneficial effects in their children throughout life.
In chapter 5, we hypothesized that ApoE4 and ApoE-/- mice are vulnerable to high-fat diet 
induced neurodegeneration and cognitive impairment. Our experiments show that short term 
memory was not affected by a high-fat diet in 15 months old female ApoE4, ApoE-/- and WT mice. 
All mice demonstrated a spatial learning effect in the MWM task, where ApoE-/- mice performed 
better than WT mice. The high-fat diet displayed a beneficial effect on spatial learning in WT 
mice, while no effect of the diet was observed in ApoE4 and ApoE-/- mice. In the current study, 
it appears that female ApoE-/- are impaired in the procedural component of knowing where the 
platform is located. It is not likely that these findings can be attributed to estrogen, as the female 
mice in our study have already reached (post-)menopausal stages where androgen levels are 
comparable to those of male mice. It is known that stress can affect the performance of the mice 
in the MWM, thus the results may be influenced by stress from forced swimming. In addition, 
differences in the temperature of the water may affect performance. Therefore, the Barnes 
maze may be a less stressful alternative test for ApoE-/- mice for assessment of  spatial learning 
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and memory. Strikingly, the ApoE-/- animals showed increased neuroinflammation when fed 
standard rodent chow, but a decrease when fed a HF diet. The same was found in ApoE4 mice. 
We hypothesized that the HF diet would decrease neurogenesis and synaptic plasticity in ApoE4 
and ApoE-/- animals due to decreased levels of brain-derived neurotrophic factor. However, on a 
control diet the ApoE-/- mice and to a lesser extent the ApoE4 mice already displayed a tendency 
for increased DCX expression. Increased DCX levels result in more neurons, but these neurons 
may not survive and/or be functional. This may indicate that a repair mechanism for neurogenesis 
and synaptic plasticity is active in the control diet, but that this effect is no longer effective on HF 
diet. Cholesterol is released from ApoE-containing lipoprotein particles and is used for support 
of synaptogenesis and maintenance of synaptic connections. From this, we expected that 
synaptic plasticity is decreased in ApoE-/- mice due to decreased cholesterol release. Indeed, we 
did not find alterations in synaptic plasticity in neither ApoE4 nor ApoE-/- mice. This suggests that 
the proposed compensation mechanism for neurodegeneration appears to be sufficient at this 
age. We expected that in a suboptimal state (hypercholesterolemia or even neurodegeneration) 
the number of GLUT-1 transporters would increase to ensure sufficient glucose transport 
(compensation mechanism). However, we found no effects in the number of GLUT-1 transporters 
in the hippocampus of both ApoE4 and WT mice after HF supplementation. Similarly, ApoE-/- 
did not show any differences in the number of GLUT-1 transporters compared to WT mice. In 
short, these data suggest that a high-fat diet induces different effects in WT mice compared 
to ApoE4 and ApoE-/- mice. Underlying mechanisms for neurogenesis, synaptic plasticity and 
neuroinflammation need to be elucidated in order to develop the dietary management for 
APOE4-carriers.
Overall, this thesis has demonstrated the influence of n-3 PUFA and flavanols on neural 
development. Especially n-3 PUFA were confirmed to have a beneficial effect on brain functioning 
starting at an early age. Flavanols have shown a potentially positive influence on brain structure 
and functioning, though the changes were very subtle in our healthy mouse model. We were 
not able to elucidate the effect of dietary cholesterol in neurodegeneration and cognitive 
impairment in mouse models at risk for atherosclerosis and Alzheimer’s disease. 
This thesis underlines the importance of a healthy and balanced diet throughout life. We 
have shown that n-3 PUFA and flavanols support neural development starting during pregnancy 
and may even be more important in at risk pregnancies. Infants suffering from disorders 
caused by nutrient deficiencies may benefit from a balanced diet even more. The beneficial 
effects of n-3 PUFA and flavanols support a healthy brain throughout life and may protect 
from neurodegeneration in later life. As cholesterol is required for membrane synthesis and 
the formation of bile acids and steroid hormones, a high-fat diet may inhibit the compensatory 
mechanisms of neuroinflammation and neurogenesis in aged female mice at risk for AD. The key 
message in obtaining and maintaining a healthy brain is finding a proper balance in nutrients 
such as n-3 PUFA, flavanols and cholesterol.
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Samenvatting
Voeding speelt een belangrijke rol in de ontwikkeling en het onderhouden van een gezond 
brein. Onderzoek heeft aangetoond dat voedingsstoffen zoals vetten en polyfenolen invloed 
hebben op de gezondheid van de hersenen. Moderne voedingspatronen leiden tot wisselende 
effecten op gezondheid door grote culturele verschillen. Een voorbeeld hiervan is het Westerse 
dieet dat wordt gekenmerkt door een hoog-vetgehalte en het risico op obesitas en cognitieve 
beperkingen verhoogt. Een Mediterraan dieet daarentegen is gebaseerd op vis, olijfolie, 
vruchten, noten, fruit en volkoren en vermindert het risico op cardiovasculaire ziekten en 
draagt bij aan een gezond brein. Onderzoekers veronderstellen dat voedingsstoffen die een 
gezond hart- en vaatstelsel ondersteunen ook verantwoordelijk zijn voor een gezond brein. Zo 
zijn voedingsstoffen die atherosclerose veroorzaken ook geassocieerd met neurodegeneratie 
en cognitieve beperkingen. In dit proefschrift werd de invloed van omega-3 vetzuren en 
flavonoïden op neurale ontwikkeling, en op de invloed van cholesterol in combinatie met 
genetische risicofactoren voor hart- en waardeverminderingen en de ziekte van Alzheimer op 
neurodegeneratie bestudeerd.
In hoofdstuk 2 werd de invloed van meervoudig onverzadigde vetzuren op de vroege 
ontwikkeling en op veroudering van de hersenen geëvalueerd. Literatuuronderzoek toonde 
aan dat meervoudig onverzadigde vetzuren gunstige effecten hebben op de gezondheid van 
het brein door een toegenomen vorming van neuronen en een afname in ontsteking van de 
hersenen. Een gezonde en evenwichtige voeding wordt niet alleen bereikt door voldoende 
inname van omega-3 vetzuren. De verhouding tussen omega-6 en -3 vetzuren is zeer belangrijk 
voor een efficiënte omzetting van deze vetzuren. Het belangrijkst voor het onderhouden van 
een gezonde vetzuurstatus is het vinden van de juiste balans tussen omega-6 en -3 vetzuren, 
met een optimale verhouding van ongeveer 1/1 - 2/1.
In hoofdstuk 3 werd getracht inzicht in de werkingsmechanismen van omega-3 vetzuren te 
verkrijgen. De beschikbaarheid van omega-3 vetzuren tijdens de dracht en gedurende het hele 
leven van muizen geven op de lange termijn positieve effecten. Een breed scala aan parameters 
werd gebruikt om de effecten op het gedrag, de structuur en functie van de hersenen te 
beoordelen. Ons onderzoek heeft aangetoond dat de inname van zowel ALA als DHA tijdens 
de vroege ontwikkeling een gunstige invloed heeft op neurale ontwikkeling en op cognitie 
en gedrag. De beschikbaarheid van omega-3 vetzuren verbeterde cognitie en gedrag in zowel 
puberale als jong volwassenen C57BL/6J muizen. Motorisch coördinatievermogen was tijdens de 
puberteit al verbeterd onder invloed van omega-3 vetzuren, maar liet geen verdere verbetering 
zien tijdens volwassenheid. Deze resultaten duiden erop dat voldoende voedselinname van 
omega-3 meervoudig onverzadigde vetzuren leidt tot een versnelde ontwikkeling van motorisch 
coördinatievermogen. In jong volwassen muizen werd een verhoogde sensorimotorische 
integratie, verbeterd ruimtelijk geheugen, en tekenen van exploratief gedrag waargenomen 
in de met omega-3 vetzuren gevoede muizen. Er werden geen specifieke testen voor angst 
uitgevoerd, er werd echter wel een toename in exploratief gedrag in met omega-3 vetzuren 
gevoede C57BL/6J muizen waargenomen. Met 31P MRS in jong volwassen C57BL/6J muizen 
werden  het energiemetabolisme en vetmetabolieten in de hersenen bestudeerd. Hoewel we 
in hoofdstuk 3 een afname van neurogenese in de hippocampus van met omega-3 vetzuren 
gevoede muizen aantoonden, konden met immunohistochemie geen veranderingen in de 
membraanvorming worden gedetecteerd. De omzet van membranen wordt weerspiegeld 
door phosphomonoesters (bouwstenen voor membranen) en fosfodiesters (afbraakproducten 
van membranen), maar toonde geen veranderingen in ons experiment. Voor zover ons 
bekend, zijn wij de eersten die een afname van neurogenese in jong volwassen muizen onder 
invloed van omega-3 vetzuren tijdens de ontwikkeling laten zien. De immunohistochemische 
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data betreffende neurogenese in de hippocampus versterken onze hypothese dat omega-3 
vetzuren een plateaufase in neurogenese veroorzaken vóór het bereiken van volwassenheid. In 
overeenstemming met deze resultaten vertoonden de met omega-3 vetzuren gevoede dieren 
een verbetering in motorisch coördinatievermogen op de Rotarod tijdens puberteit, maar 
niet tijdens volwassenheid. Op jong volwassen leeftijd vertoonden de muizen een versterkt 
ruimtelijk geheugen onder invloed van omega-3 vetzuren. Resultaten verkregen met qRT-
PCR ondersteunen deze hypothese, want de mRNA expressie van het eiwit doublecortin blijft 
onveranderd in zowel de puberteit als volwassenheid. Bovendien geven deze resultaten aan 
dat synaptische plasticiteit in de cortex kan worden verhoogd met omega-3 vetzuren tijdens 
de puberteit, terwijl deze niet verandert tijdens volwassenheid. Op basis van de resultaten uit 
hoofdstuk 3 veronderstellen we dat synaptogenese door omega-3 vetzuren wordt gestimuleerd 
tijdens de adolescentie en dat er een plateau wordt bereikt vóórdat volwassenheid bereikt is. 
Dit betekent dat perinataal toegediende omega-3 vetzuren in gezonde voldragen zuigelingen 
een optimale ontwikkeling van de hersenen te ondersteunen. Bovendien kunnen omega-3 
vetzuren ook gunstige effecten bij aandoeningen veroorzaakt door een tekort in omega-3 
vetzuren. Daarom adviseren we om gedurende het hele leven voldoende omega-3 vetzuren in 
het voedingspatroon op te nemen. Bij zwangere vrouwen vertaalt zich dit in de inname van 
drie omega-3 vetzuurrijke (met vette vis) porties per week vanaf de vroege zwangerschap. Dit 
kan bijdragen aan het voorkomen van aandoeningen die kunnen worden veroorzaakt door een 
tekort aan omega-3 vetzuren, zoals autisme spectrum stoornissen en ADHD.
In hoofdstuk 4 hebben we het effect van de inname van flavanolen tijdens de dracht en 
gedurende het hele leven van muizen bestudeerd. De effecten van diëten verrijkt met 
flavonoïden zijn reeds onderzocht in normale veroudering en modellen voor neurodegeneratie, 
maar er is nog weinig bekend over hun invloed tijdens de ontwikkeling. Onderzoekers hebben 
aangetoond dat flavonoïden bescherming kunnen bieden tegen neurodegeneratie. Een breed 
spectrum van parameters werd onderzocht om de effecten op de hersenen structuur en functie 
te bestuderen. Een met flavanolen verrijkt dieet veroorzaakte toegenomen algehele activiteit 
in muizen, maar had geen effect op het motorisch coördinatievermogen. Flavanolen hadden 
geen invloed op het breinmetabolisme, zoals werd gemeten met 1H MRS. Ook markers voor 
neurogenese, neurotrofine en neuroinflammatie vertoonden geen effect van flavanolen. 
Opmerkelijk was de waarneming dat onder invloed van flavanolen de hersendoorbloeding 
CBF in de cortex en thalamus daalde in volwassen muizen. De hersendoorbloeding in de 
hippocampus van volwassen muizen veranderde echter niet. De meeste wetenschappelijke 
studies beschrijven een verhoging van de hersendoorbloeding onder invloed van flavanolen. 
Een verklaring voor onze bevindingen kan zijn dat er veranderingen in de bloeddruk optreden 
die leiden tot een afname van de hersendoorbloeding. Daarnaast is voor een aantal flavanolen, 
zoals epigallocatechine gallaat, aangetoond dat ze zowel vaatverwijdende en vasoconstrictieve 
eigenschappen bezitten. Verder onderzoek is dan ook nodig om de dosis-afhankelijke effecten 
en de onderliggende mechanismen te bestuderen. We vonden in dit hoofdstuk geen grote 
structurele veranderingen in de hersenen zoals gemeten met DTI. We konden echter niet 
onderscheiden of de gevonden effecten verklaard kunnen worden door flavanolen of door hun 
metabolieten. In deze studie is er gebruik gemaakt van een mengsel van flavanolen. Mogelijk 
leidt dit tot andere effecten dan bij het gebruik van de individuele componenten als gevolg van 
antagonistische effecten. Al met al, toont deze studie aan dat een dieet verrijkt met flavanolen 
al op vroege leeftijd milde effecten op algehele activiteit, ruimtelijk leren, hersendoorbloeding 
en de structuur van de hersenen uit kunnen oefenen. Onze bevindingen in een gezonde 
muismodel zijn echter zeer subtiel. Onderzoekers hebben reeds aangetoond dat de potentie 
van flavanolen groter is in dieren met neurodegeneratie. Op basis van deze studie adviseren 
we zwangere vrouwen om voldoende flavanoïden in het voedingspatroon op te nemen door 
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dagelijks voldoende fruit zoals bijvoorbeeld appels en druiven te eten. Verder onderzoek is nodig 
om de mogelijk gunstige effecten in kinderen gedurende het hele leven in detail te kunnen 
bestuderen.
In hoofdstuk 5 werd de invloed van een hoog-vetdieet op neurodegeneratie en cognitie in ApoE4 
en ApoE-/- bestudeerd. Onze studie toont aan dat het korte termijngeheugen niet werd beïnvloed 
door een hoog-vetdieet in verouderde ApoE4 en ApoE-/- muizen. Alle muizen vertoonden het 
vermogen tot ruimtelijk leren in de MWM, maar ApoE-/- presteerden beter in deze test dan WT 
muizen. Het hoog-vetdieet liet een gunstig effect in het ruimtelijk leervermogen van WT muizen 
zien, maar had geen effect op ApoE4 en ApoE-/- muizen. Uit deze studie blijkt dat de ApoE-/- 
muizen beperkt zijn in de procedurele component van de test: het weten waar het platform zich 
bevindt. Het lijkt niet waarschijnlijk dat dit effect veroorzaakt wordt door oestrogeen, omdat de 
vrouwelijke muizen in deze studie zich al in de (post-)menopauze bevinden. In deze fase zijn de 
androgeenniveaus vergelijkbaar met die van mannelijke muizen. Het is al eerder aangetoond 
dat stress de prestaties van muizen in de MWM test kan beïnvloeden. Mogelijk hebben de 
muizen in deze studie dan ook stress ondervonden doordat ze gedwongen hebben moeten 
zwemmen. Ook kunnen temperatuurverschillen van het water de prestaties beïnvloeden. 
Wellicht kan de zogenaamde Barnes maze een minder stressvol alternatief bieden om het 
ruimtelijk leervermogen en geheugen van de ApoE4 en ApoE-/- te bestuderen. Het is opmerkelijk 
dat de ApoE-/- muizen een toename in neuroinflammatie laten zien op een controledieet, maar 
een afname vertonen op het hoog-vetdieet. Hetzelfde patroon werd gevonden in ApoE4 muizen. 
We hadden verwacht dat deze muizen een afname van synaptische plasticiteit en neurogenese 
onder invloed van het hoog-vetdieet zouden vertonen als gevolg van een verlaging van BDNF-
niveaus. De ApoE-/- muizen, en in mindere mate de ApoE4 muizen, laten echter een tendens 
voor toegenomen expressie van het eiwit doublecortin zien. Een verhoogde expressie van 
doublecortin leidt tot een toegenomen vorming van neuronen, maar geeft nog geen uitsluitsel 
of deze neuronen ook overleven en/of functioneel zijn. Deze resultaten kunnen erop duiden 
dat er een herstelmechanisme voor neurogenese en synaptische plasticiteit actief is onder 
invloed van het controledieet, en dat dit mechanisme niet langer werkzaam is onder invloed 
van cholesterol en verzadigde vetten. Cholesterol komt vrij uit lipoproteïnen die ApoE bevatten 
en wordt gebruikt ter ondersteuning van synaptogenese en onderhoud van de synaptische 
verbindingen. Daarom verwachtten we dat de synaptische plasticiteit in ApoE-/- muizen verlaagd 
zou zijn door de afgenomen afgifte van cholesterol. Zoals verwacht, vertoonden zowel de 
ApoE4 als de ApoE-/- muizen geen veranderingen in synaptische plasticiteit. Het lijkt erop dat het 
beschreven compensatiemechanisme voor neurodegeneratie op deze leeftijd nog werkzaam 
is in de ApoE4 en ApoE-/- muizen. Er wordt verondersteld dat het aantal GLUT-1 transporters in 
een suboptimale situatie (hypercholesterolemie of zelfs neurodegeneratie) toe zou nemen om 
voldoende transport van glucose te garanderen (als compensatiemechanisme). In hoofdstuk 5 
werden echter geen veranderingen in het aantal GLUT-1 transporters in ApoE4 en WT muizen 
gevonden onder invloed van het hoog-vetdieet. Ook in de ApoE-/- muizen werden geen 
veranderingen in GLUT-1 transporters gevonden. Al met al tonen de bevindingen uit hoofdstuk 
5 aan dat een dieet rijk aan vetten verschillen effecten veroorzaakt in WT muizen vergeleken 
met ApoE4 en ApoE-/- muizen. De onderliggende werkingsmechanismen voor neurogenese, 
synaptische plasticiteit en neuroinflammatie moeten worden opgehelderd om een dieetadvies 
voor dragers van het APOE4-gen op te kunnen stellen.
Samengevat toont dit proefschrift de invloed van de omega-3 vetzuren en flavanolen op neurale 
ontwikkeling aan. Vooral omega-3 vetzuren vertonen al vanaf jonge leeftijd een gunstige 
invloed op het functioneren van de hersenen. Flavanolen hebben mogelijk een positieve 
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invloed op de structuur en het functioneren van de hersenen, maar de veranderingen waren erg 
subtiel in gezonde muizen. De invloed van een hoog-vetdieet op neurodegeneratie en cognitie 
in muismodellen met een risico op atherosclerose en de ziekte van Alzheimer is niet geheel 
ontrafeld.
De bevindingen in dit proefschrift benadrukken het belang van een gezonde en 
evenwichtige voeding gedurende het hele leven. We hebben aangetoond dat omega-3 vetzuren 
en flavanolen de neurale ontwikkeling al vanaf het begin van de zwangerschap en gedurende 
het hele leven beïnvloeden. Deze voedingsstoffen zijn mogelijk nog meer van belang in 
risicovolle zwangerschappen waarbij sprake is van een tekort aan voedingsstoffen. Zuigelingen 
die een risico hebben op aandoeningen veroorzaakt door tekorten aan voedingsstoffen kunnen 
wellicht meer profiteren van een gebalanceerd voedingspatroon van de moeder. De positieve 
effecten van omega-3 vetzuren en flavanolen ondersteunen gezonde hersenen gedurende het 
hele leven en kunnen beschermen bieden tegen neurodegeneratie op latere leeftijd. Hoewel 
cholesterol essentieel is voor membraansynthese en de vorming van galzuren en steroïde 
hormonen, biedt een vetrijk dieet geen ondersteuning voor een gezonde veroudering van de 
hersenen. De belangrijkste boodschap van dit proefschrift voor het ontwikkelen en behouden 
van een gezond brein is het vinden van de juiste balans in voedingsstoffen zoals omega-3 
vetzuren, flavanolen en cholesterol.
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List of abbreviations
1H MRS    proton MR spectroscopy
31P MRS    phosphorus MR spectroscopy
5-LOX    5-lipoxygenase
Aβ    β-amyloid
AD    Alzheimer’s disease
ADAS-cog   cognitive subscale of the Alzheimer’s disease assessment scale
ADHD    attention deficit hyperactivity disorder
adq    adequate
ADP    adenosine diphosphate
ALA    α-linolenic acid
AMI    acute myocardial infarction
APOE    apolipoprotein E
apple+GSE   apple + grape seed extract
ARA    arachidonic acid
ASL    arterial spin labeling 
ATP    adenosine triphosphate
AUC    auditory cortex
B12    vitamin B12
B6    vitamin B6
BBB    blood brain barrier
BDNF    brain-derived neurotrophic factor
BSID    Bayley Scales of Infant Development
CA1    cornu ammonis 1
CA3    cornu ammonis 3
cAMP    cyclic adenosine monophosphate
CBF    cerebral blood flow
CC    corpus callosum
CD36    cluster of differentiation 36
CD68    cluster of differentiation 68
CDP-choline   cytidine diphosphate choline
CDR    clinical dementia rating
CIBIC-plus   clinician’s interview-based impression of change scale which  
    included caregiver-supplied information
CK    choline kinase
COX    cyclooxygenase
CPT    1,2 diacylglycerol choline phosphotransferase
CREB    cAMP response element binding protein
CRLB    Cramér-Rao lower bounds
CT    cytidine triphosphate-phosphocholine cytidyl transferase
CTP    cytidine triphosphate
CTRL    control (standard rodent chow)
DAG    diacylglycerol
DAB-Ni    diaminobenzidine-nickel
DBS    deep brain stimulation
DCX    doublecortin
def    deficient
DEPC    diethylpyrocarbonate
DG    dentate gyrus
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DGLA    dihomo-γ-linolenic acid
DHA    docosahexaenoic acid
DHASCO    docosahexaenoic acid single cell oil
DMII    diabetes mellitus type 2
DTI    diffusion tensor imaging
EGCG    epigallocatechine gallate
ELISA    enzyme-linked immunosorbent assay
EPA    eicosapentaenoic acid
F    fornix
FA    fractional anisotropy
FADS    fatty acid desaturase
FAIR    flow-sensitive alternating inversion recovery
FAME    fatty acid methyl esters
FOV    field of view
GAPDH    glyceraldehyde 3-phosphate dehydrogenase
GD    gestational day
GDNF    glial cell-derived neurotrophic factor
GE    gradient echo
GLA    γ linolenic acid
Gln     glutamine
Glu    glutamate
Glu+Gln    glutamate + glutamine
GLUT-1    glucose transporter 1
GPC     glycerophosphocholine 
HC    hippocampus
HF    high-fat
Iba1    ionized calcium-binding adapter molecule 1
I-DOPA    I-dihydroxyphenylalanine
IL-1β    interleukin-1β
IL-6    interleukin-6
IML    inner molecular layer
IQ    intelligence quotient
LA    linoleic acid
LCPUFA    long-chain polyunsaturated fatty acids
LDL    low density lipoprotein
LT    leukotrienes
MC    motor cortex
MCI    mild cognitive impairment
MCP-1    monocyte chemoattractant protein-1
MD    mean diffusivity
MDI    mental development index
MetS    metabolic syndrome
mI     myo-Inositol 
mI+Gly    myo-Inositol + glycine
MMSE    mini-mental state examination
MPTP    1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
MR    magnetic resonance
MWM    Morris water maze
n-3 PUFA    omega-3 polyunsaturated fatty acids
n-6 PUFA    omega-6 polyunsaturated fatty acids
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n.a.    not applicable
NAA     N-acetylaspartate
NAAG    N-acetylaspartate + N-acetylaspartateglutamate
NPD1    neuroprotectin D1
NPI    neuropsychiatric inventory
NS    not significant
OML    outer molecular layer
OT    optic tract
p.p.    post-partum
PBS    phosphate buffered saline
PC    phosphatidylcholine
PCr    phosphocreatine
PD    Parkinson’s disease
PDE    phosphodiesters
PDI    psychomotor development index
PE    phosphatidylethanolamine
PF    paraformaldehyde
PG    prostaglandins
Pi    inorganic phosphate
PME    phosphomonoesters
PND    postnatal day
PPAR    peroxisome proliferator-activated receptor
PRESS    point-resolved spectroscopy sequence
PS    phosphatidylserine
PSD95    postsynaptic density 95
qRT-PCR    quantitative real-time polymerase chain reaction
RAR    retinoic acid receptor
RBANS    repeatable battery for the assessment of neuropsychological  
    status
rCBF    relative cerebral blood flow
rdbpc    randomized double blind placebo controlled
ROI    region of interest
ROS    reactive oxygen species
RT    room temperature
RXR    retinoid X receptor
SC    sensory cortex
SE-EPI    spin-echo planar imaging protocol
SEM    standard error of the mean
SEN    sensory cortex
SFA    saturated fatty acids
SIPBs    synaptophysin immunoreactive presynaptic boutons
SL    stratum lucidum
SNpc    substantia nigra pars compacta
SR    stratum radiatum
SSC    somatosensory cortex
Tau    taurine
TBHQ    tertiary butylhydroquinone
tCho    choline + glycerophosphocholine + phosphocholine
TE    echo time
TNF-α    tumor necrosis factor-α
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TR    repetition time
Trk B    tyrosine kinase B
TX    thromboxanes
UTP    uridine triphosphate
VC    visual cortex
VEGF    vascular endothelial growth factor
VEP    visual evoked potential
VIS    visual cortex
Vit free    vitamin free
VLDL    very low density lipoprotein
VOI    volume of interest       
WT    wild-type


147
Appendices
Dankwoord | Acknowledgements
Na bijna vijf jaar van experimenten, analyses en artikelen schrijven ligt hier dan eindelijk het 
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(en muizen!). Daarom maak ik van de gelegenheid gebruik om iedereen die heeft bijgedragen 
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Dr. Judith Homberg: beste Judith, jij bent ontzettend gedreven in je werk, iets wat erg aanstekelijk 
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Geachte leden van de manuscriptcommissie, prof. dr. Olde Rikkert, prof. dr. Lafeber en prof. dr. 
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Maartje, samen stonden we aan de wieg van de uitvoering van dit project. Met vallen en opstaan 
leerden we de fijne kneepjes van het fokken van muizen. We hebben aardig wat tijd in onze 
‘kraamkamer’ door mogen brengen. Ik kijk sindsdien dan ook nooit meer op dezelfde manier 
naar een roombroodje! ;-) We hebben samen veel beleefd en ook steun aan elkaar gehad, vaak 
letterlijk en figuurlijk, haha. Zonder jou had ik dit project nooit zo succesvol af kunnen ronden en 
daarom wil ik je ontzettend bedanken voor al je werk en onze leuke tijd samen! 
Jos, al vanaf het moment dat ik aan mijn stage bij Anatomie begon, sta jij klaar om hulp en 
ondersteuning te bieden bij het uitvoeren van kleuringen. Je denkt mee bij het opzetten 
van experimenten en komt met praktische oplossingen als het even niet lukt. Je blijft altijd 
bescheiden op de achtergrond, maar dat maakt je niet minder belangrijk in de groep. Bedankt 
voor de fijne samenwerking!
Diane, onze samenwerking begon toen jij mijn stagebegeleidster was en ik vond het erg fijn om 
later ook je collega te mogen worden. Zo heb ik de fijne kneepjes van het vak van jou mogen 
leren. Een experiment is niets zonder goede voorbereiding, bedankt voor al je hulp! In onze tijd 
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Valerio, first of all thank you for all the imaging lessons throughout the years (and especially for 
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my data. Besides from helping me out with imaging, I would like to thank you for your ability to 
remain calm in times when I was totally stressing out. Your relaxed attitude prevented me from 
several meltdowns.
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Ilse, samen met die andere twee musketiers begon je aan je stage en daar begon ook onze 
samenwerking. Toen je aan je eigen promotie begon werden we kamergenootjes. Je staat altijd 
klaar om een helpende hand te bieden bij het opzetten en uitvoeren van experimenten. Ik heb 
erg veel bewondering voor jouw doorzettingsvermogen en veerkracht. Samen konden we 
uitgebreid kletsen over een breed spectrum aan onderwerpen, zowel wat betreft werk als privé. 
Jij weet in elke situatie de juiste snaar te raken. Lieve Ilse, heel erg bedankt dat je ook vandaag 
weer een helpende hand biedt en mijn paranimf wilt zijn!
Max, Herr Wiesmann, jouw enthousiasme voor onderzoek is ontzettend aanstekelijk, en ik wil 
je bedanken voor je hulpvaardigheid en niet te vergeten vindingrijkheid. Ook ben je werkzaam 
als DJ van de oio-kamer. Je hebt voor elke situatie een playlist klaar staan en weet daar een 
geheel eigen wending aan te geven. Het is alleen jammer dat je niet altijd naar verzoeknummers 
luistert... Zielig? Wiesmann vindt van niet. :-P
Rick, in 2013 kwam jij de oio-kamer versterken. Na verloop van tijd bleek je onze eigen 
wandelende zoekmachine te zijn en de term ‘Rickipedia’ werd geïntroduceerd. Bedankt voor de 
gezellige tijd en veel succes in ut stedje van lol en plezeer!
Tim, you’ve made it! Eindelijk sta je dan in mijn acknowledgements! :-) Ook jij begon in onze groep 
als student en bent nu aan je eigen promotie begonnen. Je bent een gezellige en waardevolle 
toevoeging aan de oio-kamer. En niet alleen vanwege al je ‘nieuwsgroepen’, Adobe-lesjes en GoT!
Bram, jij kwam de afdeling versterken als analist, maar ook als onze ICT-man (tegen wil en dank?). 
Jouw no-nonsense instelling en efficiëntie zijn een onmisbare toevoeging aan het onderzoek op 
de afdeling. Ook helpen die twee kwaliteiten ontzettend om wat orde in het oio-kippenhok te 
brengen!
Prof. dr. Dirk Ruiter: beste Dirk, bedankt voor de begeleiding aan het begin van mijn 
promotietraject. Ik ben erg blij dat je vandaag als fungerend rector bij mijn verdediging aanwezig 
bent.
Daarnaast wil ik natuurlijk iedereen van de afdeling Anatomie bedanken voor een leuke tijd en 
alle gesprekken in de koffiepauze over de zin en onzin van het leven.
Van de afdeling Radiologie wil ik Andor en Sjaak bedanken voor hun hulp en ondersteuning bij 
het uitvoeren en analyseren van de MR experimenten. Ook wil ik een paar mensen in PRIME en 
het CDL bedanken. Met name Janneke, Karin, Henk, Bianca en Nicole: bedankt voor de goede 
zorg voor mijn muizen! Ik heb ontzettend fijn met jullie samengewerkt. Jullie stonden altijd klaar 
om mee te helpen bij het opzetten en uitvoeren van de dierstudies. Voor mij zijn jullie dan ook 
het bewijs dat je van een proefdierexperiment alleen een succes kunt maken als je het belang 
van de dieren voorop stelt.
I would like to thank a few people at Mead Johnson Pediatric Nutrition Institute with whom I 
worked closely during my PhD project. Brian, Gabriele, Zeina and Ric, thank you for your input 
in our experiments. Your valuable ideas and comments have been a great contribution to our 
work. It has been a pleasure working with you! Special thanks to you Brian, for taking place in 
the corona today.
Monique, bedankt voor de prettige samenwerking bij de experimenten met de ApoE muizen. Ik 
vind het dan ook erg fijn dat je vandaag onderdeel van de corona bent.
Studenten zijn ontzettend belangrijk bij de uitvoering van onze uitgebreide experimenten. Hierbij 
wil ik mijn voormalige studenten bedanken: Sarita, Elina, Bas, Maarten, Liën, Inge, Annelies, Julle, 
Claudia en Mieke, zonder jullie had ik dit boekje niet kunnen voltooien. Jullie hebben allemaal 
je eigen inbreng in de experimenten gehad. Ik vond het erg leuk om jullie stages te begeleiden!
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Echte vrienden heb je niet voor even, die heb je voor het leven. 
Lieve Joke, al sinds de brugklas zijn we vriendinnen door dik en dun. In onze studententijd werden 
we ook nog eens huisgenootjes. Na deze tijd in Nijmegen zijn we ieder een andere (onderzoeks)
richting op gegaan, maar we zijn elkaar nooit uit het oog verloren. Ik kan altijd op je bouwen, 
in goede en in slechte tijden. Als het allemaal even niet mee zat, kon ik bij jou terecht voor een 
kop thee en een luisterend oor. Maar gelukkig maken we ook een heleboel leuke dingen mee 
en liggen we samen in een deuk om de meest onbenullige dingen. Nadat ik vorig jaar aan jouw 
zijde mocht staan als paranimf zijn de rollen dit keer omgedraaid. Bedankt dat je de lat zo hoog 
hebt gelegd, dr. Konings… ;-) Ik ben erg blij dat je ook vandaag weer mijn steunpilaar wilt zijn!
Ingrid, al sinds de middelbare school zijn we bevriend met elkaar. De laatste jaren met een flinke 
geografische afstand, maar zelfs als we elkaar pas na een paar maanden weer spreken, pikken we 
de draad zo op waar we de vorige keer zijn gebleven. 
En daar is dan mijn BMW-clubje! Het is alweer ruim 11 jaar geleden dat we bevriend raakten in 
ons eerste jaar Biomedische Wetenschappen. Hoewel er bij BMW slechts 3 van ons overbleven, 
bleef de vriendschap bestaan. We delen lief en leed met elkaar en het is elke keer weer gezellig 
als we elkaar zien. Hierbij wil ik jullie één voor één bedanken. Dat er nog vele BMW-uitjes mogen 
volgen!
Anouk, samen met Floor waren we de die-hard BMW-ers. Na flink zwoegen en gedeelde 
frustraties, volg ik nu je voorbeeld en ben ik ook aan de beurt om mijn proefschrift te verdedigen. 
Regelmatig verzorgde je een BBQ in het zonnige zuiden om even bij te komen en bij te kletsen. 
Tevens zorg je op zijn tijd voor een vitamine-boost uit Tims groentetuin (zelfs die enorme 
pompoen ging gelukkig toch op!).
Frances, na het eerste jaar BMW ben je naar Utrecht gegaan om diergeneeskunde te studeren, 
maar dat betekende niet dat we elkaar uit het oog verloren. Inmiddels ben jij alsnog een 
promotietraject gestart en ik kijk met spanning uit naar jouw boekje (doe rustig aan, je hebt 
nog even). Je weet precies op de juiste momenten een hart onder de riem te steken. Dankjewel 
daarvoor!
Floor, de andere die-hard BMW-er. Ook jij zat in een promotietraject en wist daarom als geen 
ander van de struikelblokken waar we samen tegenaan liepen. Ik kan nog altijd veel leren 
van jouw positieve instelling en jij hebt ook al zo’n goed voorbeeld neergezet met je eigen 
verdediging. PS: het is weer hoog tijd voor sushi!
Lian, jij maakt het BMW-clubje compleet. Jij maakte de overstap naar geneeskunde en zorgt 
voor een verfrissende blik in een vriendengroep vol promovendi. Jarenlang waren we niet alleen 
vriendinnen, maar ook huisgenootjes. Daar begon ook de filmavond. Ook al zijn we inmiddels 
geen huisgenootjes meer, de filmavond met pizza helpt nog altijd om te ontspannen en gezellig 
bij te kletsen.
Natuurlijk mag ik mijn familie niet vergeten. Allererst soll ich mich jetzt schon entschuldigen 
an die Wedershovens. Leider wird das Thema meiner Doktorarbeit für euch noch immer nicht 
ganz klar werden weil meine Präsentation auf Niederländisch ist. Aber für ‘ne Party ist Sprache 
überhaupt keine Barriere, oder? Das versteht ihr als die Besten! ;-) 
Na jaren van vage verhalen over voeding en muizen hoop ik vandaag wat duidelijkheid te 
scheppen. Eindelijk kan ik jullie laten zien wat ik nu in hemelsnaam heb uitgevreten de afgelopen 
jaren. Ik hoop dat jullie er allemaal bij kunnen zijn om na mijn verdediging een feestje te vieren! 
Oma, ugge mondharmonica meug thoes blieve huer! Veur de muziek wuert al gezurg. :-)
Ik wil ook even stilstaan bij mijn familieleden die er vandaag helaas niet meer bij kunnen zijn. 
Mijn lieve opa’s en oma, al van kleins af aan lieten jullie me merken dat jullie trots op me waren. Ik 
weet zeker dat jullie dat vandaag ook zouden zijn. Brigitte en Frits, mijn lieve tante en peetoom, 
jullie hadden als geen ander van dit feestje genoten. Ik denk nog vaak aan het compliment van 
Frits bij mijn afstuderen. Het was er eentje zoals alleen hij dat kon: “Wat busse toch un sjlum wief!” 
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Dan ben ik nu eindelijk aangekomen bij degenen aan wie ik dit proefschrift heb opgedragen, 
mijn lieve ouders! Pap en mam, ich wil ug hieël erg bedanke veur alle steun daet ge mich door de 
jaore haer gebaoje heb. Al van kleins af aan heb ge mich gelierd um altied ut beste oet michzelf 
te haole en door te zetten tot ich mien doel bereik had. Nag altied kin ich beej ug terech um 
efkes beej te komme van alle rompslomp. Zonger uch zoel ich heej vandaag neet staon en ich 
haop dan auch det ge vandaag gruuëts op mich kint zien. Dit bukske is beej lange nao neet diek 
genóg um mienen dank voloet onger weurt te bringe... Daorum haaj ich ut simpel: Bedangk 
veur alles!!!
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toxicologie en geneesmiddelenonderzoek. 
Tijdens haar eerste masterstage onderzocht zij de potentie van atorvastatine om ischemie-
reperfusieschade te voorkomen in gezonde vrijwilligers (onder begeleiding van dr. C.W. 
Wouters en prof. dr. G.A. Rongen, afdeling Farmacologie-Toxicologie, Radboudumc, Nijmegen). 
Gedurende haar opleiding werd tevens haar interesse voor proefdieronderzoek gewekt. Dit 
kwam goed van pas in haar tweede masterstage, waarin zij het effect van met DHA-verrijkte 
diëten op neurodegeneratie in een muismodel voor de ziekte van Alzheimer onderzocht (onder 
begeleiding van dr. D. Jansen, dr. V. Zerbi en dr. A.J. Kiliaan, afdeling Anatomie, Radboudumc, 
Nijmegen).
In januari 2010 begon Carola aan haar promotie-onderzoek op de afdeling Anatomie van 
het Radboudumc in Nijmegen onder begeleiding van copromotoren dr. A.J. Kiliaan (afdeling 
Anatomie) en dr. J.R. Homberg (afdeling Cognitive Neuroscience) en promotoren prof. dr. 
L.T. Kozicz (afdeling Anatomie) en prof. dr. A. Heerschap (afdeling Radiologie). Tijdens haar 
promotie, beschreven in dit proefschrift, begeleidde zij een tiental studenten gedurende hun 
stages. Tevens presenteerde zij haar bevindingen op verschillende nationale en internationale 
bijeenkomsten, in de vorm van posters en mondelinge presentaties. Op basis van haar CV en 
resultaten won Carola in 2014 een travel grant op het FENS Forum of Neuroscience. Sinds maart 
2015 is zij werkzaam als Consultant Life Sciences bij Hezelburcht B.V. in Nijmegen.
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